id	sid	tid	token	lemma	pos
ct-9353	1	1	introduction	introduction	NOUN
ct-9353	1	2	many	many	ADJ
ct-9353	1	3	progestins	progestin	NOUN
ct-9353	1	4	have	have	AUX
ct-9353	1	5	been	be	AUX
ct-9353	1	6	investigated	investigate	VERB
ct-9353	1	7	in	in	ADP
ct-9353	1	8	equine	equine	NOUN
ct-9353	1	9	veterinary	veterinary	ADJ
ct-9353	1	10	medicine	medicine	NOUN
ct-9353	1	11	,	,	PUNCT
ct-9353	1	12	including	include	VERB
ct-9353	1	13	medroxyprogesterone	medroxyprogesterone	NOUN
ct-9353	1	14	acetate	acetate	NOUN
ct-9353	1	15	,	,	PUNCT
ct-9353	1	16	hydroxyprogesterone	hydroxyprogesterone	NOUN
ct-9353	1	17	hexanoate	hexanoate	NOUN
ct-9353	1	18	,	,	PUNCT
ct-9353	1	19	norgestomet	norgestomet	ADJ
ct-9353	1	20	,	,	PUNCT
ct-9353	1	21	megesteral	megesteral	ADJ
ct-9353	1	22	acetate	acetate	NOUN
ct-9353	1	23	,	,	PUNCT
ct-9353	1	24	melengestrol	melengestrol	NOUN
ct-9353	1	25	acetate	acetate	NOUN
ct-9353	1	26	,	,	PUNCT
ct-9353	1	27	and	and	CCONJ
ct-9353	1	28	proligestone	proligestone	NOUN
ct-9353	1	29	(	(	PUNCT
ct-9353	1	30	table	table	NOUN
ct-9353	1	31	)	)	PUNCT
ct-9353	1	32	.	.	PUNCT
ct-9353	2	1	several	several	ADJ
ct-9353	2	2	studies1	studies1	NOUN
ct-9353	2	3	-	-	SYM
ct-9353	2	4	5	5	NUM
ct-9353	2	5	investigated	investigate	VERB
ct-9353	2	6	the	the	DET
ct-9353	2	7	progestogenic	progestogenic	ADJ
ct-9353	2	8	efficacy	efficacy	NOUN
ct-9353	2	9	of	of	ADP
ct-9353	2	10	these	these	DET
ct-9353	2	11	progestins	progestin	NOUN
ct-9353	2	12	and	and	CCONJ
ct-9353	2	13	determined	determine	VERB
ct-9353	2	14	only	only	ADV
ct-9353	2	15	altrenogest	altrenog	ADJ
ct-9353	2	16	to	to	PART
ct-9353	2	17	be	be	AUX
ct-9353	2	18	effective	effective	ADJ
ct-9353	2	19	.	.	PUNCT
ct-9353	3	1	altrenogest	altrenogest	PROPN
ct-9353	3	2	maintained	maintain	VERB
ct-9353	3	3	pregnancy	pregnancy	NOUN
ct-9353	3	4	after	after	ADP
ct-9353	3	5	a	a	DET
ct-9353	3	6	luteolytic	luteolytic	ADJ
ct-9353	3	7	dose	dose	NOUN
ct-9353	3	8	of	of	ADP
ct-9353	3	9	prostaglandin	prostaglandin	PROPN
ct-9353	3	10	f2α	f2α	PROPN
ct-9353	3	11	(	(	PUNCT
ct-9353	3	12	pgf2α	pgf2α	PROPN
ct-9353	3	13	)	)	PUNCT
ct-9353	3	14	,	,	PUNCT
ct-9353	3	15	whereas	whereas	SCONJ
ct-9353	3	16	medroxyprogesterone	medroxyprogesterone	NOUN
ct-9353	3	17	acetate	acetate	NOUN
ct-9353	3	18	(	(	PUNCT
ct-9353	3	19	mpa	mpa	PROPN
ct-9353	3	20	)	)	PUNCT
ct-9353	3	21	,	,	PUNCT
ct-9353	3	22	hydroxyprogesterone	hydroxyprogesterone	PROPN
ct-9353	3	23	hexanoate	hexanoate	NOUN
ct-9353	3	24	,	,	PUNCT
ct-9353	3	25	norgestomet	norgestomet	NOUN
ct-9353	3	26	,	,	PUNCT
ct-9353	3	27	and	and	CCONJ
ct-9353	3	28	megesteral	megesteral	ADJ
ct-9353	3	29	acetate	acetate	NOUN
ct-9353	3	30	treatment	treatment	NOUN
ct-9353	3	31	were	be	AUX
ct-9353	3	32	unable	unable	ADJ
ct-9353	3	33	to	to	PART
ct-9353	3	34	prevent	prevent	VERB
ct-9353	3	35	abortion.1	abortion.1	PROPN
ct-9353	3	36	furthermore	furthermore	ADV
ct-9353	3	37	,	,	PUNCT
ct-9353	3	38	the	the	DET
ct-9353	3	39	ability	ability	NOUN
ct-9353	3	40	of	of	ADP
ct-9353	3	41	proligestone	proligestone	NOUN
ct-9353	3	42	,	,	PUNCT
ct-9353	3	43	mpa	mpa	PROPN
ct-9353	3	44	,	,	PUNCT
ct-9353	3	45	and	and	CCONJ
ct-9353	3	46	melengestrol	melengestrol	PROPN
ct-9353	3	47	acetate	acetate	NOUN
ct-9353	3	48	to	to	PART
ct-9353	3	49	bring	bring	VERB
ct-9353	3	50	mares	mare	NOUN
ct-9353	3	51	out	out	ADP
ct-9353	3	52	of	of	ADP
ct-9353	3	53	seasonal	seasonal	ADJ
ct-9353	3	54	transition	transition	NOUN
ct-9353	3	55	was	be	AUX
ct-9353	3	56	not	not	PART
ct-9353	3	57	consistent.2	consistent.2	ADJ
ct-9353	3	58	-	-	X
ct-9353	3	59	4	4	NUM
ct-9353	3	60	in	in	ADP
ct-9353	3	61	contrast	contrast	NOUN
ct-9353	3	62	,	,	PUNCT
ct-9353	3	63	both	both	PRON
ct-9353	3	64	progesterone	progesterone	NOUN
ct-9353	3	65	in	in	ADP
ct-9353	3	66	oil2	oil2	PROPN
ct-9353	3	67	and	and	CCONJ
ct-9353	3	68	altrenogest5	altrenogest5	PROPN
ct-9353	3	69	effectively	effectively	ADV
ct-9353	3	70	hastened	hasten	VERB
ct-9353	3	71	estrus	estrus	NOUN
ct-9353	3	72	and	and	CCONJ
ct-9353	3	73	conception	conception	NOUN
ct-9353	3	74	in	in	ADP
ct-9353	3	75	both	both	CCONJ
ct-9353	3	76	early	early	ADJ
ct-9353	3	77	and	and	CCONJ
ct-9353	3	78	late	late	ADV
ct-9353	3	79	seasonally	seasonally	ADV
ct-9353	3	80	transitional	transitional	ADJ
ct-9353	3	81	mares	mare	NOUN
ct-9353	3	82	.	.	PUNCT
ct-9353	4	1	therefore	therefore	ADV
ct-9353	4	2	,	,	PUNCT
ct-9353	4	3	this	this	DET
ct-9353	4	4	review	review	NOUN
ct-9353	4	5	will	will	AUX
ct-9353	4	6	focus	focus	VERB
ct-9353	4	7	on	on	ADP
ct-9353	4	8	altrenogest	altrenogest	ADV
ct-9353	4	9	,	,	PUNCT
ct-9353	4	10	with	with	ADP
ct-9353	4	11	minimal	minimal	ADJ
ct-9353	4	12	inferences	inference	NOUN
ct-9353	4	13	to	to	ADP
ct-9353	4	14	other	other	ADJ
ct-9353	4	15	progestins	progestin	NOUN
ct-9353	4	16	.	.	PUNCT
ct-9353	5	1	pharmacokinetics	pharmacokinetic	NOUN
ct-9353	5	2	of	of	ADP
ct-9353	5	3	altrenogest	altrenog	ADJ
ct-9353	5	4	altrenogest	altrenog	ADJ
ct-9353	5	5	(	(	PUNCT
ct-9353	5	6	17α	17α	ADV
ct-9353	5	7	-	-	PUNCT
ct-9353	5	8	allyl-17β	allyl-17β	PROPN
ct-9353	5	9	-	-	PUNCT
ct-9353	5	10	hydroxy	hydroxy	VERB
ct-9353	5	11	-	-	PUNCT
ct-9353	5	12	estra-4	estra-4	NOUN
ct-9353	5	13	,	,	PUNCT
ct-9353	5	14	9	9	NUM
ct-9353	5	15	,	,	PUNCT
ct-9353	5	16	11	11	NUM
ct-9353	5	17	-	-	PUNCT
ct-9353	5	18	trien-3	trien-3	NUM
ct-9353	5	19	-	-	PUNCT
ct-9353	5	20	one	one	NUM
ct-9353	5	21	)	)	PUNCT
ct-9353	5	22	is	be	AUX
ct-9353	5	23	also	also	ADV
ct-9353	5	24	known	know	VERB
ct-9353	5	25	as	as	ADP
ct-9353	5	26	allyltrenbolone	allyltrenbolone	ADJ
ct-9353	5	27	.	.	PUNCT
ct-9353	6	1	although	although	SCONJ
ct-9353	6	2	classified	classify	VERB
ct-9353	6	3	as	as	ADP
ct-9353	6	4	a	a	DET
ct-9353	6	5	progestin	progestin	NOUN
ct-9353	6	6	,	,	PUNCT
ct-9353	6	7	altrenogest	altrenog	ADJ
ct-9353	6	8	structurally	structurally	ADV
ct-9353	6	9	resembles	resemble	VERB
ct-9353	6	10	androgens	androgen	NOUN
ct-9353	6	11	and	and	CCONJ
ct-9353	6	12	binds	bind	VERB
ct-9353	6	13	to	to	ADP
ct-9353	6	14	the	the	DET
ct-9353	6	15	androgen	androgen	NOUN
ct-9353	6	16	receptor	receptor	NOUN
ct-9353	6	17	with	with	ADP
ct-9353	6	18	75	75	NUM
ct-9353	6	19	%	%	NOUN
ct-9353	6	20	affinity	affinity	NOUN
ct-9353	6	21	of	of	ADP
ct-9353	6	22	dihydrotestosterone,6	dihydrotestosterone,6	NOUN
ct-9353	6	23	although	although	SCONJ
ct-9353	6	24	minimal	minimal	ADJ
ct-9353	6	25	anabolic	anabolic	NOUN
ct-9353	6	26	effects	effect	NOUN
ct-9353	6	27	have	have	AUX
ct-9353	6	28	been	be	AUX
ct-9353	6	29	noted	note	VERB
ct-9353	6	30	,	,	PUNCT
ct-9353	6	31	including	include	VERB
ct-9353	6	32	no	no	DET
ct-9353	6	33	increase	increase	NOUN
ct-9353	6	34	in	in	ADP
ct-9353	6	35	body	body	NOUN
ct-9353	6	36	mass	mass	NOUN
ct-9353	6	37	in	in	ADP
ct-9353	6	38	either	either	CCONJ
ct-9353	6	39	intact	intact	ADJ
ct-9353	6	40	stallions	stallion	NOUN
ct-9353	6	41	or	or	CCONJ
ct-9353	6	42	mares.7	mares.7	NOUN
ct-9353	6	43	however	however	ADV
ct-9353	6	44	,	,	PUNCT
ct-9353	6	45	mares	mare	NOUN
ct-9353	6	46	treated	treat	VERB
ct-9353	6	47	with	with	ADP
ct-9353	6	48	altrenogest	altrenogest	NOUN
ct-9353	6	49	in	in	ADP
ct-9353	6	50	late	late	ADJ
ct-9353	6	51	pregnancy	pregnancy	NOUN
ct-9353	6	52	had	have	VERB
ct-9353	6	53	fillies	filly	NOUN
ct-9353	6	54	born	bear	VERB
ct-9353	6	55	with	with	ADP
ct-9353	6	56	an	an	DET
ct-9353	6	57	enlarged	enlarged	ADJ
ct-9353	6	58	clitoris	clitoris	NOUN
ct-9353	6	59	(	(	PUNCT
ct-9353	6	60	figure	figure	NOUN
ct-9353	6	61	1).8	1).8	NUM
ct-9353	6	62	trace	trace	NOUN
ct-9353	6	63	concentrations	concentration	NOUN
ct-9353	6	64	of	of	ADP
ct-9353	6	65	androgen	androgen	NOUN
ct-9353	6	66	and	and	CCONJ
ct-9353	6	67	anabolic	anabolic	NOUN
ct-9353	6	68	steroid	steroid	NOUN
ct-9353	6	69	trenbolone	trenbolone	NOUN
ct-9353	6	70	were	be	AUX
ct-9353	6	71	noted	note	VERB
ct-9353	6	72	in	in	ADP
ct-9353	6	73	horses	horse	NOUN
ct-9353	6	74	receiving	receive	VERB
ct-9353	6	75	altrenogest	altrenogest	NOUN
ct-9353	6	76	,	,	PUNCT
ct-9353	6	77	leading	lead	VERB
ct-9353	6	78	to	to	ADP
ct-9353	6	79	restrictions	restriction	NOUN
ct-9353	6	80	of	of	ADP
ct-9353	6	81	its	its	PRON
ct-9353	6	82	use	use	NOUN
ct-9353	6	83	in	in	ADP
ct-9353	6	84	many	many	ADJ
ct-9353	6	85	equine	equine	NOUN
ct-9353	6	86	organizations	organization	NOUN
ct-9353	6	87	,	,	PUNCT
ct-9353	6	88	including	include	VERB
ct-9353	6	89	irish	irish	PROPN
ct-9353	6	90	horseracing	horseracing	PROPN
ct-9353	6	91	regulatory	regulatory	PROPN
ct-9353	6	92	board	board	NOUN
ct-9353	6	93	,	,	PUNCT
ct-9353	6	94	british	british	PROPN
ct-9353	6	95	horseracing	horseracing	PROPN
ct-9353	6	96	association	association	PROPN
ct-9353	6	97	,	,	PUNCT
ct-9353	6	98	australian	australian	ADJ
ct-9353	6	99	progestin	progestin	NOUN
ct-9353	6	100	use	use	VERB
ct-9353	6	101	in	in	ADP
ct-9353	6	102	mares	mare	NOUN
ct-9353	6	103	carleigh	carleigh	PROPN
ct-9353	6	104	fedorka	fedorka	PROPN
ct-9353	6	105	department	department	PROPN
ct-9353	6	106	of	of	ADP
ct-9353	6	107	veterinary	veterinary	ADJ
ct-9353	6	108	science	science	NOUN
ct-9353	6	109	,	,	PUNCT
ct-9353	6	110	university	university	NOUN
ct-9353	6	111	of	of	ADP
ct-9353	6	112	kentucky	kentucky	PROPN
ct-9353	6	113	,	,	PUNCT
ct-9353	6	114	lexington	lexington	PROPN
ct-9353	6	115	,	,	PUNCT
ct-9353	6	116	ky	ky	PROPN
ct-9353	6	117	abstract	abstract	ADJ
ct-9353	6	118	progesterone	progesterone	NOUN
ct-9353	6	119	is	be	AUX
ct-9353	6	120	in	in	ADP
ct-9353	6	121	constant	constant	ADJ
ct-9353	6	122	fluctuation	fluctuation	NOUN
ct-9353	6	123	throughout	throughout	ADP
ct-9353	6	124	the	the	DET
ct-9353	6	125	lifespan	lifespan	NOUN
ct-9353	6	126	of	of	ADP
ct-9353	6	127	the	the	DET
ct-9353	6	128	horse	horse	NOUN
ct-9353	6	129	.	.	PUNCT
ct-9353	7	1	as	as	ADP
ct-9353	7	2	a	a	DET
ct-9353	7	3	key	key	ADJ
ct-9353	7	4	regulator	regulator	NOUN
ct-9353	7	5	of	of	ADP
ct-9353	7	6	the	the	DET
ct-9353	7	7	hypothalamic	hypothalamic	ADJ
ct-9353	7	8	-	-	PUNCT
ct-9353	7	9	pituitary	pituitary	ADJ
ct-9353	7	10	-	-	PUNCT
ct-9353	7	11	gonadal	gonadal	NOUN
ct-9353	7	12	axis	axis	NOUN
ct-9353	7	13	,	,	PUNCT
ct-9353	7	14	progesterone	progesterone	NOUN
ct-9353	7	15	is	be	AUX
ct-9353	7	16	involved	involve	VERB
ct-9353	7	17	in	in	ADP
ct-9353	7	18	numerous	numerous	ADJ
ct-9353	7	19	aspects	aspect	NOUN
ct-9353	7	20	of	of	ADP
ct-9353	7	21	reproduction	reproduction	NOUN
ct-9353	7	22	.	.	PUNCT
ct-9353	8	1	synthetic	synthetic	ADJ
ct-9353	8	2	analogs	analog	NOUN
ct-9353	8	3	of	of	ADP
ct-9353	8	4	progesterone	progesterone	NOUN
ct-9353	8	5	,	,	PUNCT
ct-9353	8	6	deemed	deem	VERB
ct-9353	8	7	progestins	progestin	NOUN
ct-9353	8	8	,	,	PUNCT
ct-9353	8	9	are	be	AUX
ct-9353	8	10	widely	widely	ADV
ct-9353	8	11	available	available	ADJ
ct-9353	8	12	to	to	ADP
ct-9353	8	13	industry	industry	NOUN
ct-9353	8	14	to	to	PART
ct-9353	8	15	act	act	VERB
ct-9353	8	16	as	as	ADP
ct-9353	8	17	progestogenic	progestogenic	ADJ
ct-9353	8	18	within	within	ADP
ct-9353	8	19	the	the	DET
ct-9353	8	20	reproductive	reproductive	ADJ
ct-9353	8	21	tract	tract	NOUN
ct-9353	8	22	,	,	PUNCT
ct-9353	8	23	although	although	SCONJ
ct-9353	8	24	few	few	ADJ
ct-9353	8	25	are	be	AUX
ct-9353	8	26	bioactive	bioactive	ADJ
ct-9353	8	27	in	in	ADP
ct-9353	8	28	the	the	DET
ct-9353	8	29	horse	horse	NOUN
ct-9353	8	30	.	.	PUNCT
ct-9353	9	1	utilized	utilize	VERB
ct-9353	9	2	to	to	PART
ct-9353	9	3	suppress	suppress	VERB
ct-9353	9	4	estrous	estrous	ADJ
ct-9353	9	5	,	,	PUNCT
ct-9353	9	6	delay	delay	NOUN
ct-9353	9	7	ovulation	ovulation	NOUN
ct-9353	9	8	,	,	PUNCT
ct-9353	9	9	maintain	maintain	VERB
ct-9353	9	10	pregnancy	pregnancy	NOUN
ct-9353	9	11	,	,	PUNCT
ct-9353	9	12	and	and	CCONJ
ct-9353	9	13	for	for	ADP
ct-9353	9	14	behavioral	behavioral	ADJ
ct-9353	9	15	modifications	modification	NOUN
ct-9353	9	16	,	,	PUNCT
ct-9353	9	17	progestins	progestin	NOUN
ct-9353	9	18	are	be	AUX
ct-9353	9	19	one	one	NUM
ct-9353	9	20	of	of	ADP
ct-9353	9	21	the	the	DET
ct-9353	9	22	most	most	ADV
ct-9353	9	23	common	common	ADJ
ct-9353	9	24	class	class	NOUN
ct-9353	9	25	of	of	ADP
ct-9353	9	26	pharmaceuticals	pharmaceutical	NOUN
ct-9353	9	27	in	in	ADP
ct-9353	9	28	veterinary	veterinary	ADJ
ct-9353	9	29	medicine	medicine	NOUN
ct-9353	9	30	.	.	PUNCT
ct-9353	10	1	in	in	ADP
ct-9353	10	2	this	this	DET
ct-9353	10	3	review	review	NOUN
ct-9353	10	4	,	,	PUNCT
ct-9353	10	5	we	we	PRON
ct-9353	10	6	discuss	discuss	VERB
ct-9353	10	7	the	the	DET
ct-9353	10	8	progestins	progestin	NOUN
ct-9353	10	9	available	available	ADJ
ct-9353	10	10	to	to	PART
ct-9353	10	11	equine	equine	NOUN
ct-9353	10	12	industry	industry	NOUN
ct-9353	10	13	,	,	PUNCT
ct-9353	10	14	their	their	PRON
ct-9353	10	15	efficacy	efficacy	NOUN
ct-9353	10	16	,	,	PUNCT
ct-9353	10	17	pharmacokinetics	pharmacokinetic	NOUN
ct-9353	10	18	,	,	PUNCT
ct-9353	10	19	and	and	CCONJ
ct-9353	10	20	potential	potential	ADJ
ct-9353	10	21	side	side	NOUN
ct-9353	10	22	effects	effect	NOUN
ct-9353	10	23	following	follow	VERB
ct-9353	10	24	treatment	treatment	NOUN
ct-9353	10	25	.	.	PUNCT
ct-9353	11	1	keywords	keyword	NOUN
ct-9353	11	2	:	:	PUNCT
ct-9353	11	3	progestin	progestin	NOUN
ct-9353	11	4	,	,	PUNCT
ct-9353	11	5	estrus	estrus	NOUN
ct-9353	11	6	synchronization	synchronization	NOUN
ct-9353	11	7	,	,	PUNCT
ct-9353	11	8	delay	delay	NOUN
ct-9353	11	9	of	of	ADP
ct-9353	11	10	ovulation	ovulation	NOUN
ct-9353	11	11	,	,	PUNCT
ct-9353	11	12	pregnancy	pregnancy	NOUN
ct-9353	11	13	maintenance	maintenance	NOUN
ct-9353	11	14	racing	racing	NOUN
ct-9353	11	15	board	board	NOUN
ct-9353	11	16	,	,	PUNCT
ct-9353	11	17	and	and	CCONJ
ct-9353	11	18	federation	federation	PROPN
ct-9353	11	19	equestre	equestre	PROPN
ct-9353	11	20	internationale	internationale	PROPN
ct-9353	11	21	.	.	PUNCT
ct-9353	12	1	to	to	PART
ct-9353	12	2	predict	predict	VERB
ct-9353	12	3	withdrawal	withdrawal	NOUN
ct-9353	12	4	times	time	NOUN
ct-9353	12	5	for	for	ADP
ct-9353	12	6	altrenogest	altrenog	ADJ
ct-9353	12	7	,	,	PUNCT
ct-9353	12	8	its	its	PRON
ct-9353	12	9	pharmacokinetics	pharmacokinetic	NOUN
ct-9353	12	10	were	be	AUX
ct-9353	12	11	determined	determine	VERB
ct-9353	12	12	after	after	ADP
ct-9353	12	13	oral	oral	ADJ
ct-9353	12	14	,	,	PUNCT
ct-9353	12	15	injectable	injectable	ADJ
ct-9353	12	16	,	,	PUNCT
ct-9353	12	17	and	and	CCONJ
ct-9353	12	18	rectal	rectal	ADJ
ct-9353	12	19	treatments	treatment	NOUN
ct-9353	12	20	.	.	PUNCT
ct-9353	13	1	figure	figure	NOUN
ct-9353	13	2	1	1	NUM
ct-9353	13	3	.	.	PUNCT
ct-9353	13	4	anabolic	anabolic	NOUN
ct-9353	13	5	effects	effect	NOUN
ct-9353	13	6	(	(	PUNCT
ct-9353	13	7	enlarged	enlarge	VERB
ct-9353	13	8	clitoris	clitoris	NOUN
ct-9353	13	9	)	)	PUNCT
ct-9353	13	10	of	of	ADP
ct-9353	13	11	altrenogest	altrenog	ADJ
ct-9353	13	12	treatment	treatment	NOUN
ct-9353	13	13	during	during	ADP
ct-9353	13	14	late	late	ADJ
ct-9353	13	15	pregnancy	pregnancy	NOUN
ct-9353	13	16	clinical	clinical	ADJ
ct-9353	13	17	theriogenology	theriogenology	NOUN
ct-9353	13	18	2021	2021	NUM
ct-9353	13	19	;	;	PUNCT
ct-9353	13	20	13	13	NUM
ct-9353	13	21	:	:	SYM
ct-9353	13	22	247	247	NUM
ct-9353	13	23	adult	adult	NOUN
ct-9353	13	24	mares	mare	NOUN
ct-9353	13	25	(	(	PUNCT
ct-9353	13	26	n	n	NOUN
ct-9353	13	27	=	=	SYM
ct-9353	13	28	10	10	NUM
ct-9353	13	29	)	)	PUNCT
ct-9353	13	30	were	be	AUX
ct-9353	13	31	treated	treat	VERB
ct-9353	13	32	with	with	ADP
ct-9353	13	33	oral	oral	ADJ
ct-9353	13	34	altrenogest	altrenogest	NOUN
ct-9353	13	35	(	(	PUNCT
ct-9353	13	36	0.044	0.044	NUM
ct-9353	13	37	mg	mg	PROPN
ct-9353	13	38	/	/	SYM
ct-9353	13	39	kg).9	kg).9	NOUN
ct-9353	13	40	in	in	ADP
ct-9353	13	41	most	most	ADJ
ct-9353	13	42	mares	mare	NOUN
ct-9353	13	43	,	,	PUNCT
ct-9353	13	44	maximum	maximum	ADJ
ct-9353	13	45	concentration	concentration	NOUN
ct-9353	13	46	(	(	PUNCT
ct-9353	13	47	cmax	cmax	NOUN
ct-9353	13	48	)	)	PUNCT
ct-9353	13	49	was	be	AUX
ct-9353	13	50	reached	reach	VERB
ct-9353	13	51	within	within	ADP
ct-9353	13	52	15	15	NUM
ct-9353	13	53	30	30	NUM
ct-9353	13	54	minutes	minute	NOUN
ct-9353	13	55	.	.	PUNCT
ct-9353	14	1	mean	mean	ADJ
ct-9353	14	2	cmax	cmax	NOUN
ct-9353	14	3	was	be	AUX
ct-9353	14	4	35	35	NUM
ct-9353	14	5	ng	ng	NOUN
ct-9353	14	6	/	/	SYM
ct-9353	14	7	ml	ml	NOUN
ct-9353	14	8	on	on	ADP
ct-9353	14	9	day	day	NOUN
ct-9353	14	10	1	1	NUM
ct-9353	14	11	and	and	CCONJ
ct-9353	14	12	31	31	NUM
ct-9353	14	13	ng	ng	PROPN
ct-9353	14	14	/	/	SYM
ct-9353	14	15	ml	ml	NOUN
ct-9353	14	16	on	on	ADP
ct-9353	14	17	day	day	NOUN
ct-9353	14	18	5	5	NUM
ct-9353	14	19	.	.	PUNCT
ct-9353	15	1	in	in	ADP
ct-9353	15	2	contrast	contrast	NOUN
ct-9353	15	3	,	,	PUNCT
ct-9353	15	4	mean	mean	ADJ
ct-9353	15	5	cmax	cmax	NOUN
ct-9353	15	6	in	in	ADP
ct-9353	15	7	urine	urine	NOUN
ct-9353	15	8	was	be	AUX
ct-9353	15	9	1720	1720	NUM
ct-9353	15	10	ng	ng	NOUN
ct-9353	15	11	/	/	SYM
ct-9353	15	12	ml	ml	ADV
ct-9353	15	13	on	on	ADP
ct-9353	15	14	day	day	NOUN
ct-9353	15	15	1	1	NUM
ct-9353	15	16	and	and	CCONJ
ct-9353	15	17	2107	2107	NUM
ct-9353	15	18	ng	ng	PROPN
ct-9353	15	19	/	/	SYM
ct-9353	15	20	ml	ml	NOUN
ct-9353	15	21	on	on	ADP
ct-9353	15	22	day	day	NOUN
ct-9353	15	23	5	5	NUM
ct-9353	15	24	.	.	NOUN
ct-9353	15	25	time	time	NOUN
ct-9353	15	26	for	for	ADP
ct-9353	15	27	total	total	ADJ
ct-9353	15	28	clearance	clearance	NOUN
ct-9353	15	29	(	(	PUNCT
ct-9353	15	30	with	with	ADP
ct-9353	15	31	a	a	DET
ct-9353	15	32	limit	limit	NOUN
ct-9353	15	33	of	of	ADP
ct-9353	15	34	detection	detection	NOUN
ct-9353	15	35	of	of	ADP
ct-9353	15	36	2	2	NUM
ct-9353	15	37	ng	ng	NOUN
ct-9353	15	38	/	/	SYM
ct-9353	15	39	ml	ml	PROPN
ct-9353	15	40	)	)	PUNCT
ct-9353	15	41	was	be	AUX
ct-9353	15	42	12	12	NUM
ct-9353	15	43	days	day	NOUN
ct-9353	15	44	.	.	PUNCT
ct-9353	16	1	due	due	ADP
ct-9353	16	2	to	to	ADP
ct-9353	16	3	risk	risk	NOUN
ct-9353	16	4	of	of	ADP
ct-9353	16	5	human	human	ADJ
ct-9353	16	6	interaction	interaction	NOUN
ct-9353	16	7	with	with	ADP
ct-9353	16	8	oral	oral	ADJ
ct-9353	16	9	altrenogest	altrenogest	NOUN
ct-9353	16	10	,	,	PUNCT
ct-9353	16	11	injectable	injectable	ADJ
ct-9353	16	12	forms	form	NOUN
ct-9353	16	13	have	have	AUX
ct-9353	16	14	gained	gain	VERB
ct-9353	16	15	popularity	popularity	NOUN
ct-9353	16	16	within	within	ADP
ct-9353	16	17	industry	industry	NOUN
ct-9353	16	18	,	,	PUNCT
ct-9353	16	19	and	and	CCONJ
ct-9353	16	20	the	the	DET
ct-9353	16	21	pharmacokinetics	pharmacokinetic	NOUN
ct-9353	16	22	of	of	ADP
ct-9353	16	23	which	which	PRON
ct-9353	16	24	have	have	AUX
ct-9353	16	25	been	be	AUX
ct-9353	16	26	investigated.10	investigated.10	ADJ
ct-9353	16	27	after	after	ADP
ct-9353	16	28	intramuscular	intramuscular	ADJ
ct-9353	16	29	treatment	treatment	NOUN
ct-9353	16	30	(	(	PUNCT
ct-9353	16	31	0.3	0.3	NUM
ct-9353	16	32	mg	mg	PROPN
ct-9353	16	33	/	/	SYM
ct-9353	16	34	kg	kg	PROPN
ct-9353	16	35	)	)	PUNCT
ct-9353	16	36	,	,	PUNCT
ct-9353	16	37	mean	mean	VERB
ct-9353	16	38	circulating	circulate	VERB
ct-9353	16	39	concentrations	concentration	NOUN
ct-9353	16	40	were	be	AUX
ct-9353	16	41	33.52	33.52	NUM
ct-9353	16	42	ng	ng	PROPN
ct-9353	16	43	/	/	SYM
ct-9353	16	44	ml	ml	NOUN
ct-9353	16	45	.	.	PUNCT
ct-9353	17	1	additionally	additionally	ADV
ct-9353	17	2	,	,	PUNCT
ct-9353	17	3	the	the	DET
ct-9353	17	4	area	area	NOUN
ct-9353	17	5	under	under	ADP
ct-9353	17	6	the	the	DET
ct-9353	17	7	curve	curve	NOUN
ct-9353	17	8	for	for	ADP
ct-9353	17	9	intramuscular	intramuscular	ADJ
ct-9353	17	10	treatment	treatment	NOUN
ct-9353	17	11	was	be	AUX
ct-9353	17	12	5.6	5.6	NUM
ct-9353	17	13	-	-	NOUN
ct-9353	17	14	fold	fold	VERB
ct-9353	17	15	higher	high	ADJ
ct-9353	17	16	than	than	ADP
ct-9353	17	17	the	the	DET
ct-9353	17	18	oral	oral	ADJ
ct-9353	17	19	product	product	NOUN
ct-9353	17	20	.	.	PUNCT
ct-9353	18	1	it	it	PRON
ct-9353	18	2	was	be	AUX
ct-9353	18	3	hypothesized	hypothesize	VERB
ct-9353	18	4	that	that	SCONJ
ct-9353	18	5	intramuscular	intramuscular	ADJ
ct-9353	18	6	treatment	treatment	NOUN
ct-9353	18	7	formed	form	VERB
ct-9353	18	8	a	a	DET
ct-9353	18	9	depot	depot	NOUN
ct-9353	18	10	that	that	PRON
ct-9353	18	11	slowed	slow	VERB
ct-9353	18	12	absorption	absorption	NOUN
ct-9353	18	13	,	,	PUNCT
ct-9353	18	14	prolonging	prolong	VERB
ct-9353	18	15	clearance	clearance	NOUN
ct-9353	18	16	compared	compare	VERB
ct-9353	18	17	to	to	ADP
ct-9353	18	18	oral	oral	ADJ
ct-9353	18	19	treatment	treatment	NOUN
ct-9353	18	20	.	.	PUNCT
ct-9353	19	1	several	several	ADJ
ct-9353	19	2	pregnant	pregnant	ADJ
ct-9353	19	3	mares	mare	NOUN
ct-9353	19	4	that	that	PRON
ct-9353	19	5	are	be	AUX
ct-9353	19	6	admitted	admit	VERB
ct-9353	19	7	to	to	ADP
ct-9353	19	8	the	the	DET
ct-9353	19	9	hospital	hospital	NOUN
ct-9353	19	10	for	for	ADP
ct-9353	19	11	medical	medical	ADJ
ct-9353	19	12	or	or	CCONJ
ct-9353	19	13	surgical	surgical	ADJ
ct-9353	19	14	events	event	NOUN
ct-9353	19	15	may	may	AUX
ct-9353	19	16	be	be	AUX
ct-9353	19	17	prohibited	prohibit	VERB
ct-9353	19	18	from	from	ADP
ct-9353	19	19	oral	oral	ADJ
ct-9353	19	20	medications	medication	NOUN
ct-9353	19	21	.	.	PUNCT
ct-9353	20	1	therefore	therefore	ADV
ct-9353	20	2	,	,	PUNCT
ct-9353	20	3	pharmacokinetics	pharmacokinetic	NOUN
ct-9353	20	4	of	of	ADP
ct-9353	20	5	intrarectal	intrarectal	ADJ
ct-9353	20	6	treatment	treatment	NOUN
ct-9353	20	7	of	of	ADP
ct-9353	20	8	altrenogest	altrenogest	NOUN
ct-9353	20	9	have	have	AUX
ct-9353	20	10	also	also	ADV
ct-9353	20	11	been	be	AUX
ct-9353	20	12	assessed	assess	VERB
ct-9353	20	13	.	.	PUNCT
ct-9353	21	1	altrenogest	altrenogest	PROPN
ct-9353	21	2	was	be	AUX
ct-9353	21	3	detected	detect	VERB
ct-9353	21	4	in	in	ADP
ct-9353	21	5	circulation	circulation	NOUN
ct-9353	21	6	as	as	ADV
ct-9353	21	7	early	early	ADV
ct-9353	21	8	as	as	ADP
ct-9353	21	9	15	15	NUM
ct-9353	21	10	minutes	minute	NOUN
ct-9353	21	11	after	after	ADP
ct-9353	21	12	oral	oral	ADJ
ct-9353	21	13	and	and	CCONJ
ct-9353	21	14	rectal	rectal	ADJ
ct-9353	21	15	treatment	treatment	NOUN
ct-9353	21	16	(	(	PUNCT
ct-9353	21	17	0.088	0.088	NUM
ct-9353	21	18	mg	mg	PROPN
ct-9353	21	19	/	/	SYM
ct-9353	21	20	kg).11	kg).11	PROPN
ct-9353	21	21	however	however	ADV
ct-9353	21	22	,	,	PUNCT
ct-9353	21	23	the	the	DET
ct-9353	21	24	cmax	cmax	NOUN
ct-9353	21	25	for	for	ADP
ct-9353	21	26	per	per	ADP
ct-9353	21	27	rectal	rectal	ADJ
ct-9353	21	28	altrenogest	altrenogest	NOUN
ct-9353	21	29	was	be	AUX
ct-9353	21	30	considerably	considerably	ADV
ct-9353	21	31	lower	low	ADJ
ct-9353	21	32	than	than	ADP
ct-9353	21	33	that	that	PRON
ct-9353	21	34	of	of	ADP
ct-9353	21	35	oral	oral	ADJ
ct-9353	21	36	treatment	treatment	NOUN
ct-9353	21	37	(	(	PUNCT
ct-9353	21	38	2.54	2.54	NUM
ct-9353	21	39	versus	versus	ADP
ct-9353	21	40	16.00	16.00	NUM
ct-9353	21	41	respectively	respectively	ADV
ct-9353	21	42	)	)	PUNCT
ct-9353	21	43	,	,	PUNCT
ct-9353	21	44	and	and	CCONJ
ct-9353	21	45	clearance	clearance	NOUN
ct-9353	21	46	of	of	ADP
ct-9353	21	47	altrenogest	altrenogest	ADV
ct-9353	21	48	was	be	AUX
ct-9353	21	49	more	more	ADV
ct-9353	21	50	rapid	rapid	ADJ
ct-9353	21	51	in	in	ADP
ct-9353	21	52	the	the	DET
ct-9353	21	53	rectal	rectal	ADJ
ct-9353	21	54	treatment	treatment	NOUN
ct-9353	21	55	group	group	NOUN
ct-9353	21	56	.	.	PUNCT
ct-9353	22	1	although	although	SCONJ
ct-9353	22	2	rectal	rectal	ADJ
ct-9353	22	3	treatment	treatment	NOUN
ct-9353	22	4	was	be	AUX
ct-9353	22	5	effective	effective	ADJ
ct-9353	22	6	in	in	ADP
ct-9353	22	7	delivering	deliver	VERB
ct-9353	22	8	altrenogest	altrenogest	NOUN
ct-9353	22	9	,	,	PUNCT
ct-9353	22	10	the	the	DET
ct-9353	22	11	bioavailability	bioavailability	NOUN
ct-9353	22	12	was	be	AUX
ct-9353	22	13	only	only	ADV
ct-9353	22	14	5.47	5.47	NUM
ct-9353	22	15	%	%	NOUN
ct-9353	22	16	compared	compare	VERB
ct-9353	22	17	to	to	ADP
ct-9353	22	18	oral	oral	ADJ
ct-9353	22	19	treatment	treatment	NOUN
ct-9353	22	20	.	.	PUNCT
ct-9353	23	1	despite	despite	SCONJ
ct-9353	23	2	the	the	DET
ct-9353	23	3	option	option	NOUN
ct-9353	23	4	that	that	SCONJ
ct-9353	23	5	rectal	rectal	ADJ
ct-9353	23	6	treatment	treatment	NOUN
ct-9353	23	7	may	may	AUX
ct-9353	23	8	be	be	AUX
ct-9353	23	9	a	a	DET
ct-9353	23	10	viable	viable	ADJ
ct-9353	23	11	alternative	alternative	NOUN
ct-9353	23	12	for	for	ADP
ct-9353	23	13	hospitalized	hospitalize	VERB
ct-9353	23	14	mares	mare	NOUN
ct-9353	23	15	,	,	PUNCT
ct-9353	23	16	a	a	DET
ct-9353	23	17	dosage	dosage	NOUN
ct-9353	23	18	of	of	ADP
ct-9353	23	19	0.088	0.088	NUM
ct-9353	23	20	mg	mg	PROPN
ct-9353	23	21	/	/	SYM
ct-9353	23	22	kg	kg	NOUN
ct-9353	23	23	every	every	DET
ct-9353	23	24	4	4	NUM
ct-9353	23	25	8	8	NUM
ct-9353	23	26	hours	hour	NOUN
ct-9353	23	27	would	would	AUX
ct-9353	23	28	be	be	AUX
ct-9353	23	29	necessary	necessary	ADJ
ct-9353	23	30	to	to	PART
ct-9353	23	31	maintain	maintain	VERB
ct-9353	23	32	therapeutic	therapeutic	ADJ
ct-9353	23	33	concentrations	concentration	NOUN
ct-9353	23	34	.	.	PUNCT
ct-9353	24	1	use	use	NOUN
ct-9353	24	2	of	of	ADP
ct-9353	24	3	progestins	progestin	NOUN
ct-9353	24	4	suppressing	suppress	VERB
ct-9353	24	5	estrus	estrus	NOUN
ct-9353	24	6	suppression	suppression	NOUN
ct-9353	24	7	of	of	ADP
ct-9353	24	8	estrus	estrus	NOUN
ct-9353	24	9	in	in	ADP
ct-9353	24	10	sport	sport	NOUN
ct-9353	24	11	and	and	CCONJ
ct-9353	24	12	race	race	NOUN
ct-9353	24	13	mares	mare	NOUN
ct-9353	24	14	is	be	AUX
ct-9353	24	15	desirable	desirable	ADJ
ct-9353	24	16	and	and	CCONJ
ct-9353	24	17	progestins	progestin	NOUN
ct-9353	24	18	are	be	AUX
ct-9353	24	19	commonly	commonly	ADV
ct-9353	24	20	used	use	VERB
ct-9353	24	21	to	to	PART
ct-9353	24	22	accomplish	accomplish	VERB
ct-9353	24	23	this	this	DET
ct-9353	24	24	goal	goal	NOUN
ct-9353	24	25	.	.	PUNCT
ct-9353	25	1	progestin	progestin	NOUN
ct-9353	25	2	treatment	treatment	NOUN
ct-9353	25	3	suppresses	suppress	VERB
ct-9353	25	4	estrus	estrus	VERB
ct-9353	25	5	in	in	ADP
ct-9353	25	6	cycling	cycle	VERB
ct-9353	25	7	mares	mare	NOUN
ct-9353	25	8	through	through	ADP
ct-9353	25	9	its	its	PRON
ct-9353	25	10	high	high	ADJ
ct-9353	25	11	affinity	affinity	NOUN
ct-9353	25	12	for	for	ADP
ct-9353	25	13	progesterone	progesterone	NOUN
ct-9353	25	14	receptor	receptor	NOUN
ct-9353	25	15	(	(	PUNCT
ct-9353	25	16	pr	pr	NOUN
ct-9353	25	17	)	)	PUNCT
ct-9353	25	18	resulting	result	VERB
ct-9353	25	19	in	in	ADP
ct-9353	25	20	endometrial	endometrial	ADJ
ct-9353	25	21	and	and	CCONJ
ct-9353	25	22	myometrial	myometrial	ADJ
ct-9353	25	23	environments	environment	NOUN
ct-9353	25	24	similar	similar	ADJ
ct-9353	25	25	to	to	ADP
ct-9353	25	26	a	a	DET
ct-9353	25	27	pregnant	pregnant	ADJ
ct-9353	25	28	mare	mare	NOUN
ct-9353	25	29	.	.	PUNCT
ct-9353	26	1	progesterone	progesterone	NOUN
ct-9353	26	2	in	in	ADP
ct-9353	26	3	oil	oil	NOUN
ct-9353	26	4	(	(	PUNCT
ct-9353	26	5	100	100	NUM
ct-9353	26	6	mg	mg	NOUN
ct-9353	26	7	)	)	PUNCT
ct-9353	26	8	effectively	effectively	ADV
ct-9353	26	9	suppressed	suppress	VERB
ct-9353	26	10	estrus	estrus	NOUN
ct-9353	26	11	and	and	CCONJ
ct-9353	26	12	mares	mare	NOUN
ct-9353	26	13	returned	return	VERB
ct-9353	26	14	to	to	PART
ct-9353	26	15	estrus	estrus	VERB
ct-9353	26	16	within	within	ADP
ct-9353	26	17	3	3	NUM
ct-9353	26	18	4	4	NUM
ct-9353	26	19	days	day	NOUN
ct-9353	26	20	after	after	ADP
ct-9353	26	21	cessation	cessation	NOUN
ct-9353	26	22	of	of	ADP
ct-9353	26	23	treatment.2	treatment.2	NOUN
ct-9353	26	24	repeated	repeat	VERB
ct-9353	26	25	treatment	treatment	NOUN
ct-9353	26	26	with	with	ADP
ct-9353	26	27	progesterone	progesterone	NOUN
ct-9353	26	28	(	(	PUNCT
ct-9353	26	29	either	either	CCONJ
ct-9353	26	30	intramuscular	intramuscular	ADJ
ct-9353	26	31	or	or	CCONJ
ct-9353	26	32	repositol	repositol	NOUN
ct-9353	26	33	)	)	PUNCT
ct-9353	26	34	led	lead	VERB
ct-9353	26	35	to	to	ADP
ct-9353	26	36	its	its	PRON
ct-9353	26	37	accumulation	accumulation	NOUN
ct-9353	26	38	within	within	ADP
ct-9353	26	39	the	the	DET
ct-9353	26	40	system	system	NOUN
ct-9353	26	41	that	that	PRON
ct-9353	26	42	persisted	persist	VERB
ct-9353	26	43	for	for	ADP
ct-9353	26	44	>	>	X
ct-9353	26	45	10	10	NUM
ct-9353	26	46	days	day	NOUN
ct-9353	26	47	after	after	ADP
ct-9353	26	48	the	the	DET
ct-9353	26	49	last	last	ADJ
ct-9353	26	50	treatment.12	treatment.12	NOUN
ct-9353	26	51	daily	daily	ADV
ct-9353	26	52	oral	oral	ADJ
ct-9353	26	53	treatments	treatment	NOUN
ct-9353	26	54	with	with	ADP
ct-9353	26	55	0.044	0.044	NUM
ct-9353	26	56	mg	mg	PROPN
ct-9353	26	57	/	/	SYM
ct-9353	26	58	kg	kg	PROPN
ct-9353	26	59	altrenogest	altrenogest	NOUN
ct-9353	26	60	was	be	AUX
ct-9353	26	61	also	also	ADV
ct-9353	26	62	sufficient	sufficient	ADJ
ct-9353	26	63	to	to	PART
ct-9353	26	64	bind	bind	VERB
ct-9353	26	65	to	to	ADP
ct-9353	26	66	the	the	DET
ct-9353	26	67	pr	pr	NOUN
ct-9353	26	68	to	to	PART
ct-9353	26	69	suppress	suppress	VERB
ct-9353	26	70	estrus.13	estrus.13	NOUN
ct-9353	26	71	similarly	similarly	ADV
ct-9353	26	72	,	,	PUNCT
ct-9353	26	73	compounded	compound	VERB
ct-9353	26	74	long	long	ADV
ct-9353	26	75	-	-	PUNCT
ct-9353	26	76	acting	act	VERB
ct-9353	26	77	injectable	injectable	ADJ
ct-9353	26	78	altrenogest	altrenogest	NOUN
ct-9353	26	79	formulations	formulation	NOUN
ct-9353	26	80	suppressed	suppress	VERB
ct-9353	26	81	behavioral	behavioral	ADJ
ct-9353	26	82	estrus	estrus	NOUN
ct-9353	26	83	when	when	SCONJ
ct-9353	26	84	used	use	VERB
ct-9353	26	85	as	as	SCONJ
ct-9353	26	86	recommended	recommend	VERB
ct-9353	26	87	by	by	ADP
ct-9353	26	88	the	the	DET
ct-9353	26	89	manufacturers.10,14	manufacturers.10,14	NOUN
ct-9353	26	90	furthermore	furthermore	ADV
ct-9353	26	91	,	,	PUNCT
ct-9353	26	92	long	long	ADJ
ct-9353	26	93	-	-	PUNCT
ct-9353	26	94	term	term	NOUN
ct-9353	26	95	altrenogest	altrenogest	NOUN
ct-9353	26	96	treatment	treatment	NOUN
ct-9353	26	97	did	do	AUX
ct-9353	26	98	not	not	PART
ct-9353	26	99	affect	affect	VERB
ct-9353	26	100	future	future	ADJ
ct-9353	26	101	fertility	fertility	NOUN
ct-9353	26	102	potential15	potential15	NOUN
ct-9353	26	103	and	and	CCONJ
ct-9353	26	104	highdose	highdose	NOUN
ct-9353	26	105	and	and	CCONJ
ct-9353	26	106	prolonged	prolonged	ADJ
ct-9353	26	107	altrenogest	altrenogest	NOUN
ct-9353	26	108	treatment	treatment	NOUN
ct-9353	26	109	did	do	AUX
ct-9353	26	110	not	not	PART
ct-9353	26	111	affect	affect	VERB
ct-9353	26	112	overall	overall	ADJ
ct-9353	26	113	hematologic	hematologic	NOUN
ct-9353	26	114	or	or	CCONJ
ct-9353	26	115	biochemical	biochemical	ADJ
ct-9353	26	116	properties	property	NOUN
ct-9353	26	117	of	of	ADP
ct-9353	26	118	the	the	DET
ct-9353	26	119	mare.16	mare.16	NOUN
ct-9353	26	120	in	in	ADP
ct-9353	26	121	contrast	contrast	NOUN
ct-9353	26	122	,	,	PUNCT
ct-9353	26	123	norgestomet	norgestomet	NOUN
ct-9353	26	124	,	,	PUNCT
ct-9353	26	125	mpa	mpa	PROPN
ct-9353	26	126	,	,	PUNCT
ct-9353	26	127	hydroxyprogesterone	hydroxyprogesterone	NOUN
ct-9353	26	128	caproate	caproate	NOUN
ct-9353	26	129	,	,	PUNCT
ct-9353	26	130	and	and	CCONJ
ct-9353	26	131	megesterol	megesterol	NOUN
ct-9353	26	132	acetate	acetate	NOUN
ct-9353	26	133	had	have	VERB
ct-9353	26	134	no	no	DET
ct-9353	26	135	effect	effect	NOUN
ct-9353	26	136	on	on	ADP
ct-9353	26	137	estrus	estrus	PROPN
ct-9353	26	138	suppression17	suppression17	PROPN
ct-9353	26	139	-	-	PUNCT
ct-9353	26	140	20	20	NUM
ct-9353	26	141	to	to	ADP
ct-9353	26	142	our	our	PRON
ct-9353	26	143	knowledge	knowledge	NOUN
ct-9353	26	144	,	,	PUNCT
ct-9353	26	145	no	no	DET
ct-9353	26	146	other	other	ADJ
ct-9353	26	147	synthetic	synthetic	ADJ
ct-9353	26	148	progestins	progestin	NOUN
ct-9353	26	149	have	have	AUX
ct-9353	26	150	been	be	AUX
ct-9353	26	151	critically	critically	ADV
ct-9353	26	152	evaluated	evaluate	VERB
ct-9353	26	153	for	for	ADP
ct-9353	26	154	their	their	PRON
ct-9353	26	155	ability	ability	NOUN
ct-9353	26	156	to	to	PART
ct-9353	26	157	suppress	suppress	VERB
ct-9353	26	158	estrus	estrus	NOUN
ct-9353	26	159	-	-	PUNCT
ct-9353	26	160	like	like	ADJ
ct-9353	26	161	behavior	behavior	NOUN
ct-9353	26	162	.	.	PUNCT
ct-9353	27	1	delaying	delay	VERB
ct-9353	27	2	ovulation	ovulation	NOUN
ct-9353	27	3	although	although	SCONJ
ct-9353	27	4	select	select	ADJ
ct-9353	27	5	progestins	progestin	NOUN
ct-9353	27	6	successfully	successfully	ADV
ct-9353	27	7	suppressed	suppress	VERB
ct-9353	27	8	estrus	estrus	NOUN
ct-9353	27	9	in	in	ADP
ct-9353	27	10	the	the	DET
ct-9353	27	11	mare	mare	NOUN
ct-9353	27	12	,	,	PUNCT
ct-9353	27	13	conflicting	conflicting	ADJ
ct-9353	27	14	results	result	NOUN
ct-9353	27	15	exist	exist	VERB
ct-9353	27	16	for	for	ADP
ct-9353	27	17	the	the	DET
ct-9353	27	18	ability	ability	NOUN
ct-9353	27	19	to	to	PART
ct-9353	27	20	delay	delay	VERB
ct-9353	27	21	ovulation	ovulation	NOUN
ct-9353	27	22	,	,	PUNCT
ct-9353	27	23	and	and	CCONJ
ct-9353	27	24	success	success	NOUN
ct-9353	27	25	may	may	AUX
ct-9353	27	26	depend	depend	VERB
ct-9353	27	27	on	on	ADP
ct-9353	27	28	the	the	DET
ct-9353	27	29	phase	phase	NOUN
ct-9353	27	30	of	of	ADP
ct-9353	27	31	the	the	DET
ct-9353	27	32	estrous	estrous	ADJ
ct-9353	27	33	cycle	cycle	NOUN
ct-9353	27	34	in	in	ADP
ct-9353	27	35	which	which	PRON
ct-9353	27	36	treatment	treatment	NOUN
ct-9353	27	37	is	be	AUX
ct-9353	27	38	initiated	initiate	VERB
ct-9353	27	39	.	.	PUNCT
ct-9353	28	1	in	in	ADP
ct-9353	28	2	one	one	NUM
ct-9353	28	3	study	study	NOUN
ct-9353	28	4	,	,	PUNCT
ct-9353	28	5	neither	neither	CCONJ
ct-9353	28	6	oral	oral	ADJ
ct-9353	28	7	altrenogest	altrenogest	NOUN
ct-9353	28	8	nor	nor	CCONJ
ct-9353	28	9	a	a	DET
ct-9353	28	10	progesterone	progesterone	NOUN
ct-9353	28	11	implant	implant	NOUN
ct-9353	28	12	(	(	PUNCT
ct-9353	28	13	controlled	control	VERB
ct-9353	28	14	intravaginal	intravaginal	ADJ
ct-9353	28	15	releasing	releasing	NOUN
ct-9353	28	16	device	device	NOUN
ct-9353	28	17	)	)	PUNCT
ct-9353	28	18	were	be	AUX
ct-9353	28	19	effective	effective	ADJ
ct-9353	28	20	in	in	ADP
ct-9353	28	21	preventing	prevent	VERB
ct-9353	28	22	ovulation	ovulation	NOUN
ct-9353	28	23	when	when	SCONJ
ct-9353	28	24	short	short	ADJ
ct-9353	28	25	-	-	PUNCT
ct-9353	28	26	term	term	NOUN
ct-9353	28	27	treatment	treatment	NOUN
ct-9353	28	28	began	begin	VERB
ct-9353	28	29	in	in	ADP
ct-9353	28	30	the	the	DET
ct-9353	28	31	preovulatory	preovulatory	ADJ
ct-9353	28	32	phase.21	phase.21	NOUN
ct-9353	28	33	in	in	ADP
ct-9353	28	34	contrast	contrast	NOUN
ct-9353	28	35	,	,	PUNCT
ct-9353	28	36	shortterm	shortterm	VERB
ct-9353	28	37	treatment	treatment	NOUN
ct-9353	28	38	of	of	ADP
ct-9353	28	39	0.044	0.044	NUM
ct-9353	28	40	mg	mg	PROPN
ct-9353	28	41	/	/	SYM
ct-9353	28	42	kg	kg	PROPN
ct-9353	28	43	altrenogest	altrenogest	NOUN
ct-9353	28	44	successfully	successfully	ADV
ct-9353	28	45	delayed	delay	VERB
ct-9353	28	46	ovulation	ovulation	NOUN
ct-9353	28	47	when	when	SCONJ
ct-9353	28	48	treated	treat	VERB
ct-9353	28	49	at	at	ADP
ct-9353	28	50	the	the	DET
ct-9353	28	51	detection	detection	NOUN
ct-9353	28	52	of	of	ADP
ct-9353	28	53	a	a	DET
ct-9353	28	54	35	35	NUM
ct-9353	28	55	mm	mm	NOUN
ct-9353	28	56	follicle.22	follicle.22	NOUN
ct-9353	28	57	when	when	SCONJ
ct-9353	28	58	a	a	DET
ct-9353	28	59	double	double	ADJ
ct-9353	28	60	dose	dose	NOUN
ct-9353	28	61	of	of	ADP
ct-9353	28	62	altrenogest	altrenog	ADJ
ct-9353	28	63	(	(	PUNCT
ct-9353	28	64	0.088	0.088	NUM
ct-9353	28	65	mg	mg	PROPN
ct-9353	28	66	/	/	SYM
ct-9353	28	67	kg	kg	PROPN
ct-9353	28	68	)	)	PUNCT
ct-9353	28	69	was	be	AUX
ct-9353	28	70	administered	administer	VERB
ct-9353	28	71	,	,	PUNCT
ct-9353	28	72	the	the	DET
ct-9353	28	73	delay	delay	NOUN
ct-9353	28	74	of	of	ADP
ct-9353	28	75	ovulation	ovulation	NOUN
ct-9353	28	76	was	be	AUX
ct-9353	28	77	noted	note	VERB
ct-9353	28	78	in	in	ADP
ct-9353	28	79	a	a	DET
ct-9353	28	80	preovulatory	preovulatory	NOUN
ct-9353	28	81	mare.23	mare.23	PROPN
ct-9353	28	82	however	however	ADV
ct-9353	28	83	,	,	PUNCT
ct-9353	28	84	this	this	PRON
ct-9353	28	85	was	be	AUX
ct-9353	28	86	not	not	PART
ct-9353	28	87	repeatable	repeatable	ADJ
ct-9353	28	88	in	in	ADP
ct-9353	28	89	a	a	DET
ct-9353	28	90	larger	large	ADJ
ct-9353	28	91	field	field	NOUN
ct-9353	28	92	setting.1	setting.1	PROPN
ct-9353	28	93	interestingly	interestingly	ADV
ct-9353	28	94	,	,	PUNCT
ct-9353	28	95	use	use	NOUN
ct-9353	28	96	of	of	ADP
ct-9353	28	97	an	an	DET
ct-9353	28	98	injectable	injectable	ADJ
ct-9353	28	99	sustained	sustain	VERB
ct-9353	28	100	-	-	PUNCT
ct-9353	28	101	release	release	NOUN
ct-9353	28	102	vehicle	vehicle	NOUN
ct-9353	28	103	with	with	ADP
ct-9353	28	104	varying	vary	VERB
ct-9353	28	105	doses	dose	NOUN
ct-9353	28	106	of	of	ADP
ct-9353	28	107	altrenogest	altrenogest	NOUN
ct-9353	28	108	delayed	delay	VERB
ct-9353	28	109	ovulation	ovulation	NOUN
ct-9353	28	110	substantially.24	substantially.24	NOUN
ct-9353	28	111	the	the	DET
ct-9353	28	112	effect	effect	NOUN
ct-9353	28	113	was	be	AUX
ct-9353	28	114	profound	profound	ADJ
ct-9353	28	115	when	when	SCONJ
ct-9353	28	116	lactide	lactide	NOUN
ct-9353	28	117	-	-	PUNCT
ct-9353	28	118	glycolide	glycolide	NOUN
ct-9353	28	119	microparticles	microparticle	NOUN
ct-9353	28	120	were	be	AUX
ct-9353	28	121	added	add	VERB
ct-9353	28	122	,	,	PUNCT
ct-9353	28	123	delaying	delay	VERB
ct-9353	28	124	ovulation	ovulation	NOUN
ct-9353	28	125	by	by	ADP
ct-9353	28	126	33.5	33.5	NUM
ct-9353	28	127	days	day	NOUN
ct-9353	28	128	after	after	ADP
ct-9353	28	129	pgf2α	pgf2α	PROPN
ct-9353	28	130	treatment	treatment	NOUN
ct-9353	28	131	.	.	PUNCT
ct-9353	29	1	however	however	ADV
ct-9353	29	2	,	,	PUNCT
ct-9353	29	3	mpa	mpa	PROPN
ct-9353	29	4	had	have	VERB
ct-9353	29	5	no	no	DET
ct-9353	29	6	effect	effect	NOUN
ct-9353	29	7	on	on	ADP
ct-9353	29	8	ovulation	ovulation	NOUN
ct-9353	29	9	when	when	SCONJ
ct-9353	29	10	combined	combine	VERB
ct-9353	29	11	with	with	ADP
ct-9353	29	12	the	the	DET
ct-9353	29	13	same	same	ADJ
ct-9353	29	14	vehicle	vehicle	NOUN
ct-9353	29	15	or	or	CCONJ
ct-9353	29	16	microparticle	microparticle	NOUN
ct-9353	29	17	formulation	formulation	NOUN
ct-9353	29	18	.	.	PUNCT
ct-9353	30	1	hastening	hasten	VERB
ct-9353	30	2	transition	transition	NOUN
ct-9353	30	3	mares	mare	NOUN
ct-9353	30	4	are	be	AUX
ct-9353	30	5	seasonally	seasonally	ADV
ct-9353	30	6	polyestrous	polyestrous	ADJ
ct-9353	30	7	long	long	ADJ
ct-9353	30	8	-	-	PUNCT
ct-9353	30	9	day	day	NOUN
ct-9353	30	10	breeders	breeder	NOUN
ct-9353	30	11	and	and	CCONJ
ct-9353	30	12	are	be	AUX
ct-9353	30	13	therefore	therefore	ADV
ct-9353	30	14	anovulatory	anovulatory	NOUN
ct-9353	30	15	in	in	ADP
ct-9353	30	16	the	the	DET
ct-9353	30	17	months	month	NOUN
ct-9353	30	18	surrounding	surround	VERB
ct-9353	30	19	the	the	DET
ct-9353	30	20	winter	winter	NOUN
ct-9353	30	21	equinox	equinox	NOUN
ct-9353	30	22	.	.	PUNCT
ct-9353	31	1	a	a	DET
ct-9353	31	2	transitionary	transitionary	ADJ
ct-9353	31	3	phase	phase	NOUN
ct-9353	31	4	exists	exist	VERB
ct-9353	31	5	between	between	ADP
ct-9353	31	6	anestrus	anestrus	NOUN
ct-9353	31	7	and	and	CCONJ
ct-9353	31	8	proper	proper	ADJ
ct-9353	31	9	cyclicity	cyclicity	NOUN
ct-9353	31	10	;	;	PUNCT
ct-9353	31	11	and	and	CCONJ
ct-9353	31	12	shortening	shorten	VERB
ct-9353	31	13	this	this	DET
ct-9353	31	14	phase	phase	NOUN
ct-9353	31	15	has	have	AUX
ct-9353	31	16	been	be	AUX
ct-9353	31	17	attempted	attempt	VERB
ct-9353	31	18	through	through	ADP
ct-9353	31	19	the	the	DET
ct-9353	31	20	administration	administration	NOUN
ct-9353	31	21	of	of	ADP
ct-9353	31	22	exogenous	exogenous	ADJ
ct-9353	31	23	steroids	steroid	NOUN
ct-9353	31	24	.	.	PUNCT
ct-9353	32	1	the	the	DET
ct-9353	32	2	proposed	propose	VERB
ct-9353	32	3	rational	rational	ADJ
ct-9353	32	4	for	for	ADP
ct-9353	32	5	progestin	progestin	NOUN
ct-9353	32	6	treatment	treatment	NOUN
ct-9353	32	7	is	be	AUX
ct-9353	32	8	believed	believe	VERB
ct-9353	32	9	to	to	PART
ct-9353	32	10	inhibit	inhibit	VERB
ct-9353	32	11	the	the	DET
ct-9353	32	12	release	release	NOUN
ct-9353	32	13	of	of	ADP
ct-9353	32	14	luteinizing	luteinize	VERB
ct-9353	32	15	hormone	hormone	NOUN
ct-9353	32	16	(	(	PUNCT
ct-9353	32	17	lh	lh	PROPN
ct-9353	32	18	)	)	PUNCT
ct-9353	32	19	from	from	ADP
ct-9353	32	20	the	the	DET
ct-9353	32	21	pituitary	pituitary	NOUN
ct-9353	32	22	,	,	PUNCT
ct-9353	32	23	allowing	allow	VERB
ct-9353	32	24	for	for	ADP
ct-9353	32	25	a	a	DET
ct-9353	32	26	repositol	repositol	NOUN
ct-9353	32	27	of	of	ADP
ct-9353	32	28	the	the	DET
ct-9353	32	29	gonadotropin	gonadotropin	NOUN
ct-9353	32	30	to	to	PART
ct-9353	32	31	form	form	VERB
ct-9353	32	32	,	,	PUNCT
ct-9353	32	33	thereby	thereby	ADV
ct-9353	32	34	allowing	allow	VERB
ct-9353	32	35	for	for	SCONJ
ct-9353	32	36	ovulation	ovulation	NOUN
ct-9353	32	37	to	to	PART
ct-9353	32	38	be	be	AUX
ct-9353	32	39	induced	induce	VERB
ct-9353	32	40	.	.	PUNCT
ct-9353	33	1	progestin	progestin	NOUN
ct-9353	33	2	treatment	treatment	NOUN
ct-9353	33	3	has	have	AUX
ct-9353	33	4	been	be	AUX
ct-9353	33	5	shown	show	VERB
ct-9353	33	6	to	to	PART
ct-9353	33	7	hasten	hasten	VERB
ct-9353	33	8	the	the	DET
ct-9353	33	9	first	first	ADJ
ct-9353	33	10	ovulation	ovulation	NOUN
ct-9353	33	11	of	of	ADP
ct-9353	33	12	the	the	DET
ct-9353	33	13	year	year	NOUN
ct-9353	33	14	dependent	dependent	ADJ
ct-9353	33	15	on	on	ADP
ct-9353	33	16	the	the	DET
ct-9353	33	17	stage	stage	NOUN
ct-9353	33	18	of	of	ADP
ct-9353	33	19	transition	transition	NOUN
ct-9353	33	20	and	and	CCONJ
ct-9353	33	21	the	the	DET
ct-9353	33	22	specific	specific	ADJ
ct-9353	33	23	progestin	progestin	NOUN
ct-9353	33	24	used	use	VERB
ct-9353	33	25	.	.	PUNCT
ct-9353	34	1	altrenogest	altrenogest	PROPN
ct-9353	34	2	hastened	hasten	VERB
ct-9353	34	3	the	the	DET
ct-9353	34	4	occurrence	occurrence	NOUN
ct-9353	34	5	of	of	ADP
ct-9353	34	6	first	first	ADJ
ct-9353	34	7	estrus	estrus	NOUN
ct-9353	34	8	and	and	CCONJ
ct-9353	34	9	reduced	reduce	VERB
ct-9353	34	10	the	the	DET
ct-9353	34	11	interval	interval	NOUN
ct-9353	34	12	to	to	PART
ct-9353	34	13	conception	conception	NOUN
ct-9353	34	14	in	in	ADP
ct-9353	34	15	late	late	ADJ
ct-9353	34	16	transitional	transitional	ADJ
ct-9353	34	17	mares	mare	NOUN
ct-9353	34	18	(	(	PUNCT
ct-9353	34	19	>	>	X
ct-9353	34	20	march	march	PROPN
ct-9353	34	21	15	15	NUM
ct-9353	34	22	,	,	PUNCT
ct-9353	34	23	20	20	NUM
ct-9353	34	24	mm	mm	NUM
ct-9353	34	25	follicle	follicle	NOUN
ct-9353	34	26	)	)	PUNCT
ct-9353	34	27	with	with	ADP
ct-9353	34	28	no	no	DET
ct-9353	34	29	impact	impact	NOUN
ct-9353	34	30	on	on	ADP
ct-9353	34	31	early	early	ADJ
ct-9353	34	32	transitional	transitional	ADJ
ct-9353	34	33	mares	mare	NOUN
ct-9353	34	34	(	(	PUNCT
ct-9353	34	35	<	<	X
ct-9353	34	36	march	march	PROPN
ct-9353	34	37	15th	15th	NOUN
ct-9353	34	38	,	,	PUNCT
ct-9353	34	39	14	14	NUM
ct-9353	34	40	mm	mm	NOUN
ct-9353	34	41	follicle).5	follicle).5	PROPN
ct-9353	34	42	however	however	ADV
ct-9353	34	43	,	,	PUNCT
ct-9353	34	44	when	when	SCONJ
ct-9353	34	45	a	a	DET
ct-9353	34	46	higher	high	ADJ
ct-9353	34	47	dose	dose	NOUN
ct-9353	34	48	(	(	PUNCT
ct-9353	34	49	0.22	0.22	NUM
ct-9353	34	50	mg	mg	PROPN
ct-9353	34	51	/	/	SYM
ct-9353	34	52	kg	kg	PROPN
ct-9353	34	53	)	)	PUNCT
ct-9353	34	54	was	be	AUX
ct-9353	34	55	used	use	VERB
ct-9353	34	56	,	,	PUNCT
ct-9353	34	57	results	result	NOUN
ct-9353	34	58	were	be	AUX
ct-9353	34	59	not	not	PART
ct-9353	34	60	repeatable.25	repeatable.25	NOUN
ct-9353	34	61	other	other	ADJ
ct-9353	34	62	progestins	progestin	NOUN
ct-9353	34	63	(	(	PUNCT
ct-9353	34	64	1500	1500	NUM
ct-9353	34	65	mg	mg	NOUN
ct-9353	34	66	of	of	ADP
ct-9353	34	67	proligestone	proligestone	NOUN
ct-9353	34	68	)	)	PUNCT
ct-9353	34	69	induced	induce	VERB
ct-9353	34	70	comparable	comparable	ADJ
ct-9353	34	71	ovulation	ovulation	NOUN
ct-9353	34	72	and	and	CCONJ
ct-9353	34	73	pregnancy	pregnancy	NOUN
ct-9353	34	74	rates	rate	NOUN
ct-9353	34	75	to	to	ADP
ct-9353	34	76	altrenogest	altrenogest	NOUN
ct-9353	34	77	treatment	treatment	NOUN
ct-9353	34	78	in	in	ADP
ct-9353	34	79	transitional	transitional	ADJ
ct-9353	34	80	mares.13	mares.13	NOUN
ct-9353	34	81	it	it	PRON
ct-9353	34	82	should	should	AUX
ct-9353	34	83	be	be	AUX
ct-9353	34	84	noted	note	VERB
ct-9353	34	85	that	that	SCONJ
ct-9353	34	86	only	only	ADV
ct-9353	34	87	a	a	DET
ct-9353	34	88	minimal	minimal	ADJ
ct-9353	34	89	number	number	NOUN
ct-9353	34	90	of	of	ADP
ct-9353	34	91	control	control	NOUN
ct-9353	34	92	mares	mare	NOUN
ct-9353	34	93	were	be	AUX
ct-9353	34	94	used	use	VERB
ct-9353	34	95	in	in	ADP
ct-9353	34	96	this	this	DET
ct-9353	34	97	study	study	NOUN
ct-9353	34	98	,	,	PUNCT
ct-9353	34	99	and	and	CCONJ
ct-9353	34	100	pretreatment	pretreatment	NOUN
ct-9353	34	101	follicular	follicular	ADJ
ct-9353	34	102	status	status	NOUN
ct-9353	34	103	was	be	AUX
ct-9353	34	104	not	not	PART
ct-9353	34	105	assessed	assess	VERB
ct-9353	34	106	.	.	PUNCT
ct-9353	35	1	controlled	control	VERB
ct-9353	35	2	release	release	NOUN
ct-9353	35	3	of	of	ADP
ct-9353	35	4	intramuscular	intramuscular	ADJ
ct-9353	35	5	progesterone	progesterone	NOUN
ct-9353	35	6	(	(	PUNCT
ct-9353	35	7	la	la	X
ct-9353	35	8	p4	p4	ADJ
ct-9353	35	9	;	;	PUNCT
ct-9353	35	10	biorelease	biorelease	NOUN
ct-9353	35	11	)	)	PUNCT
ct-9353	35	12	was	be	AUX
ct-9353	35	13	effective	effective	ADJ
ct-9353	35	14	in	in	ADP
ct-9353	35	15	shortening	shorten	VERB
ct-9353	35	16	the	the	DET
ct-9353	35	17	duration	duration	NOUN
ct-9353	35	18	to	to	ADP
ct-9353	35	19	first	first	ADJ
ct-9353	35	20	ovulation	ovulation	NOUN
ct-9353	35	21	in	in	ADP
ct-9353	35	22	late	late	ADJ
ct-9353	35	23	transitional	transitional	ADJ
ct-9353	35	24	mares	mare	NOUN
ct-9353	35	25	;	;	PUNCT
ct-9353	35	26	however	however	ADV
ct-9353	35	27	,	,	PUNCT
ct-9353	35	28	it	it	PRON
ct-9353	35	29	was	be	AUX
ct-9353	35	30	ineffective	ineffective	ADJ
ct-9353	35	31	in	in	ADP
ct-9353	35	32	the	the	DET
ct-9353	35	33	early	early	ADJ
ct-9353	35	34	transitional	transitional	ADJ
ct-9353	35	35	mare.26	mare.26	ADJ
ct-9353	35	36	studies	study	NOUN
ct-9353	35	37	using	use	VERB
ct-9353	35	38	intravaginal	intravaginal	ADJ
ct-9353	35	39	progesterone	progesterone	NOUN
ct-9353	35	40	-	-	PUNCT
ct-9353	35	41	releasing	release	VERB
ct-9353	35	42	devices	device	NOUN
ct-9353	35	43	to	to	PART
ct-9353	35	44	hasten	hasten	VERB
ct-9353	35	45	first	first	ADJ
ct-9353	35	46	ovulation	ovulation	NOUN
ct-9353	35	47	had	have	VERB
ct-9353	35	48	mixed	mixed	ADJ
ct-9353	35	49	results	result	NOUN
ct-9353	35	50	.	.	PUNCT
ct-9353	36	1	although	although	SCONJ
ct-9353	36	2	controlled	control	VERB
ct-9353	36	3	intravaginal	intravaginal	ADJ
ct-9353	36	4	releasing	releasing	NOUN
ct-9353	36	5	devices	device	NOUN
ct-9353	36	6	combined	combine	VERB
ct-9353	36	7	with	with	ADP
ct-9353	36	8	progesterone	progesterone	NOUN
ct-9353	36	9	were	be	AUX
ct-9353	36	10	ineffective	ineffective	ADJ
ct-9353	36	11	in	in	ADP
ct-9353	36	12	improving	improve	VERB
ct-9353	36	13	pregnancy	pregnancy	NOUN
ct-9353	36	14	rates	rate	NOUN
ct-9353	36	15	in	in	ADP
ct-9353	36	16	the	the	DET
ct-9353	36	17	first	first	ADJ
ct-9353	36	18	estrous	estrous	ADJ
ct-9353	36	19	cycle,27	cycle,27	NUM
ct-9353	36	20	89	89	NUM
ct-9353	36	21	%	%	NOUN
ct-9353	36	22	of	of	ADP
ct-9353	36	23	anestrous	anestrous	ADJ
ct-9353	36	24	mares	mare	NOUN
ct-9353	36	25	ovulated	ovulate	VERB
ct-9353	36	26	within	within	ADP
ct-9353	36	27	10	10	NUM
ct-9353	36	28	days	day	NOUN
ct-9353	36	29	after	after	ADP
ct-9353	36	30	progesterone	progesterone	NOUN
ct-9353	36	31	-	-	PUNCT
ct-9353	36	32	releasing	release	VERB
ct-9353	36	33	clinical	clinical	ADJ
ct-9353	36	34	theriogenology	theriogenology	NOUN
ct-9353	36	35	2021	2021	NUM
ct-9353	36	36	;	;	PUNCT
ct-9353	36	37	13	13	NUM
ct-9353	36	38	:	:	SYM
ct-9353	36	39	248	248	NUM
ct-9353	36	40	intravaginal	intravaginal	ADJ
ct-9353	36	41	devices	device	NOUN
ct-9353	36	42	were	be	AUX
ct-9353	36	43	remove.28	remove.28	NOUN
ct-9353	36	44	it	it	PRON
ct-9353	36	45	should	should	AUX
ct-9353	36	46	be	be	AUX
ct-9353	36	47	noted	note	VERB
ct-9353	36	48	that	that	SCONJ
ct-9353	36	49	mild	mild	ADJ
ct-9353	36	50	to	to	ADP
ct-9353	36	51	moderate	moderate	ADJ
ct-9353	36	52	vaginitis	vaginitis	NOUN
ct-9353	36	53	was	be	AUX
ct-9353	36	54	observed	observe	VERB
ct-9353	36	55	in	in	ADP
ct-9353	36	56	a	a	DET
ct-9353	36	57	subset	subset	NOUN
ct-9353	36	58	of	of	ADP
ct-9353	36	59	mares	mare	NOUN
ct-9353	36	60	after	after	ADP
ct-9353	36	61	implantation	implantation	NOUN
ct-9353	36	62	of	of	ADP
ct-9353	36	63	the	the	DET
ct-9353	36	64	progesterone	progesterone	NOUN
ct-9353	36	65	-	-	PUNCT
ct-9353	36	66	releasing	releasing	NOUN
ct-9353	36	67	devices	device	NOUN
ct-9353	36	68	.	.	PUNCT
ct-9353	37	1	these	these	DET
ct-9353	37	2	devices	device	NOUN
ct-9353	37	3	are	be	AUX
ct-9353	37	4	not	not	PART
ct-9353	37	5	approved	approve	VERB
ct-9353	37	6	for	for	ADP
ct-9353	37	7	equine	equine	NOUN
ct-9353	37	8	use	use	NOUN
ct-9353	37	9	in	in	ADP
ct-9353	37	10	most	most	ADJ
ct-9353	37	11	countries	country	NOUN
ct-9353	37	12	(	(	PUNCT
ct-9353	37	13	except	except	SCONJ
ct-9353	37	14	for	for	ADP
ct-9353	37	15	cue	cue	ADJ
ct-9353	37	16	-	-	PUNCT
ct-9353	37	17	mare	mare	NOUN
ct-9353	37	18	®	®	NOUN
ct-9353	37	19	in	in	ADP
ct-9353	37	20	new	new	PROPN
ct-9353	37	21	zealand	zealand	PROPN
ct-9353	37	22	)	)	PUNCT
ct-9353	37	23	.	.	PUNCT
ct-9353	38	1	overall	overall	ADV
ct-9353	38	2	,	,	PUNCT
ct-9353	38	3	the	the	DET
ct-9353	38	4	efficacy	efficacy	NOUN
ct-9353	38	5	of	of	ADP
ct-9353	38	6	progestin	progestin	NOUN
ct-9353	38	7	treatment	treatment	NOUN
ct-9353	38	8	in	in	ADP
ct-9353	38	9	shortening	shorten	VERB
ct-9353	38	10	the	the	DET
ct-9353	38	11	duration	duration	NOUN
ct-9353	38	12	to	to	ADP
ct-9353	38	13	first	first	ADJ
ct-9353	38	14	ovulation	ovulation	NOUN
ct-9353	38	15	is	be	AUX
ct-9353	38	16	inconsistent	inconsistent	ADJ
ct-9353	38	17	and	and	CCONJ
ct-9353	38	18	depends	depend	VERB
ct-9353	38	19	on	on	ADP
ct-9353	38	20	the	the	DET
ct-9353	38	21	reproductive	reproductive	ADJ
ct-9353	38	22	status	status	NOUN
ct-9353	38	23	of	of	ADP
ct-9353	38	24	the	the	DET
ct-9353	38	25	mare	mare	NOUN
ct-9353	38	26	in	in	ADP
ct-9353	38	27	addition	addition	NOUN
ct-9353	38	28	to	to	ADP
ct-9353	38	29	the	the	DET
ct-9353	38	30	progestin	progestin	NOUN
ct-9353	38	31	used	use	VERB
ct-9353	38	32	.	.	PUNCT
ct-9353	39	1	synchronizing	synchronize	VERB
ct-9353	39	2	estrus	estrus	NOUN
ct-9353	39	3	for	for	ADP
ct-9353	39	4	simplicity	simplicity	NOUN
ct-9353	39	5	of	of	ADP
ct-9353	39	6	breeding	breed	VERB
ct-9353	39	7	in	in	ADP
ct-9353	39	8	addition	addition	NOUN
ct-9353	39	9	to	to	ADP
ct-9353	39	10	timing	time	VERB
ct-9353	39	11	embryo	embryo	NOUN
ct-9353	39	12	transfer	transfer	NOUN
ct-9353	39	13	,	,	PUNCT
ct-9353	39	14	progestins	progestin	NOUN
ct-9353	39	15	are	be	AUX
ct-9353	39	16	commonly	commonly	ADV
ct-9353	39	17	used	use	VERB
ct-9353	39	18	to	to	PART
ct-9353	39	19	regulate	regulate	VERB
ct-9353	39	20	both	both	CCONJ
ct-9353	39	21	estrus	estrus	NOUN
ct-9353	39	22	and	and	CCONJ
ct-9353	39	23	diestrus	diestrus	NOUN
ct-9353	39	24	phases	phase	NOUN
ct-9353	39	25	of	of	ADP
ct-9353	39	26	the	the	DET
ct-9353	39	27	cycle	cycle	NOUN
ct-9353	39	28	.	.	PUNCT
ct-9353	40	1	although	although	SCONJ
ct-9353	40	2	progestins	progestin	NOUN
ct-9353	40	3	suppress	suppress	VERB
ct-9353	40	4	the	the	DET
ct-9353	40	5	release	release	NOUN
ct-9353	40	6	of	of	ADP
ct-9353	40	7	lh	lh	PROPN
ct-9353	40	8	,	,	PUNCT
ct-9353	40	9	their	their	PRON
ct-9353	40	10	effect	effect	NOUN
ct-9353	40	11	on	on	ADP
ct-9353	40	12	fsh	fsh	NOUN
ct-9353	40	13	is	be	AUX
ct-9353	40	14	less	less	ADV
ct-9353	40	15	evident	evident	ADJ
ct-9353	40	16	,	,	PUNCT
ct-9353	40	17	resulting	result	VERB
ct-9353	40	18	in	in	ADP
ct-9353	40	19	normal	normal	ADJ
ct-9353	40	20	follicular	follicular	ADJ
ct-9353	40	21	development.29	development.29	NOUN
ct-9353	40	22	hence	hence	ADV
ct-9353	40	23	,	,	PUNCT
ct-9353	40	24	progestin	progestin	NOUN
ct-9353	40	25	treatment	treatment	NOUN
ct-9353	40	26	results	result	NOUN
ct-9353	40	27	in	in	ADP
ct-9353	40	28	a	a	DET
ct-9353	40	29	reduction	reduction	NOUN
ct-9353	40	30	of	of	ADP
ct-9353	40	31	ovulations	ovulation	NOUN
ct-9353	40	32	,	,	PUNCT
ct-9353	40	33	but	but	CCONJ
ct-9353	40	34	does	do	AUX
ct-9353	40	35	not	not	PART
ct-9353	40	36	synchronize	synchronize	VERB
ct-9353	40	37	follicular	follicular	ADJ
ct-9353	40	38	growth	growth	NOUN
ct-9353	40	39	in	in	ADP
ct-9353	40	40	treated	treat	VERB
ct-9353	40	41	mares	mare	NOUN
ct-9353	40	42	.	.	PUNCT
ct-9353	41	1	in	in	ADP
ct-9353	41	2	order	order	NOUN
ct-9353	41	3	to	to	PART
ct-9353	41	4	effectively	effectively	ADV
ct-9353	41	5	synchronize	synchronize	VERB
ct-9353	41	6	estrus	estrus	NOUN
ct-9353	41	7	in	in	ADP
ct-9353	41	8	mares	mare	NOUN
ct-9353	41	9	,	,	PUNCT
ct-9353	41	10	a	a	DET
ct-9353	41	11	combination	combination	NOUN
ct-9353	41	12	of	of	ADP
ct-9353	41	13	progestins	progestin	NOUN
ct-9353	41	14	and	and	CCONJ
ct-9353	41	15	estrogens	estrogen	NOUN
ct-9353	41	16	can	can	AUX
ct-9353	41	17	be	be	AUX
ct-9353	41	18	used	use	VERB
ct-9353	41	19	.	.	PUNCT
ct-9353	42	1	this	this	DET
ct-9353	42	2	‘	'	PUNCT
ct-9353	42	3	p&e	p&e	NOUN
ct-9353	42	4	’	'	PUNCT
ct-9353	42	5	treatment	treatment	NOUN
ct-9353	42	6	consists	consist	VERB
ct-9353	42	7	of	of	ADP
ct-9353	42	8	10	10	NUM
ct-9353	42	9	days	day	NOUN
ct-9353	42	10	of	of	ADP
ct-9353	42	11	intramuscular	intramuscular	ADJ
ct-9353	42	12	treatment	treatment	NOUN
ct-9353	42	13	of	of	ADP
ct-9353	42	14	150	150	NUM
ct-9353	42	15	mg	mg	NOUN
ct-9353	42	16	progesterone	progesterone	NOUN
ct-9353	42	17	in	in	ADP
ct-9353	42	18	oil	oil	NOUN
ct-9353	42	19	alongside	alongside	ADP
ct-9353	42	20	10	10	NUM
ct-9353	42	21	mg	mg	PROPN
ct-9353	42	22	estradiol-17β	estradiol-17β	PROPN
ct-9353	42	23	(	(	PUNCT
ct-9353	42	24	figure	figure	NOUN
ct-9353	42	25	2	2	NUM
ct-9353	42	26	)	)	PUNCT
ct-9353	42	27	.	.	PUNCT
ct-9353	43	1	this	this	PRON
ct-9353	43	2	was	be	AUX
ct-9353	43	3	followed	follow	VERB
ct-9353	43	4	by	by	ADP
ct-9353	43	5	a	a	DET
ct-9353	43	6	luteolytic	luteolytic	ADJ
ct-9353	43	7	dose	dose	NOUN
ct-9353	43	8	of	of	ADP
ct-9353	43	9	pgf2α	pgf2α	PROPN
ct-9353	43	10	on	on	ADP
ct-9353	43	11	the	the	DET
ct-9353	43	12	10th	10th	ADJ
ct-9353	43	13	day	day	NOUN
ct-9353	43	14	of	of	ADP
ct-9353	43	15	treatment.30	treatment.30	NOUN
ct-9353	43	16	it	it	PRON
ct-9353	43	17	is	be	AUX
ct-9353	43	18	expected	expect	VERB
ct-9353	43	19	that	that	SCONJ
ct-9353	43	20	mares	mare	NOUN
ct-9353	43	21	will	will	AUX
ct-9353	43	22	have	have	VERB
ct-9353	43	23	a	a	DET
ct-9353	43	24	preovulatory	preovulatory	ADJ
ct-9353	43	25	follicle	follicle	NOUN
ct-9353	43	26	8	8	NUM
ct-9353	43	27	days	day	NOUN
ct-9353	43	28	after	after	ADP
ct-9353	43	29	cessation	cessation	NOUN
ct-9353	43	30	of	of	ADP
ct-9353	43	31	treatment	treatment	NOUN
ct-9353	43	32	and	and	CCONJ
ct-9353	43	33	respond	respond	VERB
ct-9353	43	34	to	to	ADP
ct-9353	43	35	an	an	DET
ct-9353	43	36	ovulatory	ovulatory	NOUN
ct-9353	43	37	-	-	PUNCT
ct-9353	43	38	inducing	induce	VERB
ct-9353	43	39	agent	agent	NOUN
ct-9353	43	40	.	.	PUNCT
ct-9353	44	1	this	this	PRON
ct-9353	44	2	has	have	AUX
ct-9353	44	3	been	be	AUX
ct-9353	44	4	repeated	repeat	VERB
ct-9353	44	5	by	by	ADP
ct-9353	44	6	replacing	replace	VERB
ct-9353	44	7	progesterone	progesterone	NOUN
ct-9353	44	8	in	in	ADP
ct-9353	44	9	oil	oil	NOUN
ct-9353	44	10	with	with	ADP
ct-9353	44	11	altrenogest	altrenogest	NOUN
ct-9353	44	12	,	,	PUNCT
ct-9353	44	13	and	and	CCONJ
ct-9353	44	14	responses	response	NOUN
ct-9353	44	15	were	be	AUX
ct-9353	44	16	comparable.31	comparable.31	NOUN
ct-9353	44	17	supporting	support	VERB
ct-9353	44	18	early	early	ADJ
ct-9353	44	19	pregnancy	pregnancy	NOUN
ct-9353	44	20	progesterone	progesterone	NOUN
ct-9353	44	21	is	be	AUX
ct-9353	44	22	produced	produce	VERB
ct-9353	44	23	in	in	ADP
ct-9353	44	24	ovaries	ovary	NOUN
ct-9353	44	25	(	(	PUNCT
ct-9353	44	26	primary	primary	ADJ
ct-9353	44	27	and	and	CCONJ
ct-9353	44	28	secondary	secondary	ADJ
ct-9353	44	29	corpora	corpora	NOUN
ct-9353	44	30	lutea	lutea	NOUN
ct-9353	44	31	)	)	PUNCT
ct-9353	44	32	after	after	ADP
ct-9353	44	33	ovulation	ovulation	NOUN
ct-9353	44	34	until	until	ADP
ct-9353	44	35	120	120	NUM
ct-9353	44	36	150	150	NUM
ct-9353	44	37	days	day	NOUN
ct-9353	44	38	of	of	ADP
ct-9353	44	39	pregnancy	pregnancy	NOUN
ct-9353	44	40	when	when	SCONJ
ct-9353	44	41	pregnancy	pregnancy	NOUN
ct-9353	44	42	becomes	become	VERB
ct-9353	44	43	fully	fully	ADV
ct-9353	44	44	dependent	dependent	ADJ
ct-9353	44	45	on	on	ADP
ct-9353	44	46	5α	5α	ADV
ct-9353	44	47	-	-	PUNCT
ct-9353	44	48	reduced	reduce	VERB
ct-9353	44	49	progestogens	progestogen	NOUN
ct-9353	44	50	from	from	ADP
ct-9353	44	51	the	the	DET
ct-9353	44	52	feto	feto	PROPN
ct-9353	44	53	-	-	PUNCT
ct-9353	44	54	placental	placental	ADJ
ct-9353	44	55	unit	unit	NOUN
ct-9353	44	56	,	,	PUNCT
ct-9353	44	57	including	include	VERB
ct-9353	44	58	5α	5α	PROPN
ct-9353	44	59	-	-	PUNCT
ct-9353	44	60	dhp	dhp	PROPN
ct-9353	44	61	and	and	CCONJ
ct-9353	44	62	20α-5p.32	20α-5p.32	NUM
ct-9353	44	63	-	-	SYM
ct-9353	44	64	35	35	NUM
ct-9353	44	65	secondary	secondary	ADJ
ct-9353	44	66	luteal	luteal	ADJ
ct-9353	44	67	deficiency	deficiency	NOUN
ct-9353	44	68	,	,	PUNCT
ct-9353	44	69	as	as	ADP
ct-9353	44	70	a	a	DET
ct-9353	44	71	result	result	NOUN
ct-9353	44	72	of	of	ADP
ct-9353	44	73	endogenous	endogenous	ADJ
ct-9353	44	74	release	release	NOUN
ct-9353	44	75	of	of	ADP
ct-9353	44	76	pgf2α	pgf2α	PROPN
ct-9353	44	77	,	,	PUNCT
ct-9353	44	78	is	be	AUX
ct-9353	44	79	associated	associate	VERB
ct-9353	44	80	with	with	ADP
ct-9353	44	81	systemic	systemic	ADJ
ct-9353	44	82	or	or	CCONJ
ct-9353	44	83	uterine	uterine	ADJ
ct-9353	44	84	inflammation	inflammation	NOUN
ct-9353	44	85	and	and	CCONJ
ct-9353	44	86	endotoxemia	endotoxemia	NOUN
ct-9353	44	87	.	.	PUNCT
ct-9353	45	1	this	this	DET
ct-9353	45	2	premature	premature	ADJ
ct-9353	45	3	release	release	NOUN
ct-9353	45	4	is	be	AUX
ct-9353	45	5	detrimental	detrimental	ADJ
ct-9353	45	6	to	to	ADP
ct-9353	45	7	pregnancy	pregnancy	NOUN
ct-9353	45	8	if	if	SCONJ
ct-9353	45	9	it	it	PRON
ct-9353	45	10	occurs	occur	VERB
ct-9353	45	11	prior	prior	ADV
ct-9353	45	12	to	to	ADP
ct-9353	45	13	this	this	DET
ct-9353	45	14	shift	shift	NOUN
ct-9353	45	15	in	in	ADP
ct-9353	45	16	progestogen	progestogen	NOUN
ct-9353	45	17	release	release	NOUN
ct-9353	45	18	.	.	PUNCT
ct-9353	46	1	although	although	SCONJ
ct-9353	46	2	low	low	ADJ
ct-9353	46	3	systemic	systemic	ADJ
ct-9353	46	4	progesterone	progesterone	NOUN
ct-9353	46	5	concentrations	concentration	NOUN
ct-9353	46	6	are	be	AUX
ct-9353	46	7	incompatible	incompatible	ADJ
ct-9353	46	8	with	with	ADP
ct-9353	46	9	maintenance	maintenance	NOUN
ct-9353	46	10	of	of	ADP
ct-9353	46	11	pregnancy	pregnancy	NOUN
ct-9353	46	12	,	,	PUNCT
ct-9353	46	13	there	there	PRON
ct-9353	46	14	are	be	VERB
ct-9353	46	15	limited	limit	VERB
ct-9353	46	16	scientific	scientific	ADJ
ct-9353	46	17	data	datum	NOUN
ct-9353	46	18	to	to	PART
ct-9353	46	19	support	support	VERB
ct-9353	46	20	a	a	DET
ct-9353	46	21	primary	primary	ADJ
ct-9353	46	22	failure	failure	NOUN
ct-9353	46	23	of	of	ADP
ct-9353	46	24	the	the	DET
ct-9353	46	25	corpus	corpus	NOUN
ct-9353	46	26	luteum	luteum	NOUN
ct-9353	46	27	(	(	PUNCT
ct-9353	46	28	cl	cl	NOUN
ct-9353	46	29	)	)	PUNCT
ct-9353	46	30	as	as	ADP
ct-9353	46	31	a	a	DET
ct-9353	46	32	cause	cause	NOUN
ct-9353	46	33	of	of	ADP
ct-9353	46	34	embryonic	embryonic	ADJ
ct-9353	46	35	loss.36	loss.36	NOUN
ct-9353	46	36	measuring	measure	VERB
ct-9353	46	37	circulating	circulate	VERB
ct-9353	46	38	progesterone	progesterone	NOUN
ct-9353	46	39	concentrations	concentration	NOUN
ct-9353	46	40	in	in	ADP
ct-9353	46	41	a	a	DET
ct-9353	46	42	single	single	ADJ
ct-9353	46	43	blood	blood	NOUN
ct-9353	46	44	sample	sample	NOUN
ct-9353	46	45	to	to	PART
ct-9353	46	46	determine	determine	VERB
ct-9353	46	47	if	if	SCONJ
ct-9353	46	48	pregnancy	pregnancy	NOUN
ct-9353	46	49	is	be	AUX
ct-9353	46	50	at	at	ADP
ct-9353	46	51	risk	risk	NOUN
ct-9353	46	52	is	be	AUX
ct-9353	46	53	not	not	PART
ct-9353	46	54	accurate	accurate	ADJ
ct-9353	46	55	unless	unless	SCONJ
ct-9353	46	56	it	it	PRON
ct-9353	46	57	is	be	AUX
ct-9353	46	58	less	less	ADJ
ct-9353	46	59	than	than	ADP
ct-9353	46	60	1	1	NUM
ct-9353	46	61	ng	ng	PROPN
ct-9353	46	62	/	/	SYM
ct-9353	46	63	ml	ml	PROPN
ct-9353	46	64	,	,	PUNCT
ct-9353	46	65	due	due	ADP
ct-9353	46	66	to	to	ADP
ct-9353	46	67	variations	variation	NOUN
ct-9353	46	68	in	in	ADP
ct-9353	46	69	secretion	secretion	NOUN
ct-9353	46	70	of	of	ADP
ct-9353	46	71	this	this	DET
ct-9353	46	72	hormone	hormone	NOUN
ct-9353	46	73	during	during	ADP
ct-9353	46	74	the	the	DET
ct-9353	46	75	day	day	NOUN
ct-9353	46	76	.	.	PUNCT
ct-9353	47	1	studies	study	NOUN
ct-9353	47	2	have	have	AUX
ct-9353	47	3	indicated	indicate	VERB
ct-9353	47	4	the	the	DET
ct-9353	47	5	progestogenic	progestogenic	ADJ
ct-9353	47	6	potential	potential	NOUN
ct-9353	47	7	of	of	ADP
ct-9353	47	8	altrenogest	altrenog	ADJ
ct-9353	47	9	,	,	PUNCT
ct-9353	47	10	while	while	SCONJ
ct-9353	47	11	no	no	DET
ct-9353	47	12	other	other	ADJ
ct-9353	47	13	synthetic	synthetic	ADJ
ct-9353	47	14	progestin	progestin	NOUN
ct-9353	47	15	has	have	AUX
ct-9353	47	16	been	be	AUX
ct-9353	47	17	found	find	VERB
ct-9353	47	18	as	as	ADP
ct-9353	47	19	effective	effective	ADJ
ct-9353	47	20	.	.	PUNCT
ct-9353	48	1	either	either	PRON
ct-9353	48	2	150	150	NUM
ct-9353	48	3	mg	mg	NOUN
ct-9353	48	4	progesterone	progesterone	NOUN
ct-9353	48	5	in	in	ADP
ct-9353	48	6	oil	oil	NOUN
ct-9353	48	7	or	or	CCONJ
ct-9353	48	8	0.044	0.044	NUM
ct-9353	48	9	mg	mg	PROPN
ct-9353	48	10	/	/	SYM
ct-9353	48	11	kg	kg	PROPN
ct-9353	48	12	altrenogest	altrenogest	PROPN
ct-9353	48	13	maintained	maintain	VERB
ct-9353	48	14	pregnancy	pregnancy	NOUN
ct-9353	48	15	after	after	ADP
ct-9353	48	16	a	a	DET
ct-9353	48	17	luteolytic	luteolytic	ADJ
ct-9353	48	18	dose	dose	NOUN
ct-9353	48	19	of	of	ADP
ct-9353	48	20	pgf2α	pgf2α	PROPN
ct-9353	48	21	in	in	ADP
ct-9353	48	22	ovariectomized	ovariectomize	VERB
ct-9353	48	23	mares.37	mares.37	PROPN
ct-9353	48	24	interestingly	interestingly	ADV
ct-9353	48	25	,	,	PUNCT
ct-9353	48	26	a	a	DET
ct-9353	48	27	double	double	ADJ
ct-9353	48	28	dose	dose	NOUN
ct-9353	48	29	of	of	ADP
ct-9353	48	30	altrenogest	altrenog	ADJ
ct-9353	48	31	(	(	PUNCT
ct-9353	48	32	0.088	0.088	NUM
ct-9353	48	33	mg	mg	PROPN
ct-9353	48	34	/	/	SYM
ct-9353	48	35	kg	kg	PROPN
ct-9353	48	36	)	)	PUNCT
ct-9353	48	37	was	be	AUX
ct-9353	48	38	more	more	ADV
ct-9353	48	39	effective	effective	ADJ
ct-9353	48	40	in	in	ADP
ct-9353	48	41	pregnancy	pregnancy	NOUN
ct-9353	48	42	maintenance	maintenance	NOUN
ct-9353	48	43	in	in	ADP
ct-9353	48	44	ovariectomized	ovariectomize	VERB
ct-9353	48	45	recipient	recipient	NOUN
ct-9353	48	46	mares	mare	NOUN
ct-9353	48	47	after	after	ADP
ct-9353	48	48	embryo	embryo	NOUN
ct-9353	48	49	transfer.38	transfer.38	PROPN
ct-9353	48	50	in	in	ADP
ct-9353	48	51	this	this	DET
ct-9353	48	52	study	study	NOUN
ct-9353	48	53	,	,	PUNCT
ct-9353	48	54	it	it	PRON
ct-9353	48	55	was	be	AUX
ct-9353	48	56	determined	determine	VERB
ct-9353	48	57	that	that	SCONJ
ct-9353	48	58	the	the	DET
ct-9353	48	59	standard	standard	NOUN
ct-9353	48	60	dose	dose	NOUN
ct-9353	48	61	of	of	ADP
ct-9353	48	62	0.044	0.044	NUM
ct-9353	48	63	mg	mg	PROPN
ct-9353	48	64	/	/	SYM
ct-9353	48	65	kg	kg	PROPN
ct-9353	48	66	produced	produce	VERB
ct-9353	48	67	poor	poor	ADJ
ct-9353	48	68	uterine	uterine	ADJ
ct-9353	48	69	tone	tone	NOUN
ct-9353	48	70	and	and	CCONJ
ct-9353	48	71	decreased	decrease	VERB
ct-9353	48	72	cervical	cervical	ADJ
ct-9353	48	73	competence	competence	NOUN
ct-9353	48	74	.	.	PUNCT
ct-9353	49	1	the	the	DET
ct-9353	49	2	authors	author	NOUN
ct-9353	49	3	recommended	recommend	VERB
ct-9353	49	4	the	the	DET
ct-9353	49	5	double	double	ADJ
ct-9353	49	6	dose	dose	NOUN
ct-9353	49	7	to	to	PART
ct-9353	49	8	be	be	AUX
ct-9353	49	9	utilized	utilize	VERB
ct-9353	49	10	during	during	ADP
ct-9353	49	11	embryo	embryo	NOUN
ct-9353	49	12	transfer	transfer	NOUN
ct-9353	49	13	procedures	procedure	NOUN
ct-9353	49	14	.	.	PUNCT
ct-9353	50	1	several	several	ADJ
ct-9353	50	2	other	other	ADJ
ct-9353	50	3	synthetic	synthetic	ADJ
ct-9353	50	4	progestins	progestin	NOUN
ct-9353	50	5	(	(	PUNCT
ct-9353	50	6	1000	1000	NUM
ct-9353	50	7	mg	mg	PROPN
ct-9353	50	8	hydroxyprogesterone	hydroxyprogesterone	NOUN
ct-9353	50	9	caproate	caproate	NOUN
ct-9353	50	10	,	,	PUNCT
ct-9353	50	11	1000	1000	NUM
ct-9353	50	12	mg	mg	PROPN
ct-9353	50	13	mpa	mpa	PROPN
ct-9353	50	14	,	,	PUNCT
ct-9353	50	15	500	500	NUM
ct-9353	50	16	mg	mg	PROPN
ct-9353	50	17	hydroxyprogesterone	hydroxyprogesterone	PROPN
ct-9353	50	18	hexanoate	hexanoate	NOUN
ct-9353	50	19	,	,	PUNCT
ct-9353	50	20	15	15	NUM
ct-9353	50	21	mg	mg	NOUN
ct-9353	50	22	norgestomet	norgestomet	NOUN
ct-9353	50	23	,	,	PUNCT
ct-9353	50	24	and	and	CCONJ
ct-9353	50	25	500	500	NUM
ct-9353	50	26	mg	mg	PROPN
ct-9353	50	27	megestrol	megestrol	NOUN
ct-9353	50	28	acetate	acetate	NOUN
ct-9353	50	29	)	)	PUNCT
ct-9353	50	30	were	be	AUX
ct-9353	50	31	unable	unable	ADJ
ct-9353	50	32	to	to	PART
ct-9353	50	33	maintain	maintain	VERB
ct-9353	50	34	pregnancy.39	pregnancy.39	ADJ
ct-9353	50	35	mares	mare	NOUN
ct-9353	50	36	treated	treat	VERB
ct-9353	50	37	with	with	ADP
ct-9353	50	38	altrenogest	altrenogest	NOUN
ct-9353	50	39	maintained	maintain	VERB
ct-9353	50	40	pregnancy	pregnancy	NOUN
ct-9353	50	41	after	after	ADP
ct-9353	50	42	pgf2α	pgf2α	NOUN
ct-9353	50	43	treatment	treatment	NOUN
ct-9353	50	44	whereas	whereas	SCONJ
ct-9353	50	45	other	other	ADJ
ct-9353	50	46	progestins	progestin	NOUN
ct-9353	50	47	were	be	AUX
ct-9353	50	48	not	not	PART
ct-9353	50	49	able	able	ADJ
ct-9353	50	50	to	to	PART
ct-9353	50	51	prevent	prevent	VERB
ct-9353	50	52	abortion.1	abortion.1	PROPN
ct-9353	50	53	in	in	ADP
ct-9353	50	54	addition	addition	NOUN
ct-9353	50	55	,	,	PUNCT
ct-9353	50	56	long	long	ADV
ct-9353	50	57	-	-	PUNCT
ct-9353	50	58	acting	act	VERB
ct-9353	50	59	progesterone	progesterone	NOUN
ct-9353	50	60	(	(	PUNCT
ct-9353	50	61	150	150	NUM
ct-9353	50	62	mg	mg	NOUN
ct-9353	50	63	)	)	PUNCT
ct-9353	50	64	compounds	compound	NOUN
ct-9353	50	65	were	be	AUX
ct-9353	50	66	effective	effective	ADJ
ct-9353	50	67	in	in	ADP
ct-9353	50	68	preventing	prevent	VERB
ct-9353	50	69	early	early	ADJ
ct-9353	50	70	pregnancy	pregnancy	NOUN
ct-9353	50	71	loss	loss	NOUN
ct-9353	50	72	after	after	ADP
ct-9353	50	73	a	a	DET
ct-9353	50	74	luteolytic	luteolytic	ADJ
ct-9353	50	75	dose	dose	NOUN
ct-9353	50	76	of	of	ADP
ct-9353	50	77	pgf2α	pgf2α	PROPN
ct-9353	50	78	and	and	CCONJ
ct-9353	50	79	are	be	AUX
ct-9353	50	80	worth	worth	ADJ
ct-9353	50	81	considering.40	considering.40	PROPN
ct-9353	50	82	there	there	PRON
ct-9353	50	83	is	be	VERB
ct-9353	50	84	no	no	DET
ct-9353	50	85	cross	cross	NOUN
ct-9353	50	86	reactivity	reactivity	NOUN
ct-9353	50	87	between	between	ADP
ct-9353	50	88	altrenogest	altrenogest	NOUN
ct-9353	50	89	and	and	CCONJ
ct-9353	50	90	progesterone	progesterone	NOUN
ct-9353	50	91	in	in	ADP
ct-9353	50	92	commercial	commercial	ADJ
ct-9353	50	93	progesterone	progesterone	NOUN
ct-9353	50	94	assays	assay	NOUN
ct-9353	50	95	;	;	PUNCT
ct-9353	50	96	therefore	therefore	ADV
ct-9353	50	97	,	,	PUNCT
ct-9353	50	98	progesterone	progesterone	NOUN
ct-9353	50	99	assays	assay	NOUN
ct-9353	50	100	are	be	AUX
ct-9353	50	101	helpful	helpful	ADJ
ct-9353	50	102	in	in	ADP
ct-9353	50	103	determining	determine	VERB
ct-9353	50	104	whether	whether	SCONJ
ct-9353	50	105	a	a	DET
ct-9353	50	106	cl	cl	NOUN
ct-9353	50	107	has	have	AUX
ct-9353	50	108	undergone	undergo	VERB
ct-9353	50	109	luteolysis	luteolysis	NOUN
ct-9353	50	110	(	(	PUNCT
ct-9353	50	111	p4	p4	ADJ
ct-9353	50	112	<	<	X
ct-9353	50	113	1	1	NUM
ct-9353	50	114	ng	ng	PROPN
ct-9353	50	115	/	/	SYM
ct-9353	50	116	ml	ml	NOUN
ct-9353	50	117	)	)	PUNCT
ct-9353	50	118	or	or	CCONJ
ct-9353	50	119	is	be	AUX
ct-9353	50	120	still	still	ADV
ct-9353	50	121	active	active	ADJ
ct-9353	50	122	during	during	ADP
ct-9353	50	123	treatment	treatment	NOUN
ct-9353	50	124	.	.	PUNCT
ct-9353	51	1	assay	assay	PROPN
ct-9353	51	2	results	result	NOUN
ct-9353	51	3	can	can	AUX
ct-9353	51	4	guide	guide	VERB
ct-9353	51	5	the	the	DET
ct-9353	51	6	clinician	clinician	NOUN
ct-9353	51	7	to	to	PART
ct-9353	51	8	make	make	VERB
ct-9353	51	9	a	a	DET
ct-9353	51	10	decision	decision	NOUN
ct-9353	51	11	(	(	PUNCT
ct-9353	51	12	discontinue	discontinue	VERB
ct-9353	51	13	or	or	CCONJ
ct-9353	51	14	continue	continue	VERB
ct-9353	51	15	treatment	treatment	NOUN
ct-9353	51	16	)	)	PUNCT
ct-9353	51	17	until	until	SCONJ
ct-9353	51	18	the	the	DET
ct-9353	51	19	feto	feto	VERB
ct-9353	51	20	-	-	PUNCT
ct-9353	51	21	placental	placental	ADJ
ct-9353	51	22	unit	unit	NOUN
ct-9353	51	23	provides	provide	VERB
ct-9353	51	24	necessary	necessary	ADJ
ct-9353	51	25	progestogen	progestogen	NOUN
ct-9353	51	26	support	support	NOUN
ct-9353	51	27	to	to	PART
ct-9353	51	28	maintain	maintain	VERB
ct-9353	51	29	pregnancy	pregnancy	NOUN
ct-9353	51	30	.	.	PUNCT
ct-9353	52	1	however	however	ADV
ct-9353	52	2	,	,	PUNCT
ct-9353	52	3	altrenogest	altrenog	ADJ
ct-9353	52	4	treatment	treatment	NOUN
ct-9353	52	5	can	can	AUX
ct-9353	52	6	suppress	suppress	VERB
ct-9353	52	7	endogenous	endogenous	ADJ
ct-9353	52	8	production	production	NOUN
ct-9353	52	9	of	of	ADP
ct-9353	52	10	progesterone	progesterone	NOUN
ct-9353	52	11	and	and	CCONJ
ct-9353	52	12	may	may	AUX
ct-9353	52	13	interfere	interfere	VERB
ct-9353	52	14	with	with	ADP
ct-9353	52	15	formation	formation	NOUN
ct-9353	52	16	of	of	ADP
ct-9353	52	17	secondary	secondary	ADJ
ct-9353	52	18	cl.41,42	cl.41,42	NOUN
ct-9353	52	19	one	one	NUM
ct-9353	52	20	study	study	NOUN
ct-9353	52	21	found	find	VERB
ct-9353	52	22	altrenogest	altrenog	ADJ
ct-9353	52	23	supplementation	supplementation	NOUN
ct-9353	52	24	to	to	PART
ct-9353	52	25	decrease	decrease	VERB
ct-9353	52	26	the	the	DET
ct-9353	52	27	production	production	NOUN
ct-9353	52	28	of	of	ADP
ct-9353	52	29	equine	equine	NOUN
ct-9353	52	30	chorionic	chorionic	ADJ
ct-9353	52	31	gonadotropin	gonadotropin	NOUN
ct-9353	52	32	(	(	PUNCT
ct-9353	52	33	ecg	ecg	PROPN
ct-9353	52	34	)	)	PUNCT
ct-9353	52	35	in	in	ADP
ct-9353	52	36	mares	mare	NOUN
ct-9353	52	37	greater	great	ADJ
ct-9353	52	38	than	than	ADP
ct-9353	52	39	8	8	NUM
ct-9353	52	40	years	year	NOUN
ct-9353	52	41	of	of	ADP
ct-9353	52	42	age	age	NOUN
ct-9353	52	43	,	,	PUNCT
ct-9353	52	44	but	but	CCONJ
ct-9353	52	45	also	also	ADV
ct-9353	52	46	found	find	VERB
ct-9353	52	47	altrenogest	altrenog	ADJ
ct-9353	52	48	treatment	treatment	NOUN
ct-9353	52	49	to	to	PART
ct-9353	52	50	maximize	maximize	VERB
ct-9353	52	51	embryo	embryo	NOUN
ct-9353	52	52	size	size	NOUN
ct-9353	52	53	in	in	ADP
ct-9353	52	54	the	the	DET
ct-9353	52	55	aged	aged	ADJ
ct-9353	52	56	mare	mare	NOUN
ct-9353	52	57	population.43	population.43	NOUN
ct-9353	52	58	figure	figure	NOUN
ct-9353	52	59	2	2	NUM
ct-9353	52	60	:	:	PUNCT
ct-9353	52	61	standard	standard	ADJ
ct-9353	52	62	progesterone	progesterone	NOUN
ct-9353	52	63	and	and	CCONJ
ct-9353	52	64	estrogen	estrogen	NOUN
ct-9353	52	65	‘	'	PUNCT
ct-9353	52	66	p&e	p&e	NOUN
ct-9353	52	67	’	'	PUNCT
ct-9353	52	68	treatment	treatment	NOUN
ct-9353	52	69	protocol	protocol	NOUN
ct-9353	52	70	(	(	PUNCT
ct-9353	52	71	daily	daily	ADJ
ct-9353	52	72	150	150	NUM
ct-9353	52	73	mg	mg	NOUN
ct-9353	52	74	progesterone	progesterone	NOUN
ct-9353	52	75	in	in	ADP
ct-9353	52	76	oil	oil	NOUN
ct-9353	52	77	or	or	CCONJ
ct-9353	52	78	0.044	0.044	NUM
ct-9353	52	79	mg	mg	PROPN
ct-9353	52	80	/	/	SYM
ct-9353	52	81	kg	kg	PROPN
ct-9353	52	82	altrenogest	altrenogest	NOUN
ct-9353	52	83	with	with	ADP
ct-9353	52	84	10	10	NUM
ct-9353	52	85	mg	mg	NUM
ct-9353	52	86	estradiol-17β	estradiol-17β	PROPN
ct-9353	52	87	)	)	PUNCT
ct-9353	52	88	.	.	PUNCT
ct-9353	53	1	treatment	treatment	NOUN
ct-9353	53	2	is	be	AUX
ct-9353	53	3	initiated	initiate	VERB
ct-9353	53	4	when	when	SCONJ
ct-9353	53	5	a	a	DET
ct-9353	53	6	25	25	NUM
ct-9353	53	7	mm	mm	NOUN
ct-9353	53	8	follicle	follicle	NOUN
ct-9353	53	9	is	be	AUX
ct-9353	53	10	detected	detect	VERB
ct-9353	53	11	.	.	PUNCT
ct-9353	54	1	a	a	DET
ct-9353	54	2	luteolytic	luteolytic	ADJ
ct-9353	54	3	dose	dose	NOUN
ct-9353	54	4	of	of	ADP
ct-9353	54	5	pgf2α	pgf2α	PROPN
ct-9353	54	6	is	be	AUX
ct-9353	54	7	given	give	VERB
ct-9353	54	8	on	on	ADP
ct-9353	54	9	day	day	NOUN
ct-9353	54	10	10	10	NUM
ct-9353	54	11	and	and	CCONJ
ct-9353	54	12	transrectal	transrectal	ADJ
ct-9353	54	13	ultrasonography	ultrasonography	NOUN
ct-9353	54	14	is	be	AUX
ct-9353	54	15	used	use	VERB
ct-9353	54	16	to	to	PART
ct-9353	54	17	assess	assess	VERB
ct-9353	54	18	follicular	follicular	ADJ
ct-9353	54	19	development	development	NOUN
ct-9353	54	20	.	.	PUNCT
ct-9353	55	1	when	when	SCONJ
ct-9353	55	2	a	a	DET
ct-9353	55	3	35	35	NUM
ct-9353	55	4	mm	mm	NOUN
ct-9353	55	5	follicle	follicle	NOUN
ct-9353	55	6	(	(	PUNCT
ct-9353	55	7	6	6	NUM
ct-9353	55	8	9	9	NUM
ct-9353	55	9	days	day	NOUN
ct-9353	55	10	after	after	ADP
ct-9353	55	11	cessation	cessation	NOUN
ct-9353	55	12	of	of	ADP
ct-9353	55	13	treatment	treatment	NOUN
ct-9353	55	14	)	)	PUNCT
ct-9353	55	15	is	be	AUX
ct-9353	55	16	detected	detect	VERB
ct-9353	55	17	,	,	PUNCT
ct-9353	55	18	hcg	hcg	PROPN
ct-9353	55	19	is	be	AUX
ct-9353	55	20	given	give	VERB
ct-9353	55	21	and	and	CCONJ
ct-9353	55	22	mares	mare	NOUN
ct-9353	55	23	are	be	AUX
ct-9353	55	24	inseminated	inseminate	VERB
ct-9353	55	25	24	24	NUM
ct-9353	55	26	36	36	NUM
ct-9353	55	27	hours	hour	NOUN
ct-9353	55	28	later	later	ADV
ct-9353	55	29	.	.	PUNCT
ct-9353	56	1	clinical	clinical	ADJ
ct-9353	56	2	theriogenology	theriogenology	NOUN
ct-9353	56	3	2021	2021	NUM
ct-9353	56	4	;	;	PUNCT
ct-9353	56	5	13	13	NUM
ct-9353	56	6	:	:	SYM
ct-9353	56	7	249	249	NUM
ct-9353	56	8	supporting	support	VERB
ct-9353	56	9	late	late	ADJ
ct-9353	56	10	pregnancy	pregnancy	NOUN
ct-9353	56	11	treatment	treatment	NOUN
ct-9353	56	12	with	with	ADP
ct-9353	56	13	a	a	DET
ct-9353	56	14	double	double	ADJ
ct-9353	56	15	dose	dose	NOUN
ct-9353	56	16	of	of	ADP
ct-9353	56	17	altrenogest	altrenog	ADJ
ct-9353	56	18	(	(	PUNCT
ct-9353	56	19	0.088	0.088	NUM
ct-9353	56	20	mg	mg	PROPN
ct-9353	56	21	/	/	SYM
ct-9353	56	22	kg	kg	NOUN
ct-9353	56	23	)	)	PUNCT
ct-9353	56	24	prevented	prevent	VERB
ct-9353	56	25	late	late	ADJ
ct-9353	56	26	-	-	PUNCT
ct-9353	56	27	term	term	NOUN
ct-9353	56	28	abortion	abortion	NOUN
ct-9353	56	29	in	in	ADP
ct-9353	56	30	mares	mare	NOUN
ct-9353	56	31	after	after	SCONJ
ct-9353	56	32	abortion	abortion	NOUN
ct-9353	56	33	was	be	AUX
ct-9353	56	34	attempted	attempt	VERB
ct-9353	56	35	with	with	ADP
ct-9353	56	36	a	a	DET
ct-9353	56	37	synthetic	synthetic	ADJ
ct-9353	56	38	prostaglandin	prostaglandin	NOUN
ct-9353	56	39	from	from	ADP
ct-9353	56	40	90	90	NUM
ct-9353	56	41	115	115	NUM
ct-9353	56	42	days	day	NOUN
ct-9353	56	43	of	of	ADP
ct-9353	56	44	pregnancy.44	pregnancy.44	NOUN
ct-9353	56	45	progestins	progestin	NOUN
ct-9353	56	46	have	have	AUX
ct-9353	56	47	been	be	AUX
ct-9353	56	48	suggested	suggest	VERB
ct-9353	56	49	to	to	PART
ct-9353	56	50	maintain	maintain	VERB
ct-9353	56	51	pregnancy	pregnancy	NOUN
ct-9353	56	52	in	in	ADP
ct-9353	56	53	late	late	ADJ
ct-9353	56	54	pregnancy	pregnancy	NOUN
ct-9353	56	55	by	by	ADP
ct-9353	56	56	inducing	induce	VERB
ct-9353	56	57	myometrial	myometrial	ADJ
ct-9353	56	58	quiescence	quiescence	NOUN
ct-9353	56	59	and	and	CCONJ
ct-9353	56	60	suppressing	suppress	VERB
ct-9353	56	61	pgf2α	pgf2α	PROPN
ct-9353	56	62	secretion	secretion	NOUN
ct-9353	56	63	,	,	PUNCT
ct-9353	56	64	presumably	presumably	ADV
ct-9353	56	65	by	by	ADP
ct-9353	56	66	modulation	modulation	NOUN
ct-9353	56	67	of	of	ADP
ct-9353	56	68	cytokines	cytokine	NOUN
ct-9353	56	69	.	.	PUNCT
ct-9353	57	1	therefore	therefore	ADV
ct-9353	57	2	,	,	PUNCT
ct-9353	57	3	altrenogest	altrenogest	NOUN
ct-9353	57	4	is	be	AUX
ct-9353	57	5	routinely	routinely	ADV
ct-9353	57	6	used	use	VERB
ct-9353	57	7	during	during	ADP
ct-9353	57	8	pregnancy	pregnancy	NOUN
ct-9353	57	9	for	for	ADP
ct-9353	57	10	the	the	DET
ct-9353	57	11	prevention	prevention	NOUN
ct-9353	57	12	or	or	CCONJ
ct-9353	57	13	treatment	treatment	NOUN
ct-9353	57	14	of	of	ADP
ct-9353	57	15	ascending	ascend	VERB
ct-9353	57	16	placentitis	placentitis	PROPN
ct-9353	57	17	,	,	PUNCT
ct-9353	57	18	a	a	DET
ct-9353	57	19	leading	lead	VERB
ct-9353	57	20	cause	cause	NOUN
ct-9353	57	21	of	of	ADP
ct-9353	57	22	infectious	infectious	ADJ
ct-9353	57	23	abortion	abortion	NOUN
ct-9353	57	24	in	in	ADP
ct-9353	57	25	north	north	PROPN
ct-9353	57	26	america	america	PROPN
ct-9353	57	27	.	.	PUNCT
ct-9353	58	1	combined	combined	ADJ
ct-9353	58	2	treatment	treatment	NOUN
ct-9353	58	3	of	of	ADP
ct-9353	58	4	antimicrobial	antimicrobial	ADJ
ct-9353	58	5	(	(	PUNCT
ct-9353	58	6	trimethoprim	trimethoprim	NOUN
ct-9353	58	7	sulfamethoxazole	sulfamethoxazole	NOUN
ct-9353	58	8	)	)	PUNCT
ct-9353	58	9	,	,	PUNCT
ct-9353	58	10	immunomodulator	immunomodulator	NOUN
ct-9353	58	11	(	(	PUNCT
ct-9353	58	12	pentoxifylline	pentoxifylline	PROPN
ct-9353	58	13	)	)	PUNCT
ct-9353	58	14	,	,	PUNCT
ct-9353	58	15	and	and	CCONJ
ct-9353	58	16	progestin	progestin	NOUN
ct-9353	58	17	(	(	PUNCT
ct-9353	58	18	altrenogest	altrenogest	PROPN
ct-9353	58	19	)	)	PUNCT
ct-9353	58	20	was	be	AUX
ct-9353	58	21	effective	effective	ADJ
ct-9353	58	22	in	in	ADP
ct-9353	58	23	treating	treat	VERB
ct-9353	58	24	experimentally	experimentally	ADV
ct-9353	58	25	induced	induce	VERB
ct-9353	58	26	disease	disease	NOUN
ct-9353	58	27	(	(	PUNCT
ct-9353	58	28	transcervical	transcervical	ADJ
ct-9353	58	29	inoculation	inoculation	NOUN
ct-9353	58	30	with	with	ADP
ct-9353	58	31	streptococcus	streptococcus	NOUN
ct-9353	58	32	zooepidemicus).45	zooepidemicus).45	NOUN
ct-9353	58	33	although	although	SCONJ
ct-9353	58	34	none	none	NOUN
ct-9353	58	35	of	of	ADP
ct-9353	58	36	the	the	DET
ct-9353	58	37	untreated	untreated	ADJ
ct-9353	58	38	mares	mare	NOUN
ct-9353	58	39	carried	carry	VERB
ct-9353	58	40	to	to	ADP
ct-9353	58	41	term	term	NOUN
ct-9353	58	42	,	,	PUNCT
ct-9353	58	43	10/12	10/12	NUM
ct-9353	58	44	(	(	PUNCT
ct-9353	58	45	83	83	NUM
ct-9353	58	46	%	%	NOUN
ct-9353	58	47	)	)	PUNCT
ct-9353	58	48	of	of	ADP
ct-9353	58	49	the	the	DET
ct-9353	58	50	treated	treat	VERB
ct-9353	58	51	mares	mare	NOUN
ct-9353	58	52	produced	produce	VERB
ct-9353	58	53	a	a	DET
ct-9353	58	54	viable	viable	ADJ
ct-9353	58	55	foal	foal	NOUN
ct-9353	58	56	.	.	PUNCT
ct-9353	59	1	since	since	SCONJ
ct-9353	59	2	treatments	treatment	NOUN
ct-9353	59	3	were	be	AUX
ct-9353	59	4	not	not	PART
ct-9353	59	5	assessed	assess	VERB
ct-9353	59	6	individually	individually	ADV
ct-9353	59	7	,	,	PUNCT
ct-9353	59	8	it	it	PRON
ct-9353	59	9	is	be	AUX
ct-9353	59	10	unclear	unclear	ADJ
ct-9353	59	11	if	if	SCONJ
ct-9353	59	12	altrenogest	altrenog	ADJ
ct-9353	59	13	treatment	treatment	NOUN
ct-9353	59	14	alone	alone	ADV
ct-9353	59	15	prevented	prevent	VERB
ct-9353	59	16	abortion	abortion	NOUN
ct-9353	59	17	.	.	PUNCT
ct-9353	60	1	this	this	DET
ct-9353	60	2	confers	confer	NOUN
ct-9353	60	3	with	with	ADP
ct-9353	60	4	recent	recent	ADJ
ct-9353	60	5	research	research	NOUN
ct-9353	60	6	that	that	PRON
ct-9353	60	7	demonstrated	demonstrate	VERB
ct-9353	60	8	a	a	DET
ct-9353	60	9	withdrawal	withdrawal	NOUN
ct-9353	60	10	of	of	ADP
ct-9353	60	11	pr	pr	NOUN
ct-9353	60	12	preceded	precede	VERB
ct-9353	60	13	premature	premature	ADJ
ct-9353	60	14	parturition	parturition	NOUN
ct-9353	60	15	in	in	ADP
ct-9353	60	16	experimentally	experimentally	ADV
ct-9353	60	17	induced	induce	VERB
ct-9353	60	18	disease	disease	NOUN
ct-9353	60	19	,	,	PUNCT
ct-9353	60	20	indicating	indicate	VERB
ct-9353	60	21	that	that	SCONJ
ct-9353	60	22	altrenogest	altrenogest	NOUN
ct-9353	60	23	supplementation	supplementation	NOUN
ct-9353	60	24	may	may	AUX
ct-9353	60	25	be	be	AUX
ct-9353	60	26	of	of	ADP
ct-9353	60	27	no	no	DET
ct-9353	60	28	benefit.46	benefit.46	NOUN
ct-9353	60	29	this	this	PRON
ct-9353	60	30	was	be	AUX
ct-9353	60	31	further	far	ADV
ct-9353	60	32	supported	support	VERB
ct-9353	60	33	by	by	ADP
ct-9353	60	34	a	a	DET
ct-9353	60	35	study47	study47	NOUN
ct-9353	60	36	that	that	PRON
ct-9353	60	37	demonstrated	demonstrate	VERB
ct-9353	60	38	that	that	SCONJ
ct-9353	60	39	addition	addition	NOUN
ct-9353	60	40	of	of	ADP
ct-9353	60	41	altrenogest	altrenogest	NOUN
ct-9353	60	42	treatment	treatment	NOUN
ct-9353	60	43	had	have	VERB
ct-9353	60	44	no	no	DET
ct-9353	60	45	effect	effect	NOUN
ct-9353	60	46	on	on	ADP
ct-9353	60	47	pregnancy	pregnancy	NOUN
ct-9353	60	48	length	length	NOUN
ct-9353	60	49	,	,	PUNCT
ct-9353	60	50	interval	interval	NOUN
ct-9353	60	51	from	from	ADP
ct-9353	60	52	inoculation	inoculation	NOUN
ct-9353	60	53	to	to	ADP
ct-9353	60	54	delivery	delivery	NOUN
ct-9353	60	55	,	,	PUNCT
ct-9353	60	56	or	or	CCONJ
ct-9353	60	57	neonatal	neonatal	ADJ
ct-9353	60	58	outcome	outcome	NOUN
ct-9353	60	59	in	in	ADP
ct-9353	60	60	comparison	comparison	NOUN
ct-9353	60	61	to	to	ADP
ct-9353	60	62	mares	mare	NOUN
ct-9353	60	63	solely	solely	ADV
ct-9353	60	64	treated	treat	VERB
ct-9353	60	65	with	with	ADP
ct-9353	60	66	antimicrobials	antimicrobial	NOUN
ct-9353	60	67	and	and	CCONJ
ct-9353	60	68	antiinflammatories	antiinflammatorie	NOUN
ct-9353	60	69	.	.	PUNCT
ct-9353	61	1	in	in	ADP
ct-9353	61	2	that	that	DET
ct-9353	61	3	study	study	NOUN
ct-9353	61	4	,	,	PUNCT
ct-9353	61	5	the	the	DET
ct-9353	61	6	addition	addition	NOUN
ct-9353	61	7	of	of	ADP
ct-9353	61	8	estradiol	estradiol	PROPN
ct-9353	61	9	cypionate	cypionate	PROPN
ct-9353	61	10	to	to	ADP
ct-9353	61	11	antimicrobial	antimicrobial	ADJ
ct-9353	61	12	/	/	SYM
ct-9353	61	13	antiinflammatory	antiinflammatory	NOUN
ct-9353	61	14	treatment	treatment	NOUN
ct-9353	61	15	increased	increase	VERB
ct-9353	61	16	pregnancy	pregnancy	NOUN
ct-9353	61	17	length	length	NOUN
ct-9353	61	18	from	from	ADP
ct-9353	61	19	induction	induction	NOUN
ct-9353	61	20	of	of	ADP
ct-9353	61	21	disease	disease	NOUN
ct-9353	61	22	,	,	PUNCT
ct-9353	61	23	in	in	ADP
ct-9353	61	24	addition	addition	NOUN
ct-9353	61	25	to	to	ADP
ct-9353	61	26	improving	improve	VERB
ct-9353	61	27	neonatal	neonatal	ADJ
ct-9353	61	28	viability	viability	NOUN
ct-9353	61	29	.	.	PUNCT
ct-9353	62	1	furthermore	furthermore	ADV
ct-9353	62	2	,	,	PUNCT
ct-9353	62	3	altrenogest	altrenog	ADJ
ct-9353	62	4	treatment	treatment	NOUN
ct-9353	62	5	has	have	AUX
ct-9353	62	6	been	be	AUX
ct-9353	62	7	shown	show	VERB
ct-9353	62	8	to	to	PART
ct-9353	62	9	shorten	shorten	VERB
ct-9353	62	10	pregnancy	pregnancy	NOUN
ct-9353	62	11	length.48	length.48	PROPN
ct-9353	62	12	altrenogest	altrenogest	PROPN
ct-9353	62	13	supplementation	supplementation	NOUN
ct-9353	62	14	was	be	AUX
ct-9353	62	15	also	also	ADV
ct-9353	62	16	unnecessary	unnecessary	ADJ
ct-9353	62	17	in	in	ADP
ct-9353	62	18	pregnancy	pregnancy	NOUN
ct-9353	62	19	maintenance	maintenance	NOUN
ct-9353	62	20	after	after	ADP
ct-9353	62	21	late	late	ADJ
ct-9353	62	22	ovariectomy	ovariectomy	NOUN
ct-9353	62	23	(	(	PUNCT
ct-9353	62	24	>	>	NOUN
ct-9353	62	25	100	100	NUM
ct-9353	62	26	days	day	NOUN
ct-9353	62	27	)	)	PUNCT
ct-9353	62	28	,	,	PUNCT
ct-9353	62	29	regardless	regardless	ADV
ct-9353	62	30	of	of	ADP
ct-9353	62	31	concentration	concentration	NOUN
ct-9353	62	32	or	or	CCONJ
ct-9353	62	33	time	time	NOUN
ct-9353	62	34	of	of	ADP
ct-9353	62	35	treatment.49	treatment.49	NOUN
ct-9353	62	36	there	there	PRON
ct-9353	62	37	are	be	VERB
ct-9353	62	38	some	some	DET
ct-9353	62	39	discrepancies	discrepancy	NOUN
ct-9353	62	40	with	with	ADP
ct-9353	62	41	regard	regard	NOUN
ct-9353	62	42	to	to	ADP
ct-9353	62	43	safety	safety	NOUN
ct-9353	62	44	of	of	ADP
ct-9353	62	45	altrenogest	altrenogest	NOUN
ct-9353	62	46	treatment	treatment	NOUN
ct-9353	62	47	in	in	ADP
ct-9353	62	48	midto	midto	ADJ
ct-9353	62	49	late	late	ADJ
ct-9353	62	50	-	-	PUNCT
ct-9353	62	51	pregnancy	pregnancy	NOUN
ct-9353	62	52	.	.	PUNCT
ct-9353	63	1	mares	mare	NOUN
ct-9353	63	2	treated	treat	VERB
ct-9353	63	3	with	with	ADP
ct-9353	63	4	altrenogest	altrenogest	NOUN
ct-9353	63	5	in	in	ADP
ct-9353	63	6	late	late	ADJ
ct-9353	63	7	pregnancy	pregnancy	NOUN
ct-9353	63	8	had	have	VERB
ct-9353	63	9	shorter	short	ADJ
ct-9353	63	10	gestation	gestation	NOUN
ct-9353	63	11	,	,	PUNCT
ct-9353	63	12	poorer	poor	ADJ
ct-9353	63	13	neonatal	neonatal	ADJ
ct-9353	63	14	outcomes,48	outcomes,48	NOUN
ct-9353	63	15	and	and	CCONJ
ct-9353	63	16	fillies	filly	NOUN
ct-9353	63	17	were	be	AUX
ct-9353	63	18	born	bear	VERB
ct-9353	63	19	with	with	ADP
ct-9353	63	20	an	an	DET
ct-9353	63	21	enlarged	enlarged	ADJ
ct-9353	63	22	clitoris.8	clitoris.8	NOUN
ct-9353	63	23	additionally	additionally	ADV
ct-9353	63	24	,	,	PUNCT
ct-9353	63	25	after	after	ADP
ct-9353	63	26	treatment	treatment	NOUN
ct-9353	63	27	in	in	ADP
ct-9353	63	28	late	late	ADJ
ct-9353	63	29	pregnant	pregnant	ADJ
ct-9353	63	30	mares	mare	NOUN
ct-9353	63	31	,	,	PUNCT
ct-9353	63	32	altrenogest	altrenogest	PRON
ct-9353	63	33	was	be	AUX
ct-9353	63	34	detectable	detectable	ADJ
ct-9353	63	35	within	within	ADP
ct-9353	63	36	both	both	DET
ct-9353	63	37	fetal	fetal	ADJ
ct-9353	63	38	fluid	fluid	ADJ
ct-9353	63	39	compartments	compartment	NOUN
ct-9353	63	40	and	and	CCONJ
ct-9353	63	41	in	in	ADP
ct-9353	63	42	grossly	grossly	ADV
ct-9353	63	43	higher	high	ADJ
ct-9353	63	44	concentrations	concentration	NOUN
ct-9353	63	45	in	in	ADP
ct-9353	63	46	fetal	fetal	NOUN
ct-9353	63	47	compared	compare	VERB
ct-9353	63	48	to	to	ADP
ct-9353	63	49	maternal	maternal	ADJ
ct-9353	63	50	serum.50	serum.50	NOUN
ct-9353	63	51	yet	yet	ADV
ct-9353	63	52	,	,	PUNCT
ct-9353	63	53	foals	foal	NOUN
ct-9353	63	54	born	bear	VERB
ct-9353	63	55	to	to	ADP
ct-9353	63	56	mares	mare	NOUN
ct-9353	63	57	receiving	receive	VERB
ct-9353	63	58	altrenogest	altrenogest	NOUN
ct-9353	63	59	in	in	ADP
ct-9353	63	60	late	late	ADJ
ct-9353	63	61	pregnancy	pregnancy	NOUN
ct-9353	63	62	had	have	VERB
ct-9353	63	63	normal	normal	ADJ
ct-9353	63	64	onset	onset	NOUN
ct-9353	63	65	of	of	ADP
ct-9353	63	66	puberty	puberty	NOUN
ct-9353	63	67	,	,	PUNCT
ct-9353	63	68	comparable	comparable	ADJ
ct-9353	63	69	fertility	fertility	NOUN
ct-9353	63	70	,	,	PUNCT
ct-9353	63	71	and	and	CCONJ
ct-9353	63	72	reproductive	reproductive	ADJ
ct-9353	63	73	function	function	NOUN
ct-9353	63	74	to	to	ADP
ct-9353	63	75	controls.51,52	controls.51,52	PROPN
ct-9353	63	76	based	base	VERB
ct-9353	63	77	on	on	ADP
ct-9353	63	78	these	these	DET
ct-9353	63	79	findings	finding	NOUN
ct-9353	63	80	,	,	PUNCT
ct-9353	63	81	the	the	DET
ct-9353	63	82	efficacy	efficacy	NOUN
ct-9353	63	83	and	and	CCONJ
ct-9353	63	84	necessity	necessity	NOUN
ct-9353	63	85	of	of	ADP
ct-9353	63	86	progestin	progestin	NOUN
ct-9353	63	87	supplementation	supplementation	NOUN
ct-9353	63	88	in	in	ADP
ct-9353	63	89	mid	mid	ADJ
ct-9353	63	90	to	to	ADP
ct-9353	63	91	late	late	ADJ
ct-9353	63	92	-	-	PUNCT
ct-9353	63	93	pregnancy	pregnancy	NOUN
ct-9353	63	94	needs	need	VERB
ct-9353	63	95	to	to	PART
ct-9353	63	96	be	be	AUX
ct-9353	63	97	further	far	ADV
ct-9353	63	98	investigated	investigate	VERB
ct-9353	63	99	.	.	PUNCT
ct-9353	64	1	hastening	hasten	VERB
ct-9353	64	2	postpartum	postpartum	NOUN
ct-9353	64	3	involution	involution	NOUN
ct-9353	64	4	in	in	ADP
ct-9353	64	5	mares	mare	NOUN
ct-9353	64	6	,	,	PUNCT
ct-9353	64	7	first	first	ADJ
ct-9353	64	8	postpartum	postpartum	NOUN
ct-9353	64	9	estrus	estrus	NOUN
ct-9353	64	10	occurs	occur	VERB
ct-9353	64	11	within	within	ADP
ct-9353	64	12	5	5	NUM
ct-9353	64	13	20	20	NUM
ct-9353	64	14	days53,54	days53,54	NOUN
ct-9353	64	15	while	while	SCONJ
ct-9353	64	16	the	the	DET
ct-9353	64	17	uterus	uterus	NOUN
ct-9353	64	18	is	be	AUX
ct-9353	64	19	still	still	ADV
ct-9353	64	20	undergoing	undergo	VERB
ct-9353	64	21	repair	repair	NOUN
ct-9353	64	22	from	from	ADP
ct-9353	64	23	tissue	tissue	NOUN
ct-9353	64	24	alterations	alteration	NOUN
ct-9353	64	25	during	during	ADP
ct-9353	64	26	pregnancy	pregnancy	NOUN
ct-9353	64	27	and	and	CCONJ
ct-9353	64	28	foaling	foaling	NOUN
ct-9353	64	29	.	.	PUNCT
ct-9353	65	1	uterine	uterine	ADJ
ct-9353	65	2	involution	involution	NOUN
ct-9353	65	3	is	be	AUX
ct-9353	65	4	not	not	PART
ct-9353	65	5	complete	complete	ADJ
ct-9353	65	6	until	until	SCONJ
ct-9353	65	7	15	15	NUM
ct-9353	65	8	days	day	NOUN
ct-9353	65	9	postpartum	postpartum	NOUN
ct-9353	65	10	and	and	CCONJ
ct-9353	65	11	mares	mare	NOUN
ct-9353	65	12	ovulating	ovulate	VERB
ct-9353	65	13	>	>	X
ct-9353	65	14	10	10	NUM
ct-9353	65	15	days	day	NOUN
ct-9353	65	16	postpartum	postpartum	NOUN
ct-9353	65	17	are	be	AUX
ct-9353	65	18	more	more	ADV
ct-9353	65	19	likely	likely	ADJ
ct-9353	65	20	to	to	PART
ct-9353	65	21	achieve	achieve	VERB
ct-9353	65	22	and	and	CCONJ
ct-9353	65	23	maintain	maintain	VERB
ct-9353	65	24	pregnancy	pregnancy	NOUN
ct-9353	65	25	compared	compare	VERB
ct-9353	65	26	to	to	ADP
ct-9353	65	27	those	those	PRON
ct-9353	65	28	that	that	PRON
ct-9353	65	29	ovulated	ovulate	VERB
ct-9353	65	30	earlier.55	earlier.55	NOUN
ct-9353	65	31	this	this	PRON
ct-9353	65	32	is	be	AUX
ct-9353	65	33	attributed	attribute	VERB
ct-9353	65	34	to	to	ADP
ct-9353	65	35	the	the	DET
ct-9353	65	36	interval	interval	NOUN
ct-9353	65	37	of	of	ADP
ct-9353	65	38	time	time	NOUN
ct-9353	65	39	(	(	PUNCT
ct-9353	65	40	5.5	5.5	NUM
ct-9353	65	41	days	day	NOUN
ct-9353	65	42	)	)	PUNCT
ct-9353	65	43	that	that	SCONJ
ct-9353	65	44	the	the	DET
ct-9353	65	45	embryo	embryo	NOUN
ct-9353	65	46	resides	reside	VERB
ct-9353	65	47	within	within	ADP
ct-9353	65	48	the	the	DET
ct-9353	65	49	oviduct	oviduct	NOUN
ct-9353	65	50	after	after	ADP
ct-9353	65	51	fertilization	fertilization	NOUN
ct-9353	65	52	before	before	ADP
ct-9353	65	53	migrating	migrate	VERB
ct-9353	65	54	to	to	ADP
ct-9353	65	55	uterine	uterine	ADJ
ct-9353	65	56	lumen	luman	NOUN
ct-9353	65	57	,	,	PUNCT
ct-9353	65	58	at	at	ADP
ct-9353	65	59	which	which	DET
ct-9353	65	60	point	point	NOUN
ct-9353	65	61	involution	involution	NOUN
ct-9353	65	62	should	should	AUX
ct-9353	65	63	be	be	AUX
ct-9353	65	64	complete	complete	ADJ
ct-9353	65	65	.	.	PUNCT
ct-9353	66	1	therefore	therefore	ADV
ct-9353	66	2	,	,	PUNCT
ct-9353	66	3	progestins	progestin	NOUN
ct-9353	66	4	were	be	AUX
ct-9353	66	5	used56	used56	NOUN
ct-9353	66	6	-	-	PUNCT
ct-9353	66	7	58	58	NUM
ct-9353	66	8	in	in	ADP
ct-9353	66	9	an	an	DET
ct-9353	66	10	attempt	attempt	NOUN
ct-9353	66	11	to	to	PART
ct-9353	66	12	delay	delay	VERB
ct-9353	66	13	ovulation	ovulation	NOUN
ct-9353	66	14	in	in	ADP
ct-9353	66	15	order	order	NOUN
ct-9353	66	16	to	to	PART
ct-9353	66	17	improve	improve	VERB
ct-9353	66	18	fertility	fertility	NOUN
ct-9353	66	19	at	at	ADP
ct-9353	66	20	first	first	ADJ
ct-9353	66	21	postpartum	postpartum	NOUN
ct-9353	66	22	estrus	estrus	NOUN
ct-9353	66	23	,	,	PUNCT
ct-9353	66	24	with	with	ADP
ct-9353	66	25	mixed	mixed	ADJ
ct-9353	66	26	results	result	NOUN
ct-9353	66	27	.	.	PUNCT
ct-9353	67	1	one	one	NUM
ct-9353	67	2	study	study	NOUN
ct-9353	67	3	found	find	VERB
ct-9353	67	4	altrenogest	altrenogest	NOUN
ct-9353	67	5	to	to	PART
ct-9353	67	6	delay	delay	VERB
ct-9353	67	7	ovulation	ovulation	NOUN
ct-9353	67	8	and	and	CCONJ
ct-9353	67	9	increased	increase	VERB
ct-9353	67	10	pregnancy	pregnancy	NOUN
ct-9353	67	11	rates	rate	NOUN
ct-9353	67	12	in	in	ADP
ct-9353	67	13	postpartum	postpartum	NOUN
ct-9353	67	14	mares	mare	NOUN
ct-9353	67	15	when	when	SCONJ
ct-9353	67	16	administered	administer	VERB
ct-9353	67	17	for	for	ADP
ct-9353	67	18	the	the	DET
ct-9353	67	19	initial	initial	ADJ
ct-9353	67	20	8	8	NUM
ct-9353	67	21	days.56	days.56	NOUN
ct-9353	67	22	additionally	additionally	ADV
ct-9353	67	23	,	,	PUNCT
ct-9353	67	24	altrenogest	altrenogest	PRON
ct-9353	67	25	had	have	VERB
ct-9353	67	26	no	no	DET
ct-9353	67	27	effect	effect	NOUN
ct-9353	67	28	on	on	ADP
ct-9353	67	29	other	other	ADJ
ct-9353	67	30	aspects	aspect	NOUN
ct-9353	67	31	of	of	ADP
ct-9353	67	32	uterine	uterine	ADJ
ct-9353	67	33	involution	involution	NOUN
ct-9353	67	34	,	,	PUNCT
ct-9353	67	35	including	include	VERB
ct-9353	67	36	uterine	uterine	ADJ
ct-9353	67	37	tone	tone	NOUN
ct-9353	67	38	,	,	PUNCT
ct-9353	67	39	size	size	NOUN
ct-9353	67	40	,	,	PUNCT
ct-9353	67	41	or	or	CCONJ
ct-9353	67	42	retention	retention	NOUN
ct-9353	67	43	of	of	ADP
ct-9353	67	44	fluid	fluid	NOUN
ct-9353	67	45	.	.	PUNCT
ct-9353	68	1	a	a	DET
ct-9353	68	2	second	second	ADJ
ct-9353	68	3	study	study	NOUN
ct-9353	68	4	found	find	VERB
ct-9353	68	5	altrenogest	altrenog	ADJ
ct-9353	68	6	treatment	treatment	NOUN
ct-9353	68	7	to	to	PART
ct-9353	68	8	delay	delay	VERB
ct-9353	68	9	first	first	ADJ
ct-9353	68	10	ovulation	ovulation	NOUN
ct-9353	68	11	by	by	ADP
ct-9353	68	12	10	10	NUM
ct-9353	68	13	days	day	NOUN
ct-9353	68	14	but	but	CCONJ
ct-9353	68	15	did	do	AUX
ct-9353	68	16	not	not	PART
ct-9353	68	17	improve	improve	VERB
ct-9353	68	18	pregnancy	pregnancy	NOUN
ct-9353	68	19	rates	rate	NOUN
ct-9353	68	20	when	when	SCONJ
ct-9353	68	21	fed	feed	VERB
ct-9353	68	22	for	for	ADP
ct-9353	68	23	15	15	NUM
ct-9353	68	24	days	day	NOUN
ct-9353	68	25	postpartum.57	postpartum.57	NOUN
ct-9353	68	26	progesterone	progesterone	NOUN
ct-9353	68	27	(	(	PUNCT
ct-9353	68	28	100	100	NUM
ct-9353	68	29	mg	mg	NOUN
ct-9353	68	30	)	)	PUNCT
ct-9353	68	31	in	in	ADP
ct-9353	68	32	oil	oil	NOUN
ct-9353	68	33	treatment	treatment	NOUN
ct-9353	68	34	from	from	ADP
ct-9353	68	35	days	day	NOUN
ct-9353	68	36	5	5	NUM
ct-9353	68	37	to	to	PART
ct-9353	68	38	14	14	NUM
ct-9353	68	39	postpartum	postpartum	NOUN
ct-9353	68	40	successfully	successfully	ADV
ct-9353	68	41	inhibited	inhibit	VERB
ct-9353	68	42	ovulation	ovulation	NOUN
ct-9353	68	43	in	in	ADP
ct-9353	68	44	6/9	6/9	NUM
ct-9353	68	45	mares.58	mares.58	NOUN
ct-9353	68	46	additionally	additionally	ADV
ct-9353	68	47	,	,	PUNCT
ct-9353	68	48	the	the	DET
ct-9353	68	49	researchers	researcher	NOUN
ct-9353	68	50	noted	note	VERB
ct-9353	68	51	no	no	DET
ct-9353	68	52	histological	histological	ADJ
ct-9353	68	53	changes	change	NOUN
ct-9353	68	54	in	in	ADP
ct-9353	68	55	treated	treat	VERB
ct-9353	68	56	mares	mare	NOUN
ct-9353	68	57	,	,	PUNCT
ct-9353	68	58	and	and	CCONJ
ct-9353	68	59	pregnancy	pregnancy	NOUN
ct-9353	68	60	was	be	AUX
ct-9353	68	61	achieved	achieve	VERB
ct-9353	68	62	in	in	ADP
ct-9353	68	63	66	66	NUM
ct-9353	68	64	%	%	NOUN
ct-9353	68	65	of	of	ADP
ct-9353	68	66	treated	treat	VERB
ct-9353	68	67	mares	mare	NOUN
ct-9353	68	68	,	,	PUNCT
ct-9353	68	69	comparable	comparable	ADJ
ct-9353	68	70	to	to	ADP
ct-9353	68	71	other	other	ADJ
ct-9353	68	72	estrous	estrous	ADJ
ct-9353	68	73	cycles	cycle	NOUN
ct-9353	68	74	.	.	PUNCT
ct-9353	69	1	addition	addition	NOUN
ct-9353	69	2	of	of	ADP
ct-9353	69	3	estradiol-17β	estradiol-17β	PROPN
ct-9353	69	4	to	to	ADP
ct-9353	69	5	this	this	DET
ct-9353	69	6	treatment	treatment	NOUN
ct-9353	69	7	was	be	AUX
ct-9353	69	8	tried.59	tried.59	VERB
ct-9353	69	9	there	there	PRON
ct-9353	69	10	was	be	VERB
ct-9353	69	11	no	no	DET
ct-9353	69	12	delay	delay	NOUN
ct-9353	69	13	in	in	ADP
ct-9353	69	14	ovulation	ovulation	NOUN
ct-9353	69	15	when	when	SCONJ
ct-9353	69	16	mares	mare	NOUN
ct-9353	69	17	were	be	AUX
ct-9353	69	18	treated	treat	VERB
ct-9353	69	19	with	with	ADP
ct-9353	69	20	either	either	PRON
ct-9353	69	21	150	150	NUM
ct-9353	69	22	mg	mg	NOUN
ct-9353	69	23	progesterone	progesterone	NOUN
ct-9353	69	24	in	in	ADP
ct-9353	69	25	oil	oil	NOUN
ct-9353	69	26	+	+	CCONJ
ct-9353	69	27	10	10	NUM
ct-9353	69	28	mg	mg	NOUN
ct-9353	69	29	estradiol-17β	estradiol-17β	PROPN
ct-9353	69	30	or	or	CCONJ
ct-9353	69	31	300	300	NUM
ct-9353	69	32	mg	mg	NOUN
ct-9353	69	33	progesterone	progesterone	NOUN
ct-9353	69	34	in	in	ADP
ct-9353	69	35	oil	oil	NOUN
ct-9353	69	36	+	+	CCONJ
ct-9353	69	37	20	20	NUM
ct-9353	69	38	mg	mg	NOUN
ct-9353	69	39	estradiol-17β	estradiol-17β	PROPN
ct-9353	69	40	,	,	PUNCT
ct-9353	69	41	and	and	CCONJ
ct-9353	69	42	pregnancy	pregnancy	NOUN
ct-9353	69	43	rates	rate	NOUN
ct-9353	69	44	were	be	AUX
ct-9353	69	45	comparable	comparable	ADJ
ct-9353	69	46	among	among	ADP
ct-9353	69	47	the	the	DET
ct-9353	69	48	groups	group	NOUN
ct-9353	69	49	and	and	CCONJ
ct-9353	69	50	controls.59	controls.59	NOUN
ct-9353	69	51	it	it	PRON
ct-9353	69	52	was	be	AUX
ct-9353	69	53	noted	note	VERB
ct-9353	69	54	that	that	SCONJ
ct-9353	69	55	none	none	NOUN
ct-9353	69	56	of	of	ADP
ct-9353	69	57	the	the	DET
ct-9353	69	58	p&e	p&e	NOUN
ct-9353	69	59	treated	treat	VERB
ct-9353	69	60	mares	mare	NOUN
ct-9353	69	61	ovulated	ovulate	VERB
ct-9353	69	62	prior	prior	ADV
ct-9353	69	63	to	to	ADP
ct-9353	69	64	10	10	NUM
ct-9353	69	65	days	day	NOUN
ct-9353	69	66	postpartum	postpartum	NOUN
ct-9353	69	67	,	,	PUNCT
ct-9353	69	68	whereas	whereas	SCONJ
ct-9353	69	69	20	20	NUM
ct-9353	69	70	%	%	NOUN
ct-9353	69	71	of	of	ADP
ct-9353	69	72	control	control	NOUN
ct-9353	69	73	mares	mare	NOUN
ct-9353	69	74	ovulated	ovulate	VERB
ct-9353	69	75	early	early	ADV
ct-9353	69	76	.	.	PUNCT
ct-9353	70	1	additionally	additionally	ADV
ct-9353	70	2	,	,	PUNCT
ct-9353	70	3	less	less	ADJ
ct-9353	70	4	variability	variability	NOUN
ct-9353	70	5	from	from	ADP
ct-9353	70	6	time	time	NOUN
ct-9353	70	7	to	to	ADP
ct-9353	70	8	ovulation	ovulation	NOUN
ct-9353	70	9	was	be	AUX
ct-9353	70	10	noted	note	VERB
ct-9353	70	11	in	in	ADP
ct-9353	70	12	treated	treat	VERB
ct-9353	70	13	mares	mare	NOUN
ct-9353	70	14	.	.	PUNCT
ct-9353	71	1	overall	overall	ADJ
ct-9353	71	2	,	,	PUNCT
ct-9353	71	3	progestin	progestin	ADJ
ct-9353	71	4	treatment	treatment	NOUN
ct-9353	71	5	appears	appear	VERB
ct-9353	71	6	to	to	PART
ct-9353	71	7	successfully	successfully	ADV
ct-9353	71	8	delay	delay	VERB
ct-9353	71	9	ovulation	ovulation	NOUN
ct-9353	71	10	postpartum	postpartum	NOUN
ct-9353	71	11	;	;	PUNCT
ct-9353	71	12	however	however	ADV
ct-9353	71	13	,	,	PUNCT
ct-9353	71	14	there	there	PRON
ct-9353	71	15	are	be	VERB
ct-9353	71	16	conflicting	conflicting	ADJ
ct-9353	71	17	data	datum	NOUN
ct-9353	71	18	on	on	ADP
ct-9353	71	19	its	its	PRON
ct-9353	71	20	ability	ability	NOUN
ct-9353	71	21	to	to	PART
ct-9353	71	22	improve	improve	VERB
ct-9353	71	23	first	first	ADJ
ct-9353	71	24	estrous	estrous	ADJ
ct-9353	71	25	cycle	cycle	NOUN
ct-9353	71	26	pregnancy	pregnancy	NOUN
ct-9353	71	27	rates	rate	NOUN
ct-9353	71	28	.	.	PUNCT
ct-9353	72	1	potential	potential	ADJ
ct-9353	72	2	side	side	NOUN
ct-9353	72	3	effects	effect	NOUN
ct-9353	72	4	of	of	ADP
ct-9353	72	5	progestins	progestin	NOUN
ct-9353	72	6	to	to	ADP
ct-9353	72	7	immune	immune	ADJ
ct-9353	72	8	system	system	NOUN
ct-9353	72	9	progestins	progestin	NOUN
ct-9353	72	10	affect	affect	VERB
ct-9353	72	11	the	the	DET
ct-9353	72	12	immune	immune	ADJ
ct-9353	72	13	system	system	NOUN
ct-9353	72	14	in	in	ADP
ct-9353	72	15	a	a	DET
ct-9353	72	16	variety	variety	NOUN
ct-9353	72	17	of	of	ADP
ct-9353	72	18	species.60	species.60	PROPN
ct-9353	72	19	in	in	ADP
ct-9353	72	20	humans	human	NOUN
ct-9353	72	21	,	,	PUNCT
ct-9353	72	22	similar	similar	ADJ
ct-9353	72	23	synthetic	synthetic	ADJ
ct-9353	72	24	progestins	progestin	NOUN
ct-9353	72	25	to	to	ADP
ct-9353	72	26	those	those	PRON
ct-9353	72	27	used	use	VERB
ct-9353	72	28	in	in	ADP
ct-9353	72	29	mares	mare	NOUN
ct-9353	72	30	are	be	AUX
ct-9353	72	31	available	available	ADJ
ct-9353	72	32	for	for	ADP
ct-9353	72	33	contraception	contraception	NOUN
ct-9353	72	34	,	,	PUNCT
ct-9353	72	35	many	many	ADJ
ct-9353	72	36	of	of	ADP
ct-9353	72	37	which	which	PRON
ct-9353	72	38	have	have	VERB
ct-9353	72	39	detrimental	detrimental	ADJ
ct-9353	72	40	effect	effect	NOUN
ct-9353	72	41	on	on	ADP
ct-9353	72	42	the	the	DET
ct-9353	72	43	immune	immune	ADJ
ct-9353	72	44	system	system	NOUN
ct-9353	72	45	.	.	PUNCT
ct-9353	73	1	in	in	ADP
ct-9353	73	2	most	most	ADJ
ct-9353	73	3	species	specie	NOUN
ct-9353	73	4	,	,	PUNCT
ct-9353	73	5	progesterone	progesterone	NOUN
ct-9353	73	6	is	be	AUX
ct-9353	73	7	highly	highly	ADV
ct-9353	73	8	antiinflammatory	antiinflammatory	NOUN
ct-9353	73	9	and	and	CCONJ
ct-9353	73	10	enacts	enact	VERB
ct-9353	73	11	this	this	DET
ct-9353	73	12	function	function	NOUN
ct-9353	73	13	on	on	ADP
ct-9353	73	14	the	the	DET
ct-9353	73	15	immune	immune	ADJ
ct-9353	73	16	system	system	NOUN
ct-9353	73	17	through	through	ADP
ct-9353	73	18	signaling	signal	VERB
ct-9353	73	19	on	on	ADP
ct-9353	73	20	the	the	DET
ct-9353	73	21	pr.61	pr.61	NOUN
ct-9353	73	22	-	-	PUNCT
ct-9353	73	23	64	64	NUM
ct-9353	73	24	in	in	ADP
ct-9353	73	25	contrast	contrast	NOUN
ct-9353	73	26	,	,	PUNCT
ct-9353	73	27	synthetic	synthetic	ADJ
ct-9353	73	28	progestins	progestin	NOUN
ct-9353	73	29	such	such	ADJ
ct-9353	73	30	as	as	ADP
ct-9353	73	31	mpa	mpa	NOUN
ct-9353	73	32	and	and	CCONJ
ct-9353	73	33	levonorgestrel	levonorgestrel	PROPN
ct-9353	73	34	(	(	PUNCT
ct-9353	73	35	lng	lng	NOUN
ct-9353	73	36	)	)	PUNCT
ct-9353	73	37	increase	increase	VERB
ct-9353	73	38	the	the	DET
ct-9353	73	39	expression	expression	NOUN
ct-9353	73	40	or	or	CCONJ
ct-9353	73	41	production	production	NOUN
ct-9353	73	42	of	of	ADP
ct-9353	73	43	a	a	DET
ct-9353	73	44	variety	variety	NOUN
ct-9353	73	45	of	of	ADP
ct-9353	73	46	proinflammatory	proinflammatory	ADJ
ct-9353	73	47	mediators.60,65	mediators.60,65	NOUN
ct-9353	73	48	-	-	PUNCT
ct-9353	73	49	67	67	NUM
ct-9353	73	50	additionally	additionally	ADV
ct-9353	73	51	,	,	PUNCT
ct-9353	73	52	the	the	DET
ct-9353	73	53	specific	specific	ADJ
ct-9353	73	54	function	function	NOUN
ct-9353	73	55	of	of	ADP
ct-9353	73	56	the	the	DET
ct-9353	73	57	individual	individual	ADJ
ct-9353	73	58	progestin	progestin	NOUN
ct-9353	73	59	appears	appear	VERB
ct-9353	73	60	to	to	PART
ct-9353	73	61	be	be	AUX
ct-9353	73	62	affected	affect	VERB
ct-9353	73	63	by	by	ADP
ct-9353	73	64	the	the	DET
ct-9353	73	65	receptor	receptor	NOUN
ct-9353	73	66	through	through	ADP
ct-9353	73	67	which	which	PRON
ct-9353	73	68	it	it	PRON
ct-9353	73	69	enacts	enact	VERB
ct-9353	73	70	,	,	PUNCT
ct-9353	73	71	as	as	SCONJ
ct-9353	73	72	mpa	mpa	PROPN
ct-9353	73	73	activates	activate	VERB
ct-9353	73	74	both	both	CCONJ
ct-9353	73	75	pr	pr	NOUN
ct-9353	73	76	and	and	CCONJ
ct-9353	73	77	glucocorticoid	glucocorticoid	ADJ
ct-9353	73	78	receptors	receptor	NOUN
ct-9353	73	79	,	,	PUNCT
ct-9353	73	80	whereas	whereas	SCONJ
ct-9353	73	81	lng	lng	PROPN
ct-9353	73	82	solely	solely	ADV
ct-9353	73	83	activates	activate	VERB
ct-9353	73	84	the	the	DET
ct-9353	73	85	pr.68,69	pr.68,69	NOUN
ct-9353	73	86	through	through	ADP
ct-9353	73	87	this	this	DET
ct-9353	73	88	increase	increase	NOUN
ct-9353	73	89	in	in	ADP
ct-9353	73	90	proinflammatory	proinflammatory	ADJ
ct-9353	73	91	cytokine	cytokine	NOUN
ct-9353	73	92	activation	activation	NOUN
ct-9353	73	93	,	,	PUNCT
ct-9353	73	94	in	in	ADP
ct-9353	73	95	addition	addition	NOUN
ct-9353	73	96	to	to	ADP
ct-9353	73	97	recruitment	recruitment	NOUN
ct-9353	73	98	of	of	ADP
ct-9353	73	99	varying	vary	VERB
ct-9353	73	100	immune	immune	ADJ
ct-9353	73	101	cells	cell	NOUN
ct-9353	73	102	,	,	PUNCT
ct-9353	73	103	women	woman	NOUN
ct-9353	73	104	on	on	ADP
ct-9353	73	105	synthetic	synthetic	ADJ
ct-9353	73	106	progestins	progestin	NOUN
ct-9353	73	107	were	be	AUX
ct-9353	73	108	found	find	VERB
ct-9353	73	109	to	to	PART
ct-9353	73	110	be	be	AUX
ct-9353	73	111	at	at	ADP
ct-9353	73	112	higher	high	ADJ
ct-9353	73	113	risk	risk	NOUN
ct-9353	73	114	for	for	ADP
ct-9353	73	115	a	a	DET
ct-9353	73	116	variety	variety	NOUN
ct-9353	73	117	of	of	ADP
ct-9353	73	118	diseases	disease	NOUN
ct-9353	73	119	,	,	PUNCT
ct-9353	73	120	including	include	VERB
ct-9353	73	121	hiv,70	hiv,70	NOUN
ct-9353	73	122	-	-	SYM
ct-9353	73	123	75	75	NUM
ct-9353	73	124	hsv-2,76	hsv-2,76	NOUN
ct-9353	73	125	-	-	PUNCT
ct-9353	73	126	78	78	NUM
ct-9353	73	127	chlamydia,79,80	chlamydia,79,80	NOUN
ct-9353	73	128	gonorrhea,81	gonorrhea,81	NOUN
ct-9353	73	129	and	and	CCONJ
ct-9353	73	130	even	even	ADV
ct-9353	73	131	influenza.60,82	influenza.60,82	NOUN
ct-9353	73	132	it	it	PRON
ct-9353	73	133	is	be	AUX
ct-9353	73	134	believed	believe	VERB
ct-9353	73	135	that	that	SCONJ
ct-9353	73	136	the	the	DET
ct-9353	73	137	increased	increase	VERB
ct-9353	73	138	risk	risk	NOUN
ct-9353	73	139	of	of	ADP
ct-9353	73	140	viral	viral	ADJ
ct-9353	73	141	infection	infection	NOUN
ct-9353	73	142	is	be	AUX
ct-9353	73	143	due	due	ADJ
ct-9353	73	144	to	to	ADP
ct-9353	73	145	proinflammatory	proinflammatory	ADJ
ct-9353	73	146	activation	activation	NOUN
ct-9353	73	147	of	of	ADP
ct-9353	73	148	nfκβ	nfκβ	NOUN
ct-9353	73	149	that	that	PRON
ct-9353	73	150	binds	bind	VERB
ct-9353	73	151	to	to	ADP
ct-9353	73	152	the	the	DET
ct-9353	73	153	terminal	terminal	ADJ
ct-9353	73	154	repeat	repeat	NOUN
ct-9353	73	155	of	of	ADP
ct-9353	73	156	viral	viral	ADJ
ct-9353	73	157	dna	dna	NOUN
ct-9353	73	158	,	,	PUNCT
ct-9353	73	159	thereby	thereby	ADV
ct-9353	73	160	promoting	promote	VERB
ct-9353	73	161	viral	viral	ADJ
ct-9353	73	162	replication	replication	NOUN
ct-9353	73	163	.	.	PUNCT
ct-9353	74	1	a	a	DET
ct-9353	74	2	recent	recent	ADJ
ct-9353	74	3	study	study	NOUN
ct-9353	74	4	investigated	investigate	VERB
ct-9353	74	5	effects	effect	NOUN
ct-9353	74	6	of	of	ADP
ct-9353	74	7	altrenogest	altrenogest	NOUN
ct-9353	74	8	on	on	ADP
ct-9353	74	9	the	the	DET
ct-9353	74	10	immune	immune	ADJ
ct-9353	74	11	system	system	NOUN
ct-9353	74	12	of	of	ADP
ct-9353	74	13	nonpregnant	nonpregnant	ADJ
ct-9353	74	14	mares	mare	NOUN
ct-9353	74	15	,	,	PUNCT
ct-9353	74	16	with	with	ADP
ct-9353	74	17	similar	similar	ADJ
ct-9353	74	18	results	result	NOUN
ct-9353	74	19	to	to	ADP
ct-9353	74	20	those	those	PRON
ct-9353	74	21	reported	report	VERB
ct-9353	74	22	in	in	ADP
ct-9353	74	23	humans.83	humans.83	ADV
ct-9353	74	24	in	in	ADP
ct-9353	74	25	vitro	vitro	X
ct-9353	74	26	,	,	PUNCT
ct-9353	74	27	altrenogest	altrenogest	PROPN
ct-9353	74	28	caused	cause	VERB
ct-9353	74	29	a	a	DET
ct-9353	74	30	dose	dose	NOUN
ct-9353	74	31	-	-	PUNCT
ct-9353	74	32	dependent	dependent	ADJ
ct-9353	74	33	clinical	clinical	ADJ
ct-9353	74	34	theriogenology	theriogenology	NOUN
ct-9353	74	35	2021	2021	NUM
ct-9353	74	36	;	;	PUNCT
ct-9353	74	37	13	13	NUM
ct-9353	74	38	:	:	SYM
ct-9353	74	39	250	250	NUM
ct-9353	74	40	increase	increase	NOUN
ct-9353	74	41	in	in	ADP
ct-9353	74	42	the	the	DET
ct-9353	74	43	expression	expression	NOUN
ct-9353	74	44	of	of	ADP
ct-9353	74	45	the	the	DET
ct-9353	74	46	proinflammatory	proinflammatory	ADJ
ct-9353	74	47	cytokine	cytokine	NOUN
ct-9353	74	48	il-1β	il-1β	ADJ
ct-9353	74	49	in	in	ADP
ct-9353	74	50	addition	addition	NOUN
ct-9353	74	51	to	to	ADP
ct-9353	74	52	the	the	DET
ct-9353	74	53	pleiotropic	pleiotropic	ADJ
ct-9353	74	54	cytokine	cytokine	NOUN
ct-9353	74	55	il-6	il-6	NOUN
ct-9353	74	56	,	,	PUNCT
ct-9353	74	57	in	in	ADP
ct-9353	74	58	peripheral	peripheral	ADJ
ct-9353	74	59	blood	blood	NOUN
ct-9353	74	60	mononuclear	mononuclear	ADJ
ct-9353	74	61	cells	cell	NOUN
ct-9353	74	62	.	.	PUNCT
ct-9353	75	1	this	this	PRON
ct-9353	75	2	was	be	AUX
ct-9353	75	3	also	also	ADV
ct-9353	75	4	noted	note	VERB
ct-9353	75	5	in	in	ADP
ct-9353	75	6	vivo	vivo	NOUN
ct-9353	75	7	,	,	PUNCT
ct-9353	75	8	wherein	wherein	SCONJ
ct-9353	75	9	under	under	ADP
ct-9353	75	10	the	the	DET
ct-9353	75	11	diestrus	diestrus	NOUN
ct-9353	75	12	influence	influence	NOUN
ct-9353	75	13	of	of	ADP
ct-9353	75	14	endogenous	endogenous	ADJ
ct-9353	75	15	progesterone	progesterone	NOUN
ct-9353	75	16	,	,	PUNCT
ct-9353	75	17	control	control	NOUN
ct-9353	75	18	mares	mare	NOUN
ct-9353	75	19	had	have	AUX
ct-9353	75	20	decreased	decrease	VERB
ct-9353	75	21	expression	expression	NOUN
ct-9353	75	22	of	of	ADP
ct-9353	75	23	proinflammatory	proinflammatory	ADJ
ct-9353	75	24	cytokines	cytokine	NOUN
ct-9353	75	25	(	(	PUNCT
ct-9353	75	26	ifnγ	ifnγ	NOUN
ct-9353	75	27	,	,	PUNCT
ct-9353	75	28	il-1β	il-1β	PROPN
ct-9353	75	29	,	,	PUNCT
ct-9353	75	30	and	and	CCONJ
ct-9353	75	31	il-8	il-8	NUM
ct-9353	75	32	)	)	PUNCT
ct-9353	75	33	while	while	SCONJ
ct-9353	75	34	the	the	DET
ct-9353	75	35	peripheral	peripheral	ADJ
ct-9353	75	36	blood	blood	NOUN
ct-9353	75	37	mononuclear	mononuclear	ADJ
ct-9353	75	38	cells	cell	NOUN
ct-9353	75	39	of	of	ADP
ct-9353	75	40	altrenogest	altrenogest	ADV
ct-9353	75	41	-	-	PUNCT
ct-9353	75	42	treated	treat	VERB
ct-9353	75	43	mares	mare	NOUN
ct-9353	75	44	did	do	AUX
ct-9353	75	45	not	not	PART
ct-9353	75	46	decrease	decrease	VERB
ct-9353	75	47	in	in	ADP
ct-9353	75	48	the	the	DET
ct-9353	75	49	expression	expression	NOUN
ct-9353	75	50	of	of	ADP
ct-9353	75	51	either	either	CCONJ
ct-9353	75	52	il-1β	il-1β	PROPN
ct-9353	75	53	or	or	CCONJ
ct-9353	75	54	il-8	il-8	NOUN
ct-9353	75	55	.	.	PUNCT
ct-9353	76	1	additionally	additionally	ADV
ct-9353	76	2	,	,	PUNCT
ct-9353	76	3	altrenogest	altrenogest	NOUN
ct-9353	76	4	altered	alter	VERB
ct-9353	76	5	expression	expression	NOUN
ct-9353	76	6	of	of	ADP
ct-9353	76	7	a	a	DET
ct-9353	76	8	variety	variety	NOUN
ct-9353	76	9	of	of	ADP
ct-9353	76	10	cytokines	cytokine	NOUN
ct-9353	76	11	within	within	ADP
ct-9353	76	12	the	the	DET
ct-9353	76	13	endometrium	endometrium	NOUN
ct-9353	76	14	,	,	PUNCT
ct-9353	76	15	including	include	VERB
ct-9353	76	16	ifnγ	ifnγ	NOUN
ct-9353	76	17	,	,	PUNCT
ct-9353	76	18	il-10	il-10	PRON
ct-9353	76	19	,	,	PUNCT
ct-9353	76	20	and	and	CCONJ
ct-9353	76	21	il-1rn	il-1rn	PROPN
ct-9353	76	22	,	,	PUNCT
ct-9353	76	23	indicating	indicate	VERB
ct-9353	76	24	both	both	CCONJ
ct-9353	76	25	local	local	ADJ
ct-9353	76	26	and	and	CCONJ
ct-9353	76	27	systemic	systemic	ADJ
ct-9353	76	28	effects	effect	NOUN
ct-9353	76	29	of	of	ADP
ct-9353	76	30	altrenogest	altrenogest	NOUN
ct-9353	76	31	on	on	ADP
ct-9353	76	32	the	the	DET
ct-9353	76	33	immune	immune	ADJ
ct-9353	76	34	system	system	NOUN
ct-9353	76	35	of	of	ADP
ct-9353	76	36	the	the	DET
ct-9353	76	37	mare	mare	NOUN
ct-9353	76	38	.	.	PUNCT
ct-9353	77	1	this	this	PRON
ct-9353	77	2	may	may	AUX
ct-9353	77	3	be	be	AUX
ct-9353	77	4	clinically	clinically	ADV
ct-9353	77	5	relevant	relevant	ADJ
ct-9353	77	6	,	,	PUNCT
ct-9353	77	7	as	as	SCONJ
ct-9353	77	8	altrenogest	altrenog	ADJ
ct-9353	77	9	treatment	treatment	NOUN
ct-9353	77	10	in	in	ADP
ct-9353	77	11	nonpregnant	nonpregnant	ADJ
ct-9353	77	12	mares	mare	NOUN
ct-9353	77	13	has	have	AUX
ct-9353	77	14	been	be	AUX
ct-9353	77	15	associated	associate	VERB
ct-9353	77	16	with	with	ADP
ct-9353	77	17	vaginal	vaginal	ADJ
ct-9353	77	18	candidiasis84	candidiasis84	NOUN
ct-9353	77	19	and	and	CCONJ
ct-9353	77	20	uterine	uterine	ADJ
ct-9353	77	21	inflammation.85	inflammation.85	PROPN
ct-9353	77	22	interestingly	interestingly	ADV
ct-9353	77	23	,	,	PUNCT
ct-9353	77	24	it	it	PRON
ct-9353	77	25	was	be	AUX
ct-9353	77	26	determined	determine	VERB
ct-9353	77	27	that	that	SCONJ
ct-9353	77	28	altrenogest	altrenog	ADJ
ct-9353	77	29	alters	alter	VERB
ct-9353	77	30	the	the	DET
ct-9353	77	31	immune	immune	ADJ
ct-9353	77	32	system	system	NOUN
ct-9353	77	33	of	of	ADP
ct-9353	77	34	the	the	DET
ct-9353	77	35	nonpregnant	nonpregnant	ADJ
ct-9353	77	36	mare	mare	NOUN
ct-9353	77	37	without	without	ADP
ct-9353	77	38	activating	activate	VERB
ct-9353	77	39	glucocorticoid	glucocorticoid	ADJ
ct-9353	77	40	receptors	receptor	NOUN
ct-9353	77	41	.	.	PUNCT
ct-9353	78	1	as	as	SCONJ
ct-9353	78	2	it	it	PRON
ct-9353	78	3	is	be	AUX
ct-9353	78	4	structurally	structurally	ADV
ct-9353	78	5	a	a	DET
ct-9353	78	6	19	19	NUM
ct-9353	78	7	-	-	PUNCT
ct-9353	78	8	nortestosterone	nortestosterone	NOUN
ct-9353	78	9	,	,	PUNCT
ct-9353	78	10	and	and	CCONJ
ct-9353	78	11	more	more	ADV
ct-9353	78	12	comparable	comparable	ADJ
ct-9353	78	13	to	to	ADP
ct-9353	78	14	lng	lng	PROPN
ct-9353	78	15	,	,	PUNCT
ct-9353	78	16	this	this	PRON
ct-9353	78	17	was	be	AUX
ct-9353	78	18	not	not	PART
ct-9353	78	19	surprising	surprising	ADJ
ct-9353	78	20	.	.	PUNCT
ct-9353	79	1	in	in	ADP
ct-9353	79	2	early	early	ADJ
ct-9353	79	3	pregnancy	pregnancy	NOUN
ct-9353	79	4	,	,	PUNCT
ct-9353	79	5	altrenogest	altrenog	ADJ
ct-9353	79	6	treatment	treatment	NOUN
ct-9353	79	7	decreased	decrease	VERB
ct-9353	79	8	endometrial	endometrial	ADJ
ct-9353	79	9	expression	expression	NOUN
ct-9353	79	10	of	of	ADP
ct-9353	79	11	the	the	DET
ct-9353	79	12	pr.86	pr.86	NOUN
ct-9353	79	13	additionally	additionally	ADV
ct-9353	79	14	,	,	PUNCT
ct-9353	79	15	an	an	DET
ct-9353	79	16	increase	increase	NOUN
ct-9353	79	17	in	in	ADP
ct-9353	79	18	the	the	DET
ct-9353	79	19	number	number	NOUN
ct-9353	79	20	of	of	ADP
ct-9353	79	21	polymorphonuclear	polymorphonuclear	ADJ
ct-9353	79	22	neutrophils	neutrophil	NOUN
ct-9353	79	23	was	be	AUX
ct-9353	79	24	noted	note	VERB
ct-9353	79	25	within	within	ADP
ct-9353	79	26	the	the	DET
ct-9353	79	27	endometrium	endometrium	NOUN
ct-9353	79	28	after	after	ADP
ct-9353	79	29	treatment	treatment	NOUN
ct-9353	79	30	.	.	PUNCT
ct-9353	80	1	in	in	ADP
ct-9353	80	2	late	late	ADJ
ct-9353	80	3	pregnancy	pregnancy	NOUN
ct-9353	80	4	,	,	PUNCT
ct-9353	80	5	minimal	minimal	ADJ
ct-9353	80	6	changes	change	NOUN
ct-9353	80	7	were	be	AUX
ct-9353	80	8	observed	observe	VERB
ct-9353	80	9	in	in	ADP
ct-9353	80	10	endometrial	endometrial	ADJ
ct-9353	80	11	gene	gene	NOUN
ct-9353	80	12	expression	expression	NOUN
ct-9353	80	13	of	of	ADP
ct-9353	80	14	il-6	il-6	NOUN
ct-9353	80	15	,	,	PUNCT
ct-9353	80	16	il-8	il-8	NOUN
ct-9353	80	17	,	,	PUNCT
ct-9353	80	18	or	or	CCONJ
ct-9353	80	19	cox-2	cox-2	ADV
ct-9353	80	20	after	after	ADP
ct-9353	80	21	altrenogest	altrenog	ADJ
ct-9353	80	22	treatment.85	treatment.85	PROPN
ct-9353	80	23	in	in	ADP
ct-9353	80	24	this	this	DET
ct-9353	80	25	same	same	ADJ
ct-9353	80	26	study	study	NOUN
ct-9353	80	27	,	,	PUNCT
ct-9353	80	28	altrenogest	altrenog	ADJ
ct-9353	80	29	treatment	treatment	NOUN
ct-9353	80	30	had	have	VERB
ct-9353	80	31	no	no	DET
ct-9353	80	32	effect	effect	NOUN
ct-9353	80	33	on	on	ADP
ct-9353	80	34	the	the	DET
ct-9353	80	35	expression	expression	NOUN
ct-9353	80	36	of	of	ADP
ct-9353	80	37	the	the	DET
ct-9353	80	38	progesterone	progesterone	NOUN
ct-9353	80	39	,	,	PUNCT
ct-9353	80	40	estrogen	estrogen	NOUN
ct-9353	80	41	,	,	PUNCT
ct-9353	80	42	or	or	CCONJ
ct-9353	80	43	oxytocin	oxytocin	NOUN
ct-9353	80	44	receptors	receptor	NOUN
ct-9353	80	45	,	,	PUNCT
ct-9353	80	46	conflicting	conflict	VERB
ct-9353	80	47	with	with	ADP
ct-9353	80	48	early	early	ADJ
ct-9353	80	49	pregnant	pregnant	ADJ
ct-9353	80	50	mare	mare	NOUN
ct-9353	80	51	data	datum	NOUN
ct-9353	80	52	.	.	PUNCT
ct-9353	81	1	this	this	PRON
ct-9353	81	2	is	be	AUX
ct-9353	81	3	interesting	interesting	ADJ
ct-9353	81	4	,	,	PUNCT
ct-9353	81	5	as	as	SCONJ
ct-9353	81	6	progesterone	progesterone	NOUN
ct-9353	81	7	itself	itself	PRON
ct-9353	81	8	inhibited	inhibit	VERB
ct-9353	81	9	the	the	DET
ct-9353	81	10	nfκβ	nfκβ	ADJ
ct-9353	81	11	pathway	pathway	NOUN
ct-9353	81	12	,	,	PUNCT
ct-9353	81	13	including	include	VERB
ct-9353	81	14	downstream	downstream	ADJ
ct-9353	81	15	cox-2	cox-2	NOUN
ct-9353	81	16	and	and	CCONJ
ct-9353	81	17	il-1β,87	il-1β,87	NOUN
ct-9353	81	18	again	again	ADV
ct-9353	81	19	indicating	indicate	VERB
ct-9353	81	20	a	a	DET
ct-9353	81	21	differing	differ	VERB
ct-9353	81	22	pathway	pathway	NOUN
ct-9353	81	23	of	of	ADP
ct-9353	81	24	effect	effect	NOUN
ct-9353	81	25	for	for	ADP
ct-9353	81	26	altrenogest	altrenog	ADJ
ct-9353	81	27	.	.	PUNCT
ct-9353	82	1	foals	foal	NOUN
ct-9353	82	2	born	bear	VERB
ct-9353	82	3	to	to	ADP
ct-9353	82	4	mares	mare	NOUN
ct-9353	82	5	that	that	PRON
ct-9353	82	6	were	be	AUX
ct-9353	82	7	treated	treat	VERB
ct-9353	82	8	with	with	ADP
ct-9353	82	9	altrenogest	altrenogest	NOUN
ct-9353	82	10	during	during	ADP
ct-9353	82	11	late	late	ADJ
ct-9353	82	12	pregnancy	pregnancy	NOUN
ct-9353	82	13	up	up	ADP
ct-9353	82	14	to	to	ADP
ct-9353	82	15	the	the	DET
ct-9353	82	16	day	day	NOUN
ct-9353	82	17	of	of	ADP
ct-9353	82	18	foaling	foaling	NOUN
ct-9353	82	19	were	be	AUX
ct-9353	82	20	affected	affect	VERB
ct-9353	82	21	by	by	ADP
ct-9353	82	22	treatment	treatment	NOUN
ct-9353	82	23	.	.	PUNCT
ct-9353	83	1	this	this	PRON
ct-9353	83	2	included	include	VERB
ct-9353	83	3	an	an	DET
ct-9353	83	4	imbalanced	imbalanced	ADJ
ct-9353	83	5	neutrophil	neutrophil	NOUN
ct-9353	83	6	to	to	ADP
ct-9353	83	7	lymphocyte	lymphocyte	ADJ
ct-9353	83	8	ratio	ratio	NOUN
ct-9353	83	9	,	,	PUNCT
ct-9353	83	10	increased	increase	VERB
ct-9353	83	11	cortisol	cortisol	NOUN
ct-9353	83	12	,	,	PUNCT
ct-9353	83	13	decreased	decrease	VERB
ct-9353	83	14	potassium	potassium	NOUN
ct-9353	83	15	,	,	PUNCT
ct-9353	83	16	and	and	CCONJ
ct-9353	83	17	decreased	decrease	VERB
ct-9353	83	18	calcium	calcium	NOUN
ct-9353	83	19	within	within	ADP
ct-9353	83	20	hours	hour	NOUN
ct-9353	83	21	after	after	ADP
ct-9353	83	22	birth.88	birth.88	NOUN
ct-9353	83	23	in	in	ADP
ct-9353	83	24	an	an	DET
ct-9353	83	25	additional	additional	ADJ
ct-9353	83	26	study	study	NOUN
ct-9353	83	27	,	,	PUNCT
ct-9353	83	28	neonates	neonate	NOUN
ct-9353	83	29	born	bear	VERB
ct-9353	83	30	to	to	ADP
ct-9353	83	31	mares	mare	NOUN
ct-9353	83	32	receiving	receive	VERB
ct-9353	83	33	late	late	ADJ
ct-9353	83	34	-	-	PUNCT
ct-9353	83	35	term	term	NOUN
ct-9353	83	36	altrenogest	altrenogest	NOUN
ct-9353	83	37	,	,	PUNCT
ct-9353	83	38	had	have	AUX
ct-9353	83	39	decreased	decrease	VERB
ct-9353	83	40	respiratory	respiratory	ADJ
ct-9353	83	41	function	function	NOUN
ct-9353	83	42	and	and	CCONJ
ct-9353	83	43	substantially	substantially	ADV
ct-9353	83	44	more	more	ADJ
ct-9353	83	45	problems	problem	NOUN
ct-9353	83	46	in	in	ADP
ct-9353	83	47	the	the	DET
ct-9353	83	48	perinatal	perinatal	ADJ
ct-9353	83	49	period.48	period.48	ADJ
ct-9353	83	50	conclusion	conclusion	NOUN
ct-9353	83	51	progestins	progestin	NOUN
ct-9353	83	52	are	be	AUX
ct-9353	83	53	valuable	valuable	ADJ
ct-9353	83	54	clinical	clinical	ADJ
ct-9353	83	55	tools	tool	NOUN
ct-9353	83	56	in	in	ADP
ct-9353	83	57	managing	manage	VERB
ct-9353	83	58	several	several	ADJ
ct-9353	83	59	aspects	aspect	NOUN
ct-9353	83	60	of	of	ADP
ct-9353	83	61	equine	equine	NOUN
ct-9353	83	62	reproduction	reproduction	NOUN
ct-9353	83	63	.	.	PUNCT
ct-9353	84	1	although	although	SCONJ
ct-9353	84	2	only	only	ADV
ct-9353	84	3	natural	natural	ADJ
ct-9353	84	4	and	and	CCONJ
ct-9353	84	5	synthetic	synthetic	ADJ
ct-9353	84	6	(	(	PUNCT
ct-9353	84	7	altrenogest	altrenogest	NOUN
ct-9353	84	8	)	)	PUNCT
ct-9353	84	9	progestins	progestin	NOUN
ct-9353	84	10	are	be	AUX
ct-9353	84	11	currently	currently	ADV
ct-9353	84	12	available	available	ADJ
ct-9353	84	13	,	,	PUNCT
ct-9353	84	14	both	both	DET
ct-9353	84	15	compounds	compound	NOUN
ct-9353	84	16	are	be	AUX
ct-9353	84	17	efficacious	efficacious	ADJ
ct-9353	84	18	in	in	ADP
ct-9353	84	19	suppressing	suppress	VERB
ct-9353	84	20	estrus	estrus	NOUN
ct-9353	84	21	,	,	PUNCT
ct-9353	84	22	hastening	hasten	VERB
ct-9353	84	23	transition	transition	NOUN
ct-9353	84	24	,	,	PUNCT
ct-9353	84	25	and	and	CCONJ
ct-9353	84	26	maintaining	maintain	VERB
ct-9353	84	27	early	early	ADJ
ct-9353	84	28	pregnancy	pregnancy	NOUN
ct-9353	84	29	.	.	PUNCT
ct-9353	85	1	in	in	ADP
ct-9353	85	2	the	the	DET
ct-9353	85	3	past	past	NOUN
ct-9353	85	4	,	,	PUNCT
ct-9353	85	5	progestin	progestin	NOUN
ct-9353	85	6	treatment	treatment	NOUN
ct-9353	85	7	has	have	AUX
ct-9353	85	8	been	be	AUX
ct-9353	85	9	considered	consider	VERB
ct-9353	85	10	to	to	PART
ct-9353	85	11	be	be	AUX
ct-9353	85	12	without	without	ADP
ct-9353	85	13	side	side	NOUN
ct-9353	85	14	effects	effect	NOUN
ct-9353	85	15	and	and	CCONJ
ct-9353	85	16	perhaps	perhaps	ADV
ct-9353	85	17	overused	overuse	VERB
ct-9353	85	18	as	as	ADP
ct-9353	85	19	an	an	DET
ct-9353	85	20	insurance	insurance	NOUN
ct-9353	85	21	policy	policy	NOUN
ct-9353	85	22	for	for	ADP
ct-9353	85	23	pregnancy	pregnancy	NOUN
ct-9353	85	24	maintenance	maintenance	NOUN
ct-9353	85	25	.	.	PUNCT
ct-9353	86	1	based	base	VERB
ct-9353	86	2	on	on	ADP
ct-9353	86	3	recent	recent	ADJ
ct-9353	86	4	studies	study	NOUN
ct-9353	86	5	,	,	PUNCT
ct-9353	86	6	long	long	ADJ
ct-9353	86	7	-	-	PUNCT
ct-9353	86	8	term	term	NOUN
ct-9353	86	9	use	use	NOUN
ct-9353	86	10	of	of	ADP
ct-9353	86	11	altrenogest	altrenog	ADJ
ct-9353	86	12	,	,	PUNCT
ct-9353	86	13	particularly	particularly	ADV
ct-9353	86	14	during	during	ADP
ct-9353	86	15	late	late	ADJ
ct-9353	86	16	pregnancy	pregnancy	NOUN
ct-9353	86	17	,	,	PUNCT
ct-9353	86	18	may	may	AUX
ct-9353	86	19	be	be	AUX
ct-9353	86	20	associated	associate	VERB
ct-9353	86	21	with	with	ADP
ct-9353	86	22	immune	immune	NOUN
ct-9353	86	23	-	-	PUNCT
ct-9353	86	24	related	relate	VERB
ct-9353	86	25	side	side	NOUN
ct-9353	86	26	effects	effect	NOUN
ct-9353	86	27	in	in	ADP
ct-9353	86	28	mares	mare	NOUN
ct-9353	86	29	and	and	CCONJ
ct-9353	86	30	foals	foal	NOUN
ct-9353	86	31	.	.	PUNCT
ct-9353	87	1	this	this	DET
ct-9353	87	2	possibility	possibility	NOUN
ct-9353	87	3	should	should	AUX
ct-9353	87	4	be	be	AUX
ct-9353	87	5	considered	consider	VERB
ct-9353	87	6	when	when	SCONJ
ct-9353	87	7	benefits	benefit	NOUN
ct-9353	87	8	are	be	AUX
ct-9353	87	9	weighed	weigh	VERB
ct-9353	87	10	against	against	ADP
ct-9353	87	11	risks	risk	NOUN
ct-9353	87	12	in	in	ADP
ct-9353	87	13	clinical	clinical	ADJ
ct-9353	87	14	situations	situation	NOUN
ct-9353	87	15	(	(	PUNCT
ct-9353	87	16	figure	figure	NOUN
ct-9353	87	17	3	3	NUM
ct-9353	87	18	)	)	PUNCT
ct-9353	87	19	.	.	PUNCT
ct-9353	88	1	figure	figure	VERB
ct-9353	88	2	3	3	NUM
ct-9353	88	3	.	.	NOUN
ct-9353	88	4	risk	risk	NOUN
ct-9353	88	5	to	to	PART
ct-9353	88	6	benefit	benefit	VERB
ct-9353	88	7	ratio	ratio	NOUN
ct-9353	88	8	of	of	ADP
ct-9353	88	9	altrenogest	altrenogest	NOUN
ct-9353	88	10	treatment	treatment	NOUN
ct-9353	88	11	clinical	clinical	ADJ
ct-9353	88	12	theriogenology	theriogenology	NOUN
ct-9353	88	13	2021	2021	NUM
ct-9353	88	14	;	;	PUNCT
ct-9353	88	15	13	13	NUM
ct-9353	88	16	:	:	SYM
ct-9353	88	17	251	251	NUM
ct-9353	88	18	conflict	conflict	NOUN
ct-9353	88	19	of	of	ADP
ct-9353	88	20	interest	interest	NOUN
ct-9353	88	21	author	author	NOUN
ct-9353	88	22	has	have	VERB
ct-9353	88	23	no	no	DET
ct-9353	88	24	affiliations	affiliation	NOUN
ct-9353	88	25	,	,	PUNCT
ct-9353	88	26	memberships	membership	NOUN
ct-9353	88	27	,	,	PUNCT
ct-9353	88	28	funding	funding	NOUN
ct-9353	88	29	,	,	PUNCT
ct-9353	88	30	or	or	CCONJ
ct-9353	88	31	financial	financial	ADJ
ct-9353	88	32	holdings	holding	NOUN
ct-9353	88	33	that	that	PRON
ct-9353	88	34	might	might	AUX
ct-9353	88	35	be	be	AUX
ct-9353	88	36	perceived	perceive	VERB
ct-9353	88	37	as	as	ADP
ct-9353	88	38	affecting	affect	VERB
ct-9353	88	39	the	the	DET
ct-9353	88	40	objectivity	objectivity	NOUN
ct-9353	88	41	of	of	ADP
ct-9353	88	42	this	this	DET
ct-9353	88	43	review	review	NOUN
ct-9353	88	44	.	.	PUNCT
ct-9353	89	1	references	reference	NOUN
ct-9353	89	2	1	1	NUM
ct-9353	89	3	.	.	PUNCT
ct-9353	90	1	bruemmer	bruemmer	PROPN
ct-9353	90	2	je	je	PROPN
ct-9353	90	3	,	,	PUNCT
ct-9353	90	4	coy	coy	PROPN
ct-9353	90	5	rc	rc	PROPN
ct-9353	90	6	,	,	PUNCT
ct-9353	90	7	olson	olson	NOUN
ct-9353	90	8	a	a	PROPN
ct-9353	90	9	,	,	PUNCT
ct-9353	90	10	et	et	PROPN
ct-9353	90	11	al	al	PROPN
ct-9353	90	12	:	:	PUNCT
ct-9353	90	13	efficacy	efficacy	NOUN
ct-9353	90	14	of	of	ADP
ct-9353	90	15	altrenogest	altrenogest	PROPN
ct-9353	90	16	administration	administration	NOUN
ct-9353	90	17	to	to	PART
ct-9353	90	18	postpone	postpone	VERB
ct-9353	90	19	ovulation	ovulation	NOUN
ct-9353	90	20	and	and	CCONJ
ct-9353	90	21	subsequent	subsequent	ADJ
ct-9353	90	22	fertility	fertility	NOUN
ct-9353	90	23	in	in	ADP
ct-9353	90	24	mares	mare	NOUN
ct-9353	90	25	.	.	PUNCT
ct-9353	91	1	j	j	PROPN
ct-9353	91	2	eq	eq	PROPN
ct-9353	91	3	vet	vet	PROPN
ct-9353	91	4	sci	sci	PROPN
ct-9353	91	5	2000;20:450	2000;20:450	PROPN
ct-9353	91	6	-	-	NUM
ct-9353	91	7	453	453	NUM
ct-9353	91	8	.	.	NOUN
ct-9353	91	9	2	2	X
ct-9353	91	10	.	.	X
ct-9353	91	11	loy	loy	PROPN
ct-9353	91	12	rg	rg	PROPN
ct-9353	91	13	,	,	PUNCT
ct-9353	91	14	swan	swan	PROPN
ct-9353	91	15	sm	sm	PROPN
ct-9353	91	16	:	:	PUNCT
ct-9353	91	17	effects	effect	NOUN
ct-9353	91	18	of	of	ADP
ct-9353	91	19	exogenous	exogenous	ADJ
ct-9353	91	20	progestogens	progestogen	NOUN
ct-9353	91	21	on	on	ADP
ct-9353	91	22	reproductive	reproductive	ADJ
ct-9353	91	23	phenomena	phenomenon	NOUN
ct-9353	91	24	in	in	ADP
ct-9353	91	25	mares	mare	NOUN
ct-9353	91	26	.	.	PUNCT
ct-9353	92	1	j	j	PROPN
ct-9353	92	2	anim	anim	PROPN
ct-9353	92	3	sci	sci	PROPN
ct-9353	92	4	1966;25:821	1966;25:821	PROPN
ct-9353	92	5	-	-	PUNCT
ct-9353	92	6	826	826	NUM
ct-9353	92	7	.	.	PUNCT
ct-9353	93	1	3	3	X
ct-9353	93	2	.	.	X
ct-9353	93	3	van	van	PROPN
ct-9353	93	4	der	der	PROPN
ct-9353	93	5	holst	holst	VERB
ct-9353	93	6	w	w	PROPN
ct-9353	93	7	,	,	PUNCT
ct-9353	93	8	van	van	PROPN
ct-9353	93	9	laar	laar	NOUN
ct-9353	93	10	ph	ph	VERB
ct-9353	93	11	,	,	PUNCT
ct-9353	93	12	oldenkamp	oldenkamp	ADJ
ct-9353	93	13	ep	ep	PROPN
ct-9353	93	14	:	:	PUNCT
ct-9353	93	15	prolonged	prolonged	ADJ
ct-9353	93	16	spring	spring	NOUN
ct-9353	93	17	oestrus	oestrus	NOUN
ct-9353	93	18	in	in	ADP
ct-9353	93	19	mares	mare	NOUN
ct-9353	93	20	:	:	PUNCT
ct-9353	93	21	the	the	DET
ct-9353	93	22	use	use	NOUN
ct-9353	93	23	of	of	ADP
ct-9353	93	24	progestogens	progestogen	NOUN
ct-9353	93	25	with	with	ADP
ct-9353	93	26	specific	specific	ADJ
ct-9353	93	27	reference	reference	NOUN
ct-9353	93	28	to	to	ADP
ct-9353	93	29	proligestone	proligestone	NOUN
ct-9353	93	30	.	.	PUNCT
ct-9353	94	1	theriogenology	theriogenology	NOUN
ct-9353	94	2	1985;24:609	1985;24:609	PROPN
ct-9353	94	3	-	-	PUNCT
ct-9353	94	4	617	617	NUM
ct-9353	94	5	.	.	NOUN
ct-9353	94	6	4	4	NUM
ct-9353	94	7	.	.	X
ct-9353	95	1	lopez	lopez	NOUN
ct-9353	95	2	-	-	PUNCT
ct-9353	95	3	bayghen	bayghen	NOUN
ct-9353	95	4	c	c	NOUN
ct-9353	95	5	,	,	PUNCT
ct-9353	95	6	zozaya	zozaya	PROPN
ct-9353	95	7	h	h	PROPN
ct-9353	95	8	,	,	PUNCT
ct-9353	95	9	ocampo	ocampo	PROPN
ct-9353	95	10	l	l	NOUN
ct-9353	95	11	,	,	PUNCT
ct-9353	95	12	et	et	PROPN
ct-9353	95	13	al	al	PROPN
ct-9353	95	14	:	:	PUNCT
ct-9353	95	15	melengestrol	melengestrol	NOUN
ct-9353	95	16	acetate	acetate	NOUN
ct-9353	95	17	as	as	ADP
ct-9353	95	18	a	a	DET
ct-9353	95	19	tool	tool	NOUN
ct-9353	95	20	for	for	ADP
ct-9353	95	21	inducing	induce	VERB
ct-9353	95	22	early	early	ADJ
ct-9353	95	23	ovulation	ovulation	NOUN
ct-9353	95	24	in	in	ADP
ct-9353	95	25	transitional	transitional	ADJ
ct-9353	95	26	mares	mare	NOUN
ct-9353	95	27	.	.	PUNCT
ct-9353	96	1	acta	acta	PROPN
ct-9353	96	2	vet	vet	PROPN
ct-9353	96	3	hung	hang	VERB
ct-9353	96	4	2008;56:125	2008;56:125	PROPN
ct-9353	96	5	-	-	SYM
ct-9353	96	6	131	131	NUM
ct-9353	96	7	.	.	NOUN
ct-9353	97	1	5	5	NUM
ct-9353	97	2	.	.	NOUN
ct-9353	97	3	webel	webel	PROPN
ct-9353	97	4	sk	sk	PROPN
ct-9353	97	5	,	,	PUNCT
ct-9353	97	6	squires	squires	PROPN
ct-9353	97	7	el	el	PROPN
ct-9353	97	8	:	:	PUNCT
ct-9353	97	9	control	control	NOUN
ct-9353	97	10	of	of	ADP
ct-9353	97	11	the	the	DET
ct-9353	97	12	oestrous	oestrous	ADJ
ct-9353	97	13	cycle	cycle	NOUN
ct-9353	97	14	in	in	ADP
ct-9353	97	15	mares	mare	NOUN
ct-9353	97	16	with	with	ADP
ct-9353	97	17	altrenogest	altrenogest	PROPN
ct-9353	97	18	.	.	PUNCT
ct-9353	98	1	j	j	PROPN
ct-9353	98	2	reprod	reprod	PROPN
ct-9353	98	3	fertil	fertil	VERB
ct-9353	98	4	suppl	suppl	ADJ
ct-9353	98	5	1982;32:193	1982;32:193	PROPN
ct-9353	98	6	-	-	SYM
ct-9353	98	7	198	198	NUM
ct-9353	98	8	.	.	PUNCT
ct-9353	99	1	6	6	NUM
ct-9353	99	2	.	.	PUNCT
ct-9353	99	3	bauer	bauer	PROPN
ct-9353	99	4	er	er	INTJ
ct-9353	99	5	,	,	PUNCT
ct-9353	99	6	daxenberger	daxenberger	NOUN
ct-9353	99	7	a	a	PRON
ct-9353	99	8	,	,	PUNCT
ct-9353	99	9	petri	petri	ADJ
ct-9353	99	10	t	t	PROPN
ct-9353	99	11	,	,	PUNCT
ct-9353	99	12	et	et	PROPN
ct-9353	99	13	al	al	PROPN
ct-9353	99	14	:	:	PUNCT
ct-9353	99	15	characterisation	characterisation	NOUN
ct-9353	99	16	of	of	ADP
ct-9353	99	17	the	the	DET
ct-9353	99	18	affinity	affinity	NOUN
ct-9353	99	19	of	of	ADP
ct-9353	99	20	different	different	ADJ
ct-9353	99	21	anabolics	anabolic	NOUN
ct-9353	99	22	and	and	CCONJ
ct-9353	99	23	synthetic	synthetic	ADJ
ct-9353	99	24	hormones	hormone	NOUN
ct-9353	99	25	to	to	ADP
ct-9353	99	26	the	the	DET
ct-9353	99	27	human	human	ADJ
ct-9353	99	28	androgen	androgen	NOUN
ct-9353	99	29	receptor	receptor	NOUN
ct-9353	99	30	,	,	PUNCT
ct-9353	99	31	human	human	ADJ
ct-9353	99	32	sex	sex	NOUN
ct-9353	99	33	hormone	hormone	NOUN
ct-9353	99	34	binding	bind	VERB
ct-9353	99	35	globulin	globulin	NOUN
ct-9353	99	36	and	and	CCONJ
ct-9353	99	37	to	to	ADP
ct-9353	99	38	the	the	DET
ct-9353	99	39	bovine	bovine	NOUN
ct-9353	99	40	progestin	progestin	NOUN
ct-9353	99	41	receptor	receptor	NOUN
ct-9353	99	42	.	.	PUNCT
ct-9353	100	1	apmis	apmis	PROPN
ct-9353	100	2	2000;108:838	2000;108:838	NUM
ct-9353	100	3	-	-	SYM
ct-9353	100	4	846	846	NUM
ct-9353	100	5	.	.	PUNCT
ct-9353	100	6	7	7	X
ct-9353	100	7	.	.	X
ct-9353	100	8	hodgson	hodgson	PROPN
ct-9353	100	9	d	d	PROPN
ct-9353	100	10	,	,	PUNCT
ct-9353	100	11	howe	howe	NOUN
ct-9353	100	12	s	s	PROPN
ct-9353	100	13	,	,	PUNCT
ct-9353	100	14	jeffcott	jeffcott	PROPN
ct-9353	100	15	l	l	PROPN
ct-9353	100	16	,	,	PUNCT
ct-9353	100	17	et	et	PROPN
ct-9353	100	18	al	al	PROPN
ct-9353	100	19	:	:	PUNCT
ct-9353	100	20	effect	effect	NOUN
ct-9353	100	21	of	of	ADP
ct-9353	100	22	prolonged	prolonged	ADJ
ct-9353	100	23	use	use	NOUN
ct-9353	100	24	of	of	ADP
ct-9353	100	25	altrenogest	altrenogest	NOUN
ct-9353	100	26	on	on	ADP
ct-9353	100	27	behaviour	behaviour	NOUN
ct-9353	100	28	in	in	ADP
ct-9353	100	29	mares	mare	NOUN
ct-9353	100	30	.	.	PUNCT
ct-9353	101	1	vet	vet	NOUN
ct-9353	101	2	j	j	PROPN
ct-9353	101	3	2005;169:322	2005;169:322	PROPN
ct-9353	101	4	-	-	SYM
ct-9353	101	5	325	325	NUM
ct-9353	101	6	.	.	NOUN
ct-9353	102	1	8	8	NUM
ct-9353	102	2	.	.	X
ct-9353	102	3	shoemaker	shoemaker	PROPN
ct-9353	102	4	cf	cf	PROPN
ct-9353	102	5	,	,	PUNCT
ct-9353	102	6	squires	squires	PROPN
ct-9353	102	7	el	el	PROPN
ct-9353	102	8	,	,	PUNCT
ct-9353	102	9	shideler	shideler	NOUN
ct-9353	102	10	rk	rk	NOUN
ct-9353	102	11	:	:	PUNCT
ct-9353	102	12	safety	safety	NOUN
ct-9353	102	13	of	of	ADP
ct-9353	102	14	altrenogest	altrenogest	NOUN
ct-9353	102	15	in	in	ADP
ct-9353	102	16	pregnant	pregnant	ADJ
ct-9353	102	17	mares	mare	NOUN
ct-9353	102	18	and	and	CCONJ
ct-9353	102	19	on	on	ADP
ct-9353	102	20	health	health	NOUN
ct-9353	102	21	and	and	CCONJ
ct-9353	102	22	development	development	NOUN
ct-9353	102	23	of	of	ADP
ct-9353	102	24	offspring	offspring	NOUN
ct-9353	102	25	.	.	PUNCT
ct-9353	103	1	j	j	PROPN
ct-9353	103	2	equine	equine	PROPN
ct-9353	103	3	vet	vet	NOUN
ct-9353	103	4	sci	sci	PROPN
ct-9353	103	5	1989;9:69	1989;9:69	ADV
ct-9353	103	6	-	-	PUNCT
ct-9353	103	7	72	72	NUM
ct-9353	103	8	.	.	NOUN
ct-9353	104	1	9	9	NUM
ct-9353	104	2	.	.	X
ct-9353	104	3	machnik	machnik	PROPN
ct-9353	104	4	m	m	PROPN
ct-9353	104	5	,	,	PUNCT
ct-9353	104	6	hegger	hegger	PROPN
ct-9353	104	7	i	i	PROPN
ct-9353	104	8	,	,	PUNCT
ct-9353	104	9	kietzmann	kietzmann	PROPN
ct-9353	104	10	m	m	PROPN
ct-9353	104	11	,	,	PUNCT
ct-9353	104	12	et	et	PROPN
ct-9353	104	13	al	al	PROPN
ct-9353	104	14	:	:	PUNCT
ct-9353	104	15	pharmacokinetics	pharmacokinetic	NOUN
ct-9353	104	16	of	of	ADP
ct-9353	104	17	altrenogest	altrenogest	NOUN
ct-9353	104	18	in	in	ADP
ct-9353	104	19	horses	horse	NOUN
ct-9353	104	20	.	.	PUNCT
ct-9353	105	1	j	j	PROPN
ct-9353	105	2	vet	vet	NOUN
ct-9353	105	3	pharmacol	pharmacol	PROPN
ct-9353	105	4	ther	ther	ADV
ct-9353	105	5	2007;30:86	2007;30:86	PROPN
ct-9353	105	6	-	-	SYM
ct-9353	105	7	90	90	NUM
ct-9353	105	8	.	.	PUNCT
ct-9353	105	9	10	10	NUM
ct-9353	105	10	.	.	PUNCT
ct-9353	106	1	mcconaghy	mcconaghy	PROPN
ct-9353	106	2	ff	ff	PROPN
ct-9353	106	3	,	,	PUNCT
ct-9353	106	4	green	green	PROPN
ct-9353	106	5	la	la	PROPN
ct-9353	106	6	,	,	PUNCT
ct-9353	106	7	colgan	colgan	PROPN
ct-9353	106	8	s	s	PROPN
ct-9353	106	9	,	,	PUNCT
ct-9353	106	10	et	et	PROPN
ct-9353	106	11	al	al	PROPN
ct-9353	106	12	:	:	PUNCT
ct-9353	106	13	studies	study	NOUN
ct-9353	106	14	of	of	ADP
ct-9353	106	15	the	the	DET
ct-9353	106	16	pharmacokinetic	pharmacokinetic	ADJ
ct-9353	106	17	profile	profile	NOUN
ct-9353	106	18	,	,	PUNCT
ct-9353	106	19	in	in	ADP
ct-9353	106	20	vivo	vivo	ADJ
ct-9353	106	21	efficacy	efficacy	NOUN
ct-9353	106	22	and	and	CCONJ
ct-9353	106	23	safety	safety	NOUN
ct-9353	106	24	of	of	ADP
ct-9353	106	25	injectable	injectable	ADJ
ct-9353	106	26	altrenogest	altrenogest	NOUN
ct-9353	106	27	for	for	ADP
ct-9353	106	28	the	the	DET
ct-9353	106	29	suppression	suppression	NOUN
ct-9353	106	30	of	of	ADP
ct-9353	106	31	oestrus	oestrus	NOUN
ct-9353	106	32	in	in	ADP
ct-9353	106	33	mares	mare	NOUN
ct-9353	106	34	.	.	PUNCT
ct-9353	107	1	aust	aust	PROPN
ct-9353	107	2	vet	vet	PROPN
ct-9353	107	3	j	j	PROPN
ct-9353	107	4	2016;94:248	2016;94:248	PROPN
ct-9353	107	5	-	-	SYM
ct-9353	107	6	255	255	NUM
ct-9353	107	7	.	.	PUNCT
ct-9353	108	1	11	11	NUM
ct-9353	108	2	.	.	PUNCT
ct-9353	109	1	ellis	ellis	PROPN
ct-9353	109	2	ke	ke	PROPN
ct-9353	109	3	,	,	PUNCT
ct-9353	109	4	council	council	PROPN
ct-9353	109	5	-	-	PUNCT
ct-9353	109	6	troche	troche	PROPN
ct-9353	109	7	rm	rm	PROPN
ct-9353	109	8	,	,	PUNCT
ct-9353	109	9	von	von	PROPN
ct-9353	109	10	dollen	dollen	PROPN
ct-9353	109	11	ka	ka	PROPN
ct-9353	109	12	,	,	PUNCT
ct-9353	109	13	et	et	PROPN
ct-9353	109	14	al	al	PROPN
ct-9353	109	15	:	:	PUNCT
ct-9353	109	16	pharmacokinetics	pharmacokinetic	NOUN
ct-9353	109	17	of	of	ADP
ct-9353	109	18	intrarectal	intrarectal	ADJ
ct-9353	109	19	altrenogest	altrenogest	NOUN
ct-9353	109	20	in	in	ADP
ct-9353	109	21	horses	horse	NOUN
ct-9353	109	22	.	.	PUNCT
ct-9353	110	1	j	j	PROPN
ct-9353	110	2	equine	equine	PROPN
ct-9353	110	3	vet	vet	NOUN
ct-9353	110	4	sci	sci	PROPN
ct-9353	110	5	2019;72:41	2019;72:41	NUM
ct-9353	110	6	-	-	SYM
ct-9353	110	7	46	46	NUM
ct-9353	110	8	.	.	PUNCT
ct-9353	110	9	12	12	NUM
ct-9353	110	10	.	.	PUNCT
ct-9353	111	1	hawkins	hawkins	PROPN
ct-9353	111	2	dl	dl	PROPN
ct-9353	111	3	,	,	PUNCT
ct-9353	111	4	neely	neely	PROPN
ct-9353	111	5	dp	dp	PROPN
ct-9353	111	6	,	,	PUNCT
ct-9353	111	7	stabenfeldt	stabenfeldt	PROPN
ct-9353	111	8	gh	gh	PROPN
ct-9353	111	9	:	:	PUNCT
ct-9353	111	10	plasma	plasma	NOUN
ct-9353	111	11	progesterone	progesterone	NOUN
ct-9353	111	12	concentrations	concentration	NOUN
ct-9353	111	13	derived	derive	VERB
ct-9353	111	14	from	from	ADP
ct-9353	111	15	the	the	DET
ct-9353	111	16	administration	administration	NOUN
ct-9353	111	17	of	of	ADP
ct-9353	111	18	exogenous	exogenous	ADJ
ct-9353	111	19	progesterone	progesterone	NOUN
ct-9353	111	20	to	to	ADP
ct-9353	111	21	ovariectomized	ovariectomize	VERB
ct-9353	111	22	mares	mare	NOUN
ct-9353	111	23	.	.	PUNCT
ct-9353	112	1	j	j	PROPN
ct-9353	112	2	reprod	reprod	PROPN
ct-9353	112	3	fertil	fertil	PROPN
ct-9353	112	4	suppl	suppl	ADJ
ct-9353	112	5	1979:211	1979:211	PROPN
ct-9353	112	6	-	-	SYM
ct-9353	112	7	216	216	NUM
ct-9353	112	8	.	.	PUNCT
ct-9353	113	1	13	13	NUM
ct-9353	113	2	.	.	X
ct-9353	114	1	mccue	mccue	PROPN
ct-9353	114	2	pm	pm	PROPN
ct-9353	114	3	:	:	PUNCT
ct-9353	114	4	estrus	estrus	NOUN
ct-9353	114	5	suppression	suppression	NOUN
ct-9353	114	6	in	in	ADP
ct-9353	114	7	performance	performance	NOUN
ct-9353	114	8	horses	horse	NOUN
ct-9353	114	9	.	.	PUNCT
ct-9353	115	1	j	j	PROPN
ct-9353	115	2	equine	equine	PROPN
ct-9353	115	3	vet	vet	NOUN
ct-9353	115	4	sci	sci	PROPN
ct-9353	115	5	2003;23:341	2003;23:341	PROPN
ct-9353	115	6	-	-	SYM
ct-9353	115	7	345	345	NUM
ct-9353	115	8	.	.	PUNCT
ct-9353	116	1	14	14	NUM
ct-9353	116	2	.	.	PUNCT
ct-9353	117	1	storer	storer	PROPN
ct-9353	117	2	wa	wa	PROPN
ct-9353	117	3	,	,	PUNCT
ct-9353	117	4	thompson	thompson	PROPN
ct-9353	117	5	dl	dl	PROPN
ct-9353	117	6	,	,	PUNCT
ct-9353	117	7	gilley	gilley	PROPN
ct-9353	117	8	rm	rm	PROPN
ct-9353	117	9	,	,	PUNCT
ct-9353	117	10	et	et	PROPN
ct-9353	117	11	al	al	PROPN
ct-9353	117	12	:	:	PUNCT
ct-9353	117	13	evaluation	evaluation	NOUN
ct-9353	117	14	of	of	ADP
ct-9353	117	15	injectable	injectable	ADJ
ct-9353	117	16	sustained	sustain	VERB
ct-9353	117	17	release	release	NOUN
ct-9353	117	18	progestin	progestin	NOUN
ct-9353	117	19	formulations	formulation	NOUN
ct-9353	117	20	for	for	ADP
ct-9353	117	21	suppression	suppression	NOUN
ct-9353	117	22	of	of	ADP
ct-9353	117	23	estrus	estrus	NOUN
ct-9353	117	24	and	and	CCONJ
ct-9353	117	25	ovulation	ovulation	NOUN
ct-9353	117	26	in	in	ADP
ct-9353	117	27	mares	mare	NOUN
ct-9353	117	28	.	.	PUNCT
ct-9353	118	1	j	j	PROPN
ct-9353	118	2	equine	equine	PROPN
ct-9353	118	3	vet	vet	NOUN
ct-9353	118	4	sci	sci	PROPN
ct-9353	118	5	2009;29:33	2009;29:33	NUM
ct-9353	118	6	-	-	SYM
ct-9353	118	7	36	36	NUM
ct-9353	118	8	.	.	PUNCT
ct-9353	118	9	15	15	NUM
ct-9353	118	10	.	.	PUNCT
ct-9353	119	1	squires	squires	PROPN
ct-9353	119	2	el	el	PROPN
ct-9353	119	3	,	,	PUNCT
ct-9353	119	4	heesemann	heesemann	PROPN
ct-9353	119	5	cp	cp	PROPN
ct-9353	119	6	,	,	PUNCT
ct-9353	119	7	webel	webel	ADJ
ct-9353	119	8	sk	sk	PROPN
ct-9353	119	9	,	,	PUNCT
ct-9353	119	10	et	et	PROPN
ct-9353	119	11	al	al	PROPN
ct-9353	119	12	:	:	PUNCT
ct-9353	119	13	relationship	relationship	NOUN
ct-9353	119	14	of	of	ADP
ct-9353	119	15	altrenogest	altrenogest	NOUN
ct-9353	119	16	to	to	ADP
ct-9353	119	17	ovarian	ovarian	ADJ
ct-9353	119	18	activity	activity	NOUN
ct-9353	119	19	,	,	PUNCT
ct-9353	119	20	hormone	hormone	NOUN
ct-9353	119	21	concentrations	concentration	NOUN
ct-9353	119	22	and	and	CCONJ
ct-9353	119	23	fertility	fertility	NOUN
ct-9353	119	24	of	of	ADP
ct-9353	119	25	mares	mare	NOUN
ct-9353	119	26	.	.	PUNCT
ct-9353	120	1	j	j	PROPN
ct-9353	120	2	anim	anim	NOUN
ct-9353	120	3	sci	sci	PROPN
ct-9353	120	4	1983;56:901	1983;56:901	PROPN
ct-9353	120	5	-	-	SYM
ct-9353	120	6	910	910	NUM
ct-9353	120	7	.	.	PUNCT
ct-9353	120	8	16	16	NUM
ct-9353	120	9	.	.	PUNCT
ct-9353	121	1	shideler	shideler	PROPN
ct-9353	121	2	rk	rk	PROPN
ct-9353	121	3	,	,	PUNCT
ct-9353	121	4	voss	voss	PROPN
ct-9353	121	5	jl	jl	PROPN
ct-9353	121	6	,	,	PUNCT
ct-9353	121	7	aufderheide	aufderheide	NOUN
ct-9353	121	8	wm	wm	PROPN
ct-9353	121	9	,	,	PUNCT
ct-9353	121	10	et	et	PROPN
ct-9353	121	11	al	al	PROPN
ct-9353	121	12	:	:	PUNCT
ct-9353	121	13	the	the	DET
ct-9353	121	14	effect	effect	NOUN
ct-9353	121	15	of	of	ADP
ct-9353	121	16	altrenogest	altrenog	ADJ
ct-9353	121	17	,	,	PUNCT
ct-9353	121	18	an	an	DET
ct-9353	121	19	oral	oral	ADJ
ct-9353	121	20	progestin	progestin	NOUN
ct-9353	121	21	,	,	PUNCT
ct-9353	121	22	on	on	ADP
ct-9353	121	23	hematologic	hematologic	NOUN
ct-9353	121	24	and	and	CCONJ
ct-9353	121	25	biochemical	biochemical	ADJ
ct-9353	121	26	parameters	parameter	NOUN
ct-9353	121	27	in	in	ADP
ct-9353	121	28	mares	mare	NOUN
ct-9353	121	29	.	.	PUNCT
ct-9353	122	1	vet	vet	NOUN
ct-9353	122	2	hum	hum	NOUN
ct-9353	123	1	toxicol	toxicol	PROPN
ct-9353	123	2	1983;25:250	1983;25:250	NUM
ct-9353	123	3	-	-	SYM
ct-9353	123	4	252	252	NUM
ct-9353	123	5	.	.	PUNCT
ct-9353	123	6	17	17	NUM
ct-9353	123	7	.	.	PUNCT
ct-9353	124	1	gee	gee	INTJ
ct-9353	124	2	ek	ek	PROPN
ct-9353	124	3	,	,	PUNCT
ct-9353	124	4	deluca	deluca	PROPN
ct-9353	124	5	c	c	PROPN
ct-9353	124	6	,	,	PUNCT
ct-9353	124	7	stylski	stylski	ADJ
ct-9353	124	8	jl	jl	NOUN
ct-9353	124	9	,	,	PUNCT
ct-9353	124	10	et	et	PROPN
ct-9353	124	11	al	al	PROPN
ct-9353	124	12	:	:	PUNCT
ct-9353	124	13	efficacy	efficacy	NOUN
ct-9353	124	14	of	of	ADP
ct-9353	124	15	medroxyprogesterone	medroxyprogesterone	NOUN
ct-9353	124	16	acetate	acetate	NOUN
ct-9353	124	17	in	in	ADP
ct-9353	124	18	suppression	suppression	NOUN
ct-9353	124	19	of	of	ADP
ct-9353	124	20	estrus	estrus	NOUN
ct-9353	124	21	in	in	ADP
ct-9353	124	22	cycling	cycling	NOUN
ct-9353	124	23	mares	mare	NOUN
ct-9353	124	24	.	.	PUNCT
ct-9353	125	1	j	j	PROPN
ct-9353	125	2	equine	equine	PROPN
ct-9353	125	3	vet	vet	NOUN
ct-9353	125	4	sci	sci	PROPN
ct-9353	125	5	2009;29:140	2009;29:140	PROPN
ct-9353	125	6	-	-	SYM
ct-9353	125	7	145	145	NUM
ct-9353	125	8	.	.	PUNCT
ct-9353	125	9	18	18	NUM
ct-9353	125	10	.	.	PUNCT
ct-9353	125	11	wiepz	wiepz	PROPN
ct-9353	125	12	gj	gj	PROPN
ct-9353	125	13	,	,	PUNCT
ct-9353	125	14	squires	squires	PROPN
ct-9353	125	15	el	el	PROPN
ct-9353	125	16	,	,	PUNCT
ct-9353	125	17	chapman	chapman	PROPN
ct-9353	125	18	pl	pl	PROPN
ct-9353	125	19	:	:	PUNCT
ct-9353	125	20	effects	effect	NOUN
ct-9353	125	21	of	of	ADP
ct-9353	125	22	norgestomet	norgestomet	NOUN
ct-9353	125	23	,	,	PUNCT
ct-9353	125	24	altrenogest	altrenogest	NOUN
ct-9353	125	25	,	,	PUNCT
ct-9353	125	26	and/or	and/or	CCONJ
ct-9353	125	27	estradiol	estradiol	PROPN
ct-9353	125	28	on	on	ADP
ct-9353	125	29	follicular	follicular	ADJ
ct-9353	125	30	and	and	CCONJ
ct-9353	125	31	hormonal	hormonal	ADJ
ct-9353	125	32	characteristics	characteristic	NOUN
ct-9353	125	33	of	of	ADP
ct-9353	125	34	late	late	ADJ
ct-9353	125	35	transitional	transitional	ADJ
ct-9353	125	36	mares	mare	NOUN
ct-9353	125	37	.	.	PUNCT
ct-9353	126	1	theriogenology	theriogenology	NOUN
ct-9353	126	2	1988;30:181	1988;30:181	NUM
ct-9353	126	3	-	-	SYM
ct-9353	126	4	193	193	NUM
ct-9353	126	5	.	.	PUNCT
ct-9353	126	6	19	19	NUM
ct-9353	126	7	.	.	PUNCT
ct-9353	127	1	neely	neely	PROPN
ct-9353	127	2	dp	dp	NOUN
ct-9353	127	3	:	:	PUNCT
ct-9353	127	4	progesterone	progesterone	NOUN
ct-9353	127	5	/	/	SYM
ct-9353	127	6	progestin	progestin	NOUN
ct-9353	127	7	therapy	therapy	NOUN
ct-9353	127	8	in	in	ADP
ct-9353	127	9	the	the	DET
ct-9353	127	10	broodmare	broodmare	NOUN
ct-9353	127	11	.	.	PUNCT
ct-9353	128	1	proc	proc	PROPN
ct-9353	128	2	am	be	AUX
ct-9353	128	3	assoc	assoc	NOUN
ct-9353	128	4	equine	equine	PROPN
ct-9353	128	5	pract1988	pract1988	PROPN
ct-9353	128	6	.	.	PUNCT
ct-9353	129	1	p.	p.	NOUN
ct-9353	129	2	203	203	NUM
ct-9353	129	3	-	-	SYM
ct-9353	129	4	218	218	NUM
ct-9353	129	5	.	.	PUNCT
ct-9353	129	6	20	20	NUM
ct-9353	129	7	.	.	PUNCT
ct-9353	130	1	bristol	bristol	PROPN
ct-9353	130	2	f	f	PROPN
ct-9353	130	3	:	:	PUNCT
ct-9353	130	4	studies	study	NOUN
ct-9353	130	5	on	on	ADP
ct-9353	130	6	estrous	estrous	ADJ
ct-9353	130	7	synchronization	synchronization	NOUN
ct-9353	130	8	in	in	ADP
ct-9353	130	9	mres	mre	NOUN
ct-9353	130	10	.	.	PUNCT
ct-9353	131	1	proc	proc	NOUN
ct-9353	131	2	soc	soc	NOUN
ct-9353	131	3	of	of	ADP
ct-9353	131	4	therio1981	therio1981	PROPN
ct-9353	131	5	.	.	PUNCT
ct-9353	132	1	p.	p.	NOUN
ct-9353	132	2	258	258	NUM
ct-9353	132	3	-	-	SYM
ct-9353	132	4	264	264	NUM
ct-9353	132	5	.	.	PUNCT
ct-9353	132	6	21	21	NUM
ct-9353	132	7	.	.	PUNCT
ct-9353	132	8	canisso	canisso	PROPN
ct-9353	132	9	if	if	SCONJ
ct-9353	132	10	,	,	PUNCT
ct-9353	132	11	gallacher	gallacher	PROPN
ct-9353	132	12	k	k	PROPN
ct-9353	132	13	,	,	PUNCT
ct-9353	132	14	gilbert	gilbert	PROPN
ct-9353	132	15	ma	ma	PROPN
ct-9353	132	16	,	,	PUNCT
ct-9353	132	17	et	et	PROPN
ct-9353	132	18	al	al	PROPN
ct-9353	132	19	:	:	PUNCT
ct-9353	132	20	preovulatory	preovulatory	NOUN
ct-9353	132	21	progestagen	progestagen	NOUN
ct-9353	132	22	treatment	treatment	NOUN
ct-9353	132	23	in	in	ADP
ct-9353	132	24	mares	mare	NOUN
ct-9353	132	25	fails	fail	VERB
ct-9353	132	26	to	to	PART
ct-9353	132	27	delay	delay	VERB
ct-9353	132	28	ovulation	ovulation	NOUN
ct-9353	132	29	.	.	PUNCT
ct-9353	133	1	vet	vet	NOUN
ct-9353	133	2	j	j	PROPN
ct-9353	133	3	2013;197:324	2013;197:324	NUM
ct-9353	133	4	-	-	SYM
ct-9353	133	5	328	328	NUM
ct-9353	133	6	.	.	PUNCT
ct-9353	134	1	22	22	NUM
ct-9353	134	2	.	.	PUNCT
ct-9353	135	1	james	james	PROPN
ct-9353	135	2	an	an	PROPN
ct-9353	135	3	,	,	PUNCT
ct-9353	135	4	vogelsang	vogelsang	PROPN
ct-9353	135	5	mm	mm	PROPN
ct-9353	135	6	,	,	PUNCT
ct-9353	135	7	forest	forest	PROPN
ct-9353	135	8	dw	dw	PROPN
ct-9353	135	9	,	,	PUNCT
ct-9353	135	10	et	et	PROPN
ct-9353	135	11	al	al	PROPN
ct-9353	135	12	:	:	PUNCT
ct-9353	135	13	efficacy	efficacy	NOUN
ct-9353	135	14	of	of	ADP
ct-9353	135	15	short	short	ADJ
ct-9353	135	16	-	-	PUNCT
ct-9353	135	17	term	term	NOUN
ct-9353	135	18	administration	administration	NOUN
ct-9353	135	19	of	of	ADP
ct-9353	135	20	altrenogest	altrenog	ADJ
ct-9353	135	21	to	to	PART
ct-9353	135	22	postpone	postpone	VERB
ct-9353	135	23	ovulation	ovulation	NOUN
ct-9353	135	24	in	in	ADP
ct-9353	135	25	mares	mare	NOUN
ct-9353	135	26	.	.	PUNCT
ct-9353	136	1	j	j	PROPN
ct-9353	136	2	eq	eq	PROPN
ct-9353	136	3	vet	vet	PROPN
ct-9353	136	4	sci	sci	PROPN
ct-9353	136	5	1998;18:329	1998;18:329	PROPN
ct-9353	136	6	-	-	PUNCT
ct-9353	136	7	331	331	NUM
ct-9353	136	8	.	.	PUNCT
ct-9353	136	9	23	23	NUM
ct-9353	136	10	.	.	PUNCT
ct-9353	137	1	bruemmer	bruemmer	PROPN
ct-9353	137	2	je	je	PROPN
ct-9353	137	3	,	,	PUNCT
ct-9353	137	4	coy	coy	PROPN
ct-9353	137	5	rc	rc	PROPN
ct-9353	137	6	,	,	PUNCT
ct-9353	137	7	olson	olson	NOUN
ct-9353	137	8	a	a	PROPN
ct-9353	137	9	,	,	PUNCT
ct-9353	137	10	et	et	PROPN
ct-9353	137	11	al	al	PROPN
ct-9353	137	12	:	:	PUNCT
ct-9353	137	13	efficacy	efficacy	NOUN
ct-9353	137	14	of	of	ADP
ct-9353	137	15	altrenogest	altrenogest	PROPN
ct-9353	137	16	administration	administration	NOUN
ct-9353	137	17	to	to	PART
ct-9353	137	18	postpone	postpone	VERB
ct-9353	137	19	ovulation	ovulation	NOUN
ct-9353	137	20	and	and	CCONJ
ct-9353	137	21	subsequent	subsequent	ADJ
ct-9353	137	22	fertility	fertility	NOUN
ct-9353	137	23	in	in	ADP
ct-9353	137	24	mares	mare	NOUN
ct-9353	137	25	.	.	PUNCT
ct-9353	138	1	j	j	PROPN
ct-9353	138	2	equine	equine	PROPN
ct-9353	138	3	vet	vet	NOUN
ct-9353	138	4	sci	sci	PROPN
ct-9353	138	5	2000;20:450	2000;20:450	PROPN
ct-9353	138	6	-	-	NUM
ct-9353	138	7	453	453	NUM
ct-9353	138	8	.	.	NUM
ct-9353	139	1	24	24	NUM
ct-9353	139	2	.	.	PUNCT
ct-9353	140	1	storer	storer	PROPN
ct-9353	140	2	wa	wa	PROPN
ct-9353	140	3	,	,	PUNCT
ct-9353	140	4	thompson	thompson	PROPN
ct-9353	140	5	dl	dl	PROPN
ct-9353	140	6	,	,	PUNCT
ct-9353	140	7	gilley	gilley	PROPN
ct-9353	140	8	rm	rm	PROPN
ct-9353	140	9	,	,	PUNCT
ct-9353	140	10	et	et	PROPN
ct-9353	140	11	al	al	PROPN
ct-9353	140	12	:	:	PUNCT
ct-9353	140	13	evaluation	evaluation	NOUN
ct-9353	140	14	of	of	ADP
ct-9353	140	15	injectable	injectable	ADJ
ct-9353	140	16	sustained	sustain	VERB
ct-9353	140	17	release	release	NOUN
ct-9353	140	18	progestinformulations	progestinformulation	NOUN
ct-9353	140	19	for	for	ADP
ct-9353	140	20	suppression	suppression	NOUN
ct-9353	140	21	of	of	ADP
ct-9353	140	22	estrus	estrus	NOUN
ct-9353	140	23	and	and	CCONJ
ct-9353	140	24	ovulation	ovulation	NOUN
ct-9353	140	25	in	in	ADP
ct-9353	140	26	mares	mare	NOUN
ct-9353	140	27	.	.	PUNCT
ct-9353	141	1	j	j	PROPN
ct-9353	141	2	equine	equine	PROPN
ct-9353	141	3	vet	vet	NOUN
ct-9353	141	4	sci	sci	PROPN
ct-9353	141	5	2009;29	2009;29	PROPN
ct-9353	141	6	.	.	PUNCT
ct-9353	142	1	25	25	NUM
ct-9353	142	2	.	.	PUNCT
ct-9353	142	3	colbern	colbern	PROPN
ct-9353	142	4	gt	gt	PROPN
ct-9353	142	5	,	,	PUNCT
ct-9353	142	6	squires	squires	PROPN
ct-9353	142	7	el	el	PROPN
ct-9353	142	8	,	,	PUNCT
ct-9353	142	9	voss	voss	PROPN
ct-9353	142	10	jl	jl	PROPN
ct-9353	142	11	:	:	PUNCT
ct-9353	142	12	use	use	NOUN
ct-9353	142	13	of	of	ADP
ct-9353	142	14	altrenogest	altrenog	ADJ
ct-9353	142	15	and	and	CCONJ
ct-9353	142	16	human	human	ADJ
ct-9353	142	17	chorionic	chorionic	ADJ
ct-9353	142	18	gonadotropin	gonadotropin	NOUN
ct-9353	142	19	to	to	PART
ct-9353	142	20	induce	induce	VERB
ct-9353	142	21	normal	normal	ADJ
ct-9353	142	22	ovarian	ovarian	ADJ
ct-9353	142	23	cyclicity	cyclicity	NOUN
ct-9353	142	24	in	in	ADP
ct-9353	142	25	transitional	transitional	ADJ
ct-9353	142	26	mares	mare	NOUN
ct-9353	142	27	.	.	PUNCT
ct-9353	143	1	j	j	PROPN
ct-9353	143	2	equine	equine	PROPN
ct-9353	143	3	vet	vet	PROPN
ct-9353	143	4	sci	sci	PROPN
ct-9353	143	5	1987;7:69	1987;7:69	PROPN
ct-9353	143	6	-	-	PUNCT
ct-9353	143	7	72	72	NUM
ct-9353	143	8	.	.	NOUN
ct-9353	143	9	26	26	NUM
ct-9353	143	10	.	.	PUNCT
ct-9353	143	11	staempfli	staempfli	PROPN
ct-9353	143	12	sa	sa	PROPN
ct-9353	143	13	,	,	PUNCT
ct-9353	143	14	clavier	clavier	NOUN
ct-9353	143	15	s	s	PROPN
ct-9353	143	16	,	,	PUNCT
ct-9353	143	17	thompson	thompson	PROPN
ct-9353	143	18	dl	dl	PROPN
ct-9353	143	19	,	,	PUNCT
ct-9353	143	20	et	et	PROPN
ct-9353	143	21	al	al	PROPN
ct-9353	143	22	:	:	PUNCT
ct-9353	143	23	effect	effect	NOUN
ct-9353	143	24	of	of	ADP
ct-9353	143	25	a	a	DET
ct-9353	143	26	single	single	ADJ
ct-9353	143	27	injection	injection	NOUN
ct-9353	143	28	of	of	ADP
ct-9353	143	29	long	long	ADV
ct-9353	143	30	-	-	PUNCT
ct-9353	143	31	acting	act	VERB
ct-9353	143	32	progesterone	progesterone	NOUN
ct-9353	143	33	on	on	ADP
ct-9353	143	34	the	the	DET
ct-9353	143	35	first	first	ADJ
ct-9353	143	36	ovulation	ovulation	NOUN
ct-9353	143	37	in	in	ADP
ct-9353	143	38	early	early	ADJ
ct-9353	143	39	and	and	CCONJ
ct-9353	143	40	late	late	ADJ
ct-9353	143	41	spring	spring	NOUN
ct-9353	143	42	transitional	transitional	ADJ
ct-9353	143	43	mares	mare	NOUN
ct-9353	143	44	.	.	PUNCT
ct-9353	144	1	j	j	PROPN
ct-9353	144	2	equine	equine	PROPN
ct-9353	144	3	vet	vet	NOUN
ct-9353	144	4	sci	sci	PROPN
ct-9353	144	5	2011;31:744	2011;31:744	PROPN
ct-9353	144	6	-	-	SYM
ct-9353	144	7	748	748	NUM
ct-9353	144	8	.	.	PUNCT
ct-9353	144	9	27	27	NUM
ct-9353	144	10	.	.	PUNCT
ct-9353	145	1	cuervo	cuervo	PROPN
ct-9353	145	2	-	-	PUNCT
ct-9353	145	3	arango	arango	PROPN
ct-9353	145	4	j	j	PROPN
ct-9353	145	5	,	,	PUNCT
ct-9353	145	6	clark	clark	PROPN
ct-9353	145	7	a	a	NOUN
ct-9353	145	8	:	:	PUNCT
ct-9353	145	9	the	the	DET
ct-9353	145	10	first	first	ADJ
ct-9353	145	11	ovulation	ovulation	NOUN
ct-9353	145	12	of	of	ADP
ct-9353	145	13	the	the	DET
ct-9353	145	14	breeding	breeding	NOUN
ct-9353	145	15	season	season	NOUN
ct-9353	145	16	in	in	ADP
ct-9353	145	17	the	the	DET
ct-9353	145	18	mare	mare	NOUN
ct-9353	145	19	:	:	PUNCT
ct-9353	145	20	the	the	DET
ct-9353	145	21	effect	effect	NOUN
ct-9353	145	22	of	of	ADP
ct-9353	145	23	progesterone	progesterone	NOUN
ct-9353	145	24	priming	priming	NOUN
ct-9353	145	25	on	on	ADP
ct-9353	145	26	pregnancy	pregnancy	NOUN
ct-9353	145	27	rate	rate	NOUN
ct-9353	145	28	and	and	CCONJ
ct-9353	145	29	breeding	breeding	NOUN
ct-9353	145	30	management	management	NOUN
ct-9353	145	31	(	(	PUNCT
ct-9353	145	32	hcg	hcg	PROPN
ct-9353	145	33	response	response	NOUN
ct-9353	145	34	rate	rate	NOUN
ct-9353	145	35	and	and	CCONJ
ct-9353	145	36	number	number	NOUN
ct-9353	145	37	of	of	ADP
ct-9353	145	38	services	service	NOUN
ct-9353	145	39	per	per	ADP
ct-9353	145	40	cycle	cycle	NOUN
ct-9353	145	41	and	and	CCONJ
ct-9353	145	42	mare	mare	NOUN
ct-9353	145	43	)	)	PUNCT
ct-9353	145	44	.	.	PUNCT
ct-9353	146	1	anim	anim	PROPN
ct-9353	146	2	reprod	reprod	PROPN
ct-9353	146	3	sci	sci	PROPN
ct-9353	146	4	2010;118:265	2010;118:265	NUM
ct-9353	146	5	-	-	SYM
ct-9353	146	6	269	269	NUM
ct-9353	146	7	.	.	NOUN
ct-9353	146	8	28	28	NUM
ct-9353	146	9	.	.	PUNCT
ct-9353	147	1	newcombe	newcombe	PROPN
ct-9353	147	2	jr	jr	PROPN
ct-9353	147	3	:	:	PUNCT
ct-9353	147	4	field	field	NOUN
ct-9353	147	5	observations	observation	NOUN
ct-9353	147	6	on	on	ADP
ct-9353	147	7	the	the	DET
ct-9353	147	8	use	use	NOUN
ct-9353	147	9	of	of	ADP
ct-9353	147	10	a	a	DET
ct-9353	147	11	progesterone	progesterone	NOUN
ct-9353	147	12	-	-	PUNCT
ct-9353	147	13	releasing	release	VERB
ct-9353	147	14	intravaginal	intravaginal	ADJ
ct-9353	147	15	device	device	NOUN
ct-9353	147	16	to	to	PART
ct-9353	147	17	induce	induce	VERB
ct-9353	147	18	estrous	estrous	ADJ
ct-9353	147	19	and	and	CCONJ
ct-9353	147	20	ovulation	ovulation	NOUN
ct-9353	147	21	in	in	ADP
ct-9353	147	22	seasonally	seasonally	ADV
ct-9353	147	23	anestrous	anestrous	ADJ
ct-9353	147	24	mares	mare	NOUN
ct-9353	147	25	.	.	PUNCT
ct-9353	148	1	j	j	PROPN
ct-9353	148	2	equine	equine	PROPN
ct-9353	148	3	vet	vet	NOUN
ct-9353	148	4	sci	sci	PROPN
ct-9353	148	5	2002;22:378	2002;22:378	PROPN
ct-9353	148	6	-	-	PUNCT
ct-9353	148	7	382	382	NUM
ct-9353	148	8	.	.	PUNCT
ct-9353	149	1	29	29	NUM
ct-9353	149	2	.	.	PUNCT
ct-9353	150	1	evans	evans	PROPN
ct-9353	150	2	mj	mj	PROPN
ct-9353	150	3	,	,	PUNCT
ct-9353	150	4	loy	loy	PROPN
ct-9353	150	5	rg	rg	PROPN
ct-9353	150	6	,	,	PUNCT
ct-9353	150	7	taylor	taylor	PROPN
ct-9353	150	8	tb	tb	PROPN
ct-9353	150	9	,	,	PUNCT
ct-9353	150	10	et	et	PROPN
ct-9353	150	11	al	al	PROPN
ct-9353	150	12	:	:	PUNCT
ct-9353	150	13	effects	effect	NOUN
ct-9353	150	14	of	of	ADP
ct-9353	150	15	exogenous	exogenous	ADJ
ct-9353	150	16	steroids	steroid	NOUN
ct-9353	150	17	on	on	ADP
ct-9353	150	18	serum	serum	NOUN
ct-9353	150	19	fsh	fsh	NOUN
ct-9353	150	20	and	and	CCONJ
ct-9353	150	21	lh	lh	PROPN
ct-9353	150	22	,	,	PUNCT
ct-9353	150	23	and	and	CCONJ
ct-9353	150	24	on	on	ADP
ct-9353	150	25	follicular	follicular	ADJ
ct-9353	150	26	development	development	NOUN
ct-9353	150	27	in	in	ADP
ct-9353	150	28	cyclic	cyclic	ADJ
ct-9353	150	29	mares	mare	NOUN
ct-9353	150	30	.	.	PUNCT
ct-9353	151	1	j	j	PROPN
ct-9353	151	2	reprod	reprod	PROPN
ct-9353	151	3	fertil	fertil	VERB
ct-9353	151	4	suppl	suppl	ADJ
ct-9353	151	5	1982;32:205	1982;32:205	PROPN
ct-9353	151	6	-	-	SYM
ct-9353	151	7	212	212	NUM
ct-9353	151	8	.	.	PUNCT
ct-9353	152	1	30	30	NUM
ct-9353	152	2	.	.	PUNCT
ct-9353	153	1	loy	loy	PROPN
ct-9353	153	2	rg	rg	PROPN
ct-9353	153	3	,	,	PUNCT
ct-9353	153	4	evans	evans	PROPN
ct-9353	153	5	mj	mj	PROPN
ct-9353	153	6	,	,	PUNCT
ct-9353	153	7	pemstein	pemstein	ADV
ct-9353	153	8	r	r	NOUN
ct-9353	153	9	,	,	PUNCT
ct-9353	153	10	et	et	PROPN
ct-9353	153	11	al	al	PROPN
ct-9353	153	12	:	:	PUNCT
ct-9353	153	13	effects	effect	NOUN
ct-9353	153	14	of	of	ADP
ct-9353	153	15	injected	inject	VERB
ct-9353	153	16	ovarian	ovarian	ADJ
ct-9353	153	17	steroids	steroid	NOUN
ct-9353	153	18	on	on	ADP
ct-9353	153	19	reproductive	reproductive	ADJ
ct-9353	153	20	patterns	pattern	NOUN
ct-9353	153	21	and	and	CCONJ
ct-9353	153	22	performance	performance	NOUN
ct-9353	153	23	in	in	ADP
ct-9353	153	24	post	post	ADJ
ct-9353	153	25	-	-	ADJ
ct-9353	153	26	partum	partum	ADJ
ct-9353	153	27	mares	mare	NOUN
ct-9353	153	28	.	.	PUNCT
ct-9353	154	1	j	j	PROPN
ct-9353	154	2	reprod	reprod	PROPN
ct-9353	154	3	fertil	fertil	VERB
ct-9353	154	4	suppl	suppl	ADJ
ct-9353	154	5	1982;32:199	1982;32:199	NUM
ct-9353	154	6	-	-	SYM
ct-9353	154	7	204	204	NUM
ct-9353	154	8	.	.	PUNCT
ct-9353	155	1	31	31	NUM
ct-9353	155	2	.	.	PUNCT
ct-9353	156	1	squires	squires	PROPN
ct-9353	156	2	el	el	PROPN
ct-9353	156	3	,	,	PUNCT
ct-9353	156	4	martin	martin	PROPN
ct-9353	156	5	jm	jm	PROPN
ct-9353	156	6	,	,	PUNCT
ct-9353	156	7	jasko	jasko	PROPN
ct-9353	156	8	dj	dj	PROPN
ct-9353	156	9	:	:	PUNCT
ct-9353	156	10	reproductive	reproductive	ADJ
ct-9353	156	11	response	response	NOUN
ct-9353	156	12	of	of	ADP
ct-9353	156	13	mares	mare	NOUN
ct-9353	156	14	after	after	ADP
ct-9353	156	15	treatment	treatment	NOUN
ct-9353	156	16	with	with	ADP
ct-9353	156	17	progestogens	progestogen	NOUN
ct-9353	156	18	with	with	ADP
ct-9353	156	19	and	and	CCONJ
ct-9353	156	20	without	without	ADP
ct-9353	156	21	the	the	DET
ct-9353	156	22	additional	additional	ADJ
ct-9353	156	23	of	of	ADP
ct-9353	156	24	estradiol	estradiol	PROPN
ct-9353	156	25	.	.	PUNCT
ct-9353	157	1	j	j	PROPN
ct-9353	157	2	equine	equine	PROPN
ct-9353	157	3	vet	vet	NOUN
ct-9353	157	4	sci	sci	PROPN
ct-9353	157	5	1992;12:28	1992;12:28	NUM
ct-9353	157	6	-	-	PUNCT
ct-9353	157	7	32	32	NUM
ct-9353	157	8	.	.	PUNCT
ct-9353	158	1	32	32	NUM
ct-9353	158	2	.	.	PUNCT
ct-9353	159	1	conley	conley	PROPN
ct-9353	159	2	a	a	PROPN
ct-9353	159	3	,	,	PUNCT
ct-9353	159	4	ball	ball	PROPN
ct-9353	159	5	ba	ba	PROPN
ct-9353	159	6	:	:	PUNCT
ct-9353	159	7	steroids	steroid	NOUN
ct-9353	159	8	in	in	ADP
ct-9353	159	9	the	the	DET
ct-9353	159	10	establishment	establishment	NOUN
ct-9353	159	11	and	and	CCONJ
ct-9353	159	12	maintenance	maintenance	NOUN
ct-9353	159	13	of	of	ADP
ct-9353	159	14	pregnancy	pregnancy	NOUN
ct-9353	159	15	,	,	PUNCT
ct-9353	159	16	and	and	CCONJ
ct-9353	159	17	at	at	ADP
ct-9353	159	18	parturition	parturition	NOUN
ct-9353	159	19	in	in	ADP
ct-9353	159	20	the	the	DET
ct-9353	159	21	mare	mare	NOUN
ct-9353	159	22	.	.	PUNCT
ct-9353	160	1	reproduction	reproduction	NOUN
ct-9353	160	2	2019	2019	NUM
ct-9353	160	3	.	.	PUNCT
ct-9353	161	1	33	33	NUM
ct-9353	161	2	.	.	PUNCT
ct-9353	162	1	conley	conley	PROPN
ct-9353	162	2	aj	aj	PROPN
ct-9353	162	3	:	:	PUNCT
ct-9353	162	4	review	review	NOUN
ct-9353	162	5	of	of	ADP
ct-9353	162	6	the	the	DET
ct-9353	162	7	reproductive	reproductive	ADJ
ct-9353	162	8	endocrinology	endocrinology	NOUN
ct-9353	162	9	of	of	ADP
ct-9353	162	10	the	the	DET
ct-9353	162	11	pregnant	pregnant	ADJ
ct-9353	162	12	and	and	CCONJ
ct-9353	162	13	parturient	parturient	PROPN
ct-9353	162	14	mare	mare	PROPN
ct-9353	162	15	.	.	PUNCT
ct-9353	163	1	theriogenology	theriogenology	NOUN
ct-9353	163	2	2016;86:355	2016;86:355	NUM
ct-9353	163	3	-	-	PUNCT
ct-9353	163	4	365	365	NUM
ct-9353	163	5	.	.	PUNCT
ct-9353	163	6	34	34	NUM
ct-9353	163	7	.	.	PUNCT
ct-9353	164	1	fowden	fowden	PROPN
ct-9353	164	2	al	al	PROPN
ct-9353	164	3	,	,	PUNCT
ct-9353	164	4	forhead	forhead	PROPN
ct-9353	164	5	aj	aj	PROPN
ct-9353	164	6	,	,	PUNCT
ct-9353	164	7	ousey	ousey	PROPN
ct-9353	164	8	jc	jc	PROPN
ct-9353	164	9	:	:	PUNCT
ct-9353	164	10	the	the	DET
ct-9353	164	11	endocrinology	endocrinology	NOUN
ct-9353	164	12	of	of	ADP
ct-9353	164	13	equine	equine	NOUN
ct-9353	164	14	parturition	parturition	NOUN
ct-9353	164	15	.	.	PUNCT
ct-9353	165	1	exp	exp	NOUN
ct-9353	165	2	clin	clin	PROPN
ct-9353	165	3	endocrinol	endocrinol	NOUN
ct-9353	165	4	diabetes	diabetes	NOUN
ct-9353	165	5	2008;116:393	2008;116:393	NUM
ct-9353	165	6	-	-	SYM
ct-9353	165	7	403	403	NUM
ct-9353	165	8	.	.	PUNCT
ct-9353	165	9	35	35	NUM
ct-9353	165	10	.	.	X
ct-9353	166	1	ousey	ousey	PROPN
ct-9353	166	2	jc	jc	PROPN
ct-9353	166	3	:	:	PUNCT
ct-9353	166	4	peripartal	peripartal	ADJ
ct-9353	166	5	endocrinology	endocrinology	NOUN
ct-9353	166	6	in	in	ADP
ct-9353	166	7	the	the	DET
ct-9353	166	8	mare	mare	NOUN
ct-9353	166	9	and	and	CCONJ
ct-9353	166	10	foetus	foetus	NOUN
ct-9353	166	11	.	.	PUNCT
ct-9353	167	1	reprod	reprod	PROPN
ct-9353	167	2	domest	domest	PROPN
ct-9353	167	3	anim	anim	NOUN
ct-9353	167	4	2004;39:222	2004;39:222	PROPN
ct-9353	167	5	-	-	SYM
ct-9353	167	6	231	231	NUM
ct-9353	167	7	.	.	PUNCT
ct-9353	168	1	36	36	NUM
ct-9353	168	2	.	.	PUNCT
ct-9353	169	1	irvine	irvine	PROPN
ct-9353	169	2	ch	ch	PROPN
ct-9353	169	3	,	,	PUNCT
ct-9353	169	4	sutton	sutton	PROPN
ct-9353	169	5	p	p	PROPN
ct-9353	169	6	,	,	PUNCT
ct-9353	169	7	turner	turner	PROPN
ct-9353	169	8	je	je	PROPN
ct-9353	169	9	,	,	PUNCT
ct-9353	169	10	mennick	mennick	PROPN
ct-9353	169	11	pe	pe	NOUN
ct-9353	169	12	:	:	PUNCT
ct-9353	169	13	changes	change	NOUN
ct-9353	169	14	in	in	ADP
ct-9353	169	15	plasma	plasma	NOUN
ct-9353	169	16	progesterone	progesterone	NOUN
ct-9353	169	17	concentrations	concentration	NOUN
ct-9353	169	18	from	from	ADP
ct-9353	169	19	days	day	NOUN
ct-9353	169	20	17	17	NUM
ct-9353	169	21	to	to	PART
ct-9353	169	22	42	42	NUM
ct-9353	169	23	of	of	ADP
ct-9353	169	24	gestation	gestation	NOUN
ct-9353	169	25	in	in	ADP
ct-9353	169	26	mares	mare	NOUN
ct-9353	169	27	maintaining	maintain	VERB
ct-9353	169	28	or	or	CCONJ
ct-9353	169	29	losing	lose	VERB
ct-9353	169	30	pregnancy	pregnancy	NOUN
ct-9353	169	31	.	.	PUNCT
ct-9353	170	1	equine	equine	NOUN
ct-9353	170	2	vet	vet	PROPN
ct-9353	170	3	j	j	PROPN
ct-9353	170	4	1990;22:104	1990;22:104	PROPN
ct-9353	170	5	-	-	SYM
ct-9353	170	6	106	106	NUM
ct-9353	170	7	.	.	PUNCT
ct-9353	171	1	37	37	NUM
ct-9353	171	2	.	.	PUNCT
ct-9353	172	1	shideler	shideler	PROPN
ct-9353	172	2	rk	rk	PROPN
ct-9353	172	3	,	,	PUNCT
ct-9353	172	4	squires	squires	PROPN
ct-9353	172	5	el	el	PROPN
ct-9353	172	6	,	,	PUNCT
ct-9353	172	7	voss	voss	PROPN
ct-9353	172	8	jl	jl	PROPN
ct-9353	172	9	,	,	PUNCT
ct-9353	172	10	et	et	PROPN
ct-9353	172	11	al	al	PROPN
ct-9353	172	12	:	:	PUNCT
ct-9353	172	13	progestagen	progestagen	NOUN
ct-9353	172	14	therapy	therapy	NOUN
ct-9353	172	15	of	of	ADP
ct-9353	172	16	ovariectomized	ovariectomize	VERB
ct-9353	172	17	pregnant	pregnant	ADJ
ct-9353	172	18	mares	mare	NOUN
ct-9353	172	19	.	.	PUNCT
ct-9353	173	1	j	j	PROPN
ct-9353	173	2	reprod	reprod	PROPN
ct-9353	173	3	fertil	fertil	VERB
ct-9353	173	4	suppl	suppl	ADJ
ct-9353	173	5	1982;32:459	1982;32:459	NUM
ct-9353	173	6	-	-	SYM
ct-9353	173	7	464	464	NUM
ct-9353	173	8	.	.	PUNCT
ct-9353	174	1	38	38	NUM
ct-9353	174	2	.	.	PUNCT
ct-9353	175	1	hinrichs	hinrichs	PROPN
ct-9353	175	2	k	k	PROPN
ct-9353	175	3	,	,	PUNCT
ct-9353	175	4	sertich	sertich	PROPN
ct-9353	175	5	pl	pl	PROPN
ct-9353	175	6	,	,	PUNCT
ct-9353	175	7	kenney	kenney	PROPN
ct-9353	175	8	rm	rm	PROPN
ct-9353	175	9	:	:	PUNCT
ct-9353	175	10	use	use	NOUN
ct-9353	175	11	of	of	ADP
ct-9353	175	12	altrenogest	altrenog	ADJ
ct-9353	175	13	to	to	PART
ct-9353	175	14	prepare	prepare	VERB
ct-9353	175	15	ovariectomized	ovariectomize	VERB
ct-9353	175	16	mares	mare	NOUN
ct-9353	175	17	as	as	ADP
ct-9353	175	18	embryo	embryo	NOUN
ct-9353	175	19	transfer	transfer	NOUN
ct-9353	175	20	recipients	recipient	NOUN
ct-9353	175	21	.	.	PUNCT
ct-9353	176	1	theriogenology	theriogenology	NOUN
ct-9353	176	2	1986;26:455	1986;26:455	NUM
ct-9353	176	3	-	-	SYM
ct-9353	176	4	460	460	NUM
ct-9353	176	5	.	.	NOUN
ct-9353	176	6	39	39	NUM
ct-9353	176	7	.	.	PUNCT
ct-9353	177	1	mckinnon	mckinnon	PROPN
ct-9353	177	2	ao	ao	PROPN
ct-9353	177	3	,	,	PUNCT
ct-9353	177	4	tarrida	tarrida	PROPN
ct-9353	177	5	del	del	PROPN
ct-9353	177	6	marmol	marmol	PROPN
ct-9353	177	7	figueroa	figueroa	PROPN
ct-9353	177	8	s	s	PROPN
ct-9353	177	9	,	,	PUNCT
ct-9353	177	10	nobelius	nobelius	PROPN
ct-9353	177	11	am	am	NOUN
ct-9353	177	12	,	,	PUNCT
ct-9353	177	13	et	et	PROPN
ct-9353	177	14	al	al	PROPN
ct-9353	177	15	:	:	PUNCT
ct-9353	177	16	failure	failure	NOUN
ct-9353	177	17	of	of	ADP
ct-9353	177	18	hydroxyprogesterone	hydroxyprogesterone	NOUN
ct-9353	177	19	caproate	caproate	NOUN
ct-9353	177	20	to	to	PART
ct-9353	177	21	maintain	maintain	VERB
ct-9353	177	22	pregnancy	pregnancy	NOUN
ct-9353	177	23	in	in	ADP
ct-9353	177	24	clinical	clinical	ADJ
ct-9353	177	25	theriogenology	theriogenology	NOUN
ct-9353	177	26	2021	2021	NUM
ct-9353	177	27	;	;	PUNCT
ct-9353	177	28	13	13	NUM
ct-9353	177	29	:	:	SYM
ct-9353	177	30	252	252	NUM
ct-9353	177	31	ovariectomised	ovariectomise	VERB
ct-9353	177	32	mares	mare	NOUN
ct-9353	177	33	.	.	PUNCT
ct-9353	178	1	equine	equine	NOUN
ct-9353	178	2	vet	vet	NOUN
ct-9353	178	3	j	j	PROPN
ct-9353	178	4	1993;25:158	1993;25:158	NUM
ct-9353	178	5	-	-	SYM
ct-9353	178	6	160	160	NUM
ct-9353	178	7	.	.	NOUN
ct-9353	178	8	40	40	NUM
ct-9353	178	9	.	.	PUNCT
ct-9353	179	1	vanderwall	vanderwall	PROPN
ct-9353	179	2	dk	dk	PROPN
ct-9353	179	3	,	,	PUNCT
ct-9353	179	4	marquardt	marquardt	PROPN
ct-9353	179	5	jl	jl	PROPN
ct-9353	179	6	,	,	PUNCT
ct-9353	179	7	woods	woods	PROPN
ct-9353	179	8	gl	gl	NOUN
ct-9353	179	9	:	:	PUNCT
ct-9353	179	10	use	use	NOUN
ct-9353	179	11	of	of	ADP
ct-9353	179	12	a	a	DET
ct-9353	179	13	compounded	compound	VERB
ct-9353	179	14	long	long	ADV
ct-9353	179	15	-	-	PUNCT
ct-9353	179	16	acting	act	VERB
ct-9353	179	17	progesterone	progesterone	NOUN
ct-9353	179	18	formulation	formulation	NOUN
ct-9353	179	19	for	for	ADP
ct-9353	179	20	equine	equine	NOUN
ct-9353	179	21	pregnancy	pregnancy	NOUN
ct-9353	179	22	maintenance	maintenance	NOUN
ct-9353	179	23	.	.	PUNCT
ct-9353	180	1	j	j	PROPN
ct-9353	180	2	equine	equine	PROPN
ct-9353	180	3	vet	vet	NOUN
ct-9353	180	4	sci	sci	PROPN
ct-9353	180	5	2007;27:62	2007;27:62	NUM
ct-9353	180	6	-	-	SYM
ct-9353	180	7	66	66	NUM
ct-9353	180	8	.	.	PUNCT
ct-9353	181	1	41	41	NUM
ct-9353	181	2	.	.	PUNCT
ct-9353	182	1	daels	dael	NOUN
ct-9353	182	2	pf	pf	PROPN
ct-9353	182	3	,	,	PUNCT
ct-9353	182	4	demoreas	demoreas	PROPN
ct-9353	182	5	j	j	PROPN
ct-9353	182	6	,	,	PUNCT
ct-9353	182	7	stabenfeldt	stabenfeldt	PROPN
ct-9353	182	8	gh	gh	PROPN
ct-9353	182	9	,	,	PUNCT
ct-9353	182	10	et	et	PROPN
ct-9353	182	11	al	al	PROPN
ct-9353	182	12	:	:	PUNCT
ct-9353	182	13	the	the	DET
ct-9353	182	14	effect	effect	NOUN
ct-9353	182	15	of	of	ADP
ct-9353	182	16	altrenogest	altrenogest	NOUN
ct-9353	182	17	on	on	ADP
ct-9353	182	18	the	the	DET
ct-9353	182	19	development	development	NOUN
ct-9353	182	20	of	of	ADP
ct-9353	182	21	secondary	secondary	ADJ
ct-9353	182	22	corpora	corpora	NOUN
ct-9353	182	23	lutea	lutea	NOUN
ct-9353	182	24	.	.	PUNCT
ct-9353	183	1	proc	proc	PROPN
ct-9353	183	2	12th	12th	PROPN
ct-9353	183	3	icar1992	icar1992	PROPN
ct-9353	183	4	.	.	PUNCT
ct-9353	184	1	p.	p.	NOUN
ct-9353	184	2	1855	1855	NUM
ct-9353	184	3	-	-	SYM
ct-9353	184	4	1857	1857	NUM
ct-9353	184	5	.	.	PUNCT
ct-9353	185	1	42	42	NUM
ct-9353	185	2	.	.	PUNCT
ct-9353	186	1	deluca	deluca	PROPN
ct-9353	186	2	ca	can	AUX
ct-9353	186	3	,	,	PUNCT
ct-9353	186	4	mccue	mccue	PROPN
ct-9353	186	5	pm	pm	PROPN
ct-9353	186	6	,	,	PUNCT
ct-9353	186	7	patten	patten	ADJ
ct-9353	186	8	ml	ml	ADP
ct-9353	186	9	,	,	PUNCT
ct-9353	186	10	et	et	PROPN
ct-9353	186	11	al	al	PROPN
ct-9353	186	12	:	:	PUNCT
ct-9353	186	13	effect	effect	NOUN
ct-9353	186	14	of	of	ADP
ct-9353	186	15	nonsurgical	nonsurgical	ADJ
ct-9353	186	16	embryo	embryo	NOUN
ct-9353	186	17	transfer	transfer	NOUN
ct-9353	186	18	procedure	procedure	NOUN
ct-9353	186	19	and/or	and/or	CCONJ
ct-9353	186	20	altrenogest	altrenogest	NOUN
ct-9353	186	21	therapy	therapy	NOUN
ct-9353	186	22	on	on	ADP
ct-9353	186	23	endogenous	endogenous	ADJ
ct-9353	186	24	progesterone	progesterone	NOUN
ct-9353	186	25	concentration	concentration	NOUN
ct-9353	186	26	in	in	ADP
ct-9353	186	27	mares	mare	NOUN
ct-9353	186	28	.	.	PUNCT
ct-9353	187	1	j	j	PROPN
ct-9353	187	2	equine	equine	PROPN
ct-9353	187	3	vet	vet	NOUN
ct-9353	187	4	sci	sci	PROPN
ct-9353	187	5	2011;31:57	2011;31:57	PROPN
ct-9353	187	6	-	-	SYM
ct-9353	187	7	62	62	NUM
ct-9353	187	8	.	.	PUNCT
ct-9353	188	1	43	43	NUM
ct-9353	188	2	.	.	PUNCT
ct-9353	189	1	willmann	willmann	PROPN
ct-9353	189	2	c	c	PROPN
ct-9353	189	3	,	,	PUNCT
ct-9353	189	4	schuler	schuler	NOUN
ct-9353	189	5	g	g	PROPN
ct-9353	189	6	,	,	PUNCT
ct-9353	189	7	hoffmann	hoffmann	PROPN
ct-9353	189	8	b	b	PROPN
ct-9353	189	9	,	,	PUNCT
ct-9353	189	10	et	et	PROPN
ct-9353	189	11	al	al	PROPN
ct-9353	189	12	:	:	PUNCT
ct-9353	189	13	effects	effect	NOUN
ct-9353	189	14	of	of	ADP
ct-9353	189	15	age	age	NOUN
ct-9353	189	16	and	and	CCONJ
ct-9353	189	17	altrenogest	altrenogest	NOUN
ct-9353	189	18	treatment	treatment	NOUN
ct-9353	189	19	on	on	ADP
ct-9353	189	20	conceptus	conceptus	ADJ
ct-9353	189	21	development	development	NOUN
ct-9353	189	22	and	and	CCONJ
ct-9353	189	23	secretion	secretion	NOUN
ct-9353	189	24	of	of	ADP
ct-9353	189	25	lh	lh	PROPN
ct-9353	189	26	,	,	PUNCT
ct-9353	189	27	progesterone	progesterone	NOUN
ct-9353	189	28	and	and	CCONJ
ct-9353	189	29	ecg	ecg	PROPN
ct-9353	189	30	in	in	ADP
ct-9353	189	31	early	early	ADJ
ct-9353	189	32	-	-	PUNCT
ct-9353	189	33	pregnant	pregnant	ADJ
ct-9353	189	34	mares	mare	NOUN
ct-9353	189	35	.	.	PUNCT
ct-9353	190	1	theriogenology	theriogenology	NOUN
ct-9353	190	2	2011;75:421	2011;75:421	PROPN
ct-9353	190	3	-	-	SYM
ct-9353	190	4	428	428	NUM
ct-9353	190	5	.	.	NUM
ct-9353	190	6	44	44	NUM
ct-9353	190	7	.	.	PUNCT
ct-9353	191	1	daels	daels	PROPN
ct-9353	191	2	pf	pf	PROPN
ct-9353	191	3	,	,	PUNCT
ct-9353	191	4	besognet	besognet	NOUN
ct-9353	191	5	b	b	PROPN
ct-9353	191	6	,	,	PUNCT
ct-9353	191	7	hansen	hansen	PROPN
ct-9353	191	8	b	b	PROPN
ct-9353	191	9	,	,	PUNCT
ct-9353	191	10	et	et	PROPN
ct-9353	191	11	al	al	PROPN
ct-9353	191	12	:	:	PUNCT
ct-9353	191	13	effect	effect	NOUN
ct-9353	191	14	of	of	ADP
ct-9353	191	15	progesterone	progesterone	NOUN
ct-9353	191	16	on	on	ADP
ct-9353	191	17	prostaglandin	prostaglandin	VERB
ct-9353	191	18	f2	f2	ADJ
ct-9353	191	19	alpha	alpha	NOUN
ct-9353	191	20	secretion	secretion	NOUN
ct-9353	191	21	and	and	CCONJ
ct-9353	191	22	outcome	outcome	NOUN
ct-9353	191	23	of	of	ADP
ct-9353	191	24	pregnancy	pregnancy	NOUN
ct-9353	191	25	during	during	ADP
ct-9353	191	26	cloprostenol	cloprostenol	NOUN
ct-9353	191	27	-	-	PUNCT
ct-9353	191	28	induced	induce	VERB
ct-9353	191	29	abortion	abortion	NOUN
ct-9353	191	30	in	in	ADP
ct-9353	191	31	mares	mare	NOUN
ct-9353	191	32	.	.	PUNCT
ct-9353	192	1	am	be	AUX
ct-9353	192	2	j	j	PROPN
ct-9353	192	3	vet	vet	NOUN
ct-9353	192	4	res	re	NOUN
ct-9353	192	5	1996;57:1331	1996;57:1331	NUM
ct-9353	192	6	-	-	SYM
ct-9353	192	7	1337	1337	NUM
ct-9353	192	8	.	.	PUNCT
ct-9353	193	1	45	45	NUM
ct-9353	193	2	.	.	PUNCT
ct-9353	193	3	bailey	bailey	PROPN
ct-9353	193	4	cs	cs	PROPN
ct-9353	193	5	,	,	PUNCT
ct-9353	193	6	macpherson	macpherson	PROPN
ct-9353	193	7	ml	ml	PROPN
ct-9353	193	8	,	,	PUNCT
ct-9353	193	9	pozor	pozor	PROPN
ct-9353	193	10	ma	ma	PROPN
ct-9353	193	11	,	,	PUNCT
ct-9353	193	12	et	et	PROPN
ct-9353	193	13	al	al	PROPN
ct-9353	193	14	:	:	PUNCT
ct-9353	193	15	treatment	treatment	NOUN
ct-9353	193	16	efficacy	efficacy	NOUN
ct-9353	193	17	of	of	ADP
ct-9353	193	18	trimethoprim	trimethoprim	ADJ
ct-9353	193	19	sulfamethoxazole	sulfamethoxazole	NOUN
ct-9353	193	20	,	,	PUNCT
ct-9353	193	21	pentoxifylline	pentoxifylline	NOUN
ct-9353	193	22	and	and	CCONJ
ct-9353	193	23	altrenogest	altrenogest	NOUN
ct-9353	193	24	in	in	ADP
ct-9353	193	25	experimentally	experimentally	ADV
ct-9353	193	26	induced	induce	VERB
ct-9353	193	27	equine	equine	NOUN
ct-9353	193	28	placentitis	placentitis	PROPN
ct-9353	193	29	.	.	PUNCT
ct-9353	194	1	theriogenology	theriogenology	NOUN
ct-9353	194	2	2010;74:402	2010;74:402	PROPN
ct-9353	194	3	-	-	SYM
ct-9353	194	4	412	412	NUM
ct-9353	194	5	.	.	PUNCT
ct-9353	194	6	46	46	NUM
ct-9353	194	7	.	.	PUNCT
ct-9353	195	1	el	el	PROPN
ct-9353	195	2	-	-	PUNCT
ct-9353	195	3	sheikh	sheikh	PROPN
ct-9353	195	4	ali	ali	PROPN
ct-9353	195	5	h	h	PROPN
ct-9353	195	6	,	,	PUNCT
ct-9353	195	7	legacki	legacki	PROPN
ct-9353	195	8	el	el	PROPN
ct-9353	195	9	,	,	PUNCT
ct-9353	195	10	loux	loux	PROPN
ct-9353	195	11	sc	sc	PROPN
ct-9353	195	12	,	,	PUNCT
ct-9353	195	13	et	et	PROPN
ct-9353	195	14	al	al	PROPN
ct-9353	195	15	:	:	PUNCT
ct-9353	195	16	equine	equine	PROPN
ct-9353	195	17	placentitis	placentitis	PROPN
ct-9353	195	18	is	be	AUX
ct-9353	195	19	associated	associate	VERB
ct-9353	195	20	with	with	ADP
ct-9353	195	21	a	a	DET
ct-9353	195	22	downregulation	downregulation	NOUN
ct-9353	195	23	in	in	ADP
ct-9353	195	24	myometrial	myometrial	ADJ
ct-9353	195	25	progestin	progestin	NOUN
ct-9353	195	26	signalingdagger	signalingdagger	PROPN
ct-9353	195	27	.	.	PUNCT
ct-9353	196	1	biol	biol	PROPN
ct-9353	196	2	reprod	reprod	PROPN
ct-9353	196	3	2019	2019	NUM
ct-9353	196	4	.	.	PUNCT
ct-9353	197	1	47	47	NUM
ct-9353	197	2	.	.	PUNCT
ct-9353	198	1	curcio	curcio	PROPN
ct-9353	198	2	br	br	PROPN
ct-9353	198	3	,	,	PUNCT
ct-9353	198	4	canisso	canisso	VERB
ct-9353	198	5	if	if	SCONJ
ct-9353	198	6	,	,	PUNCT
ct-9353	198	7	pazinato	pazinato	PROPN
ct-9353	198	8	fm	fm	PROPN
ct-9353	198	9	,	,	PUNCT
ct-9353	198	10	et	et	PROPN
ct-9353	198	11	al	al	PROPN
ct-9353	198	12	:	:	PUNCT
ct-9353	198	13	estradiol	estradiol	PROPN
ct-9353	198	14	cypionate	cypionate	PROPN
ct-9353	198	15	aided	aid	VERB
ct-9353	198	16	treatment	treatment	NOUN
ct-9353	198	17	for	for	ADP
ct-9353	198	18	experimentally	experimentally	ADV
ct-9353	198	19	induced	induce	VERB
ct-9353	198	20	ascending	ascend	VERB
ct-9353	198	21	placentitis	placentitis	PROPN
ct-9353	198	22	in	in	ADP
ct-9353	198	23	mares	mare	NOUN
ct-9353	198	24	.	.	PUNCT
ct-9353	199	1	theriogenology	theriogenology	NOUN
ct-9353	199	2	2017;102:98	2017;102:98	NUM
ct-9353	199	3	-	-	SYM
ct-9353	199	4	107	107	NUM
ct-9353	199	5	.	.	PUNCT
ct-9353	199	6	48	48	NUM
ct-9353	199	7	.	.	PUNCT
ct-9353	200	1	neuhauser	neuhauser	PROPN
ct-9353	200	2	s	s	PROPN
ct-9353	200	3	,	,	PUNCT
ct-9353	200	4	palm	palm	NOUN
ct-9353	200	5	f	f	PROPN
ct-9353	200	6	,	,	PUNCT
ct-9353	200	7	ambuehl	ambuehl	PROPN
ct-9353	200	8	f	f	X
ct-9353	200	9	,	,	PUNCT
ct-9353	200	10	et	et	PROPN
ct-9353	200	11	al	al	PROPN
ct-9353	200	12	:	:	PUNCT
ct-9353	200	13	effects	effect	NOUN
ct-9353	200	14	of	of	ADP
ct-9353	200	15	altrenogest	altrenogest	NOUN
ct-9353	200	16	treatment	treatment	NOUN
ct-9353	200	17	of	of	ADP
ct-9353	200	18	mares	mare	NOUN
ct-9353	200	19	in	in	ADP
ct-9353	200	20	late	late	ADJ
ct-9353	200	21	pregnancy	pregnancy	NOUN
ct-9353	200	22	on	on	ADP
ct-9353	200	23	parturition	parturition	NOUN
ct-9353	200	24	and	and	CCONJ
ct-9353	200	25	on	on	ADP
ct-9353	200	26	neonatal	neonatal	ADJ
ct-9353	200	27	viability	viability	NOUN
ct-9353	200	28	of	of	ADP
ct-9353	200	29	their	their	PRON
ct-9353	200	30	foals	foal	NOUN
ct-9353	200	31	.	.	PUNCT
ct-9353	201	1	exp	exp	NOUN
ct-9353	201	2	clin	clin	PROPN
ct-9353	201	3	endocrinol	endocrinol	NOUN
ct-9353	201	4	diabetes	diabetes	NOUN
ct-9353	201	5	2008;116:423	2008;116:423	NUM
ct-9353	201	6	-	-	SYM
ct-9353	201	7	428	428	NUM
ct-9353	201	8	.	.	NUM
ct-9353	201	9	49	49	NUM
ct-9353	201	10	.	.	PUNCT
ct-9353	202	1	knowles	knowles	PROPN
ct-9353	202	2	je	je	PROPN
ct-9353	202	3	,	,	PUNCT
ct-9353	202	4	squires	squires	PROPN
ct-9353	202	5	el	el	PROPN
ct-9353	202	6	,	,	PUNCT
ct-9353	202	7	shideler	shideler	NOUN
ct-9353	202	8	rk	rk	NOUN
ct-9353	202	9	,	,	PUNCT
ct-9353	202	10	et	et	PROPN
ct-9353	202	11	al	al	PROPN
ct-9353	202	12	:	:	PUNCT
ct-9353	202	13	progestins	progestin	NOUN
ct-9353	202	14	in	in	ADP
ct-9353	202	15	midto	midto	ADJ
ct-9353	202	16	latepregnant	latepregnant	ADJ
ct-9353	202	17	mares	mare	NOUN
ct-9353	202	18	.	.	PUNCT
ct-9353	203	1	j	j	PROPN
ct-9353	203	2	equine	equine	PROPN
ct-9353	203	3	vet	vet	NOUN
ct-9353	203	4	sci	sci	PROPN
ct-9353	203	5	1994;14:659	1994;14:659	PROPN
ct-9353	203	6	-	-	SYM
ct-9353	203	7	63	63	NUM
ct-9353	203	8	.	.	PUNCT
ct-9353	203	9	50	50	NUM
ct-9353	203	10	.	.	PUNCT
ct-9353	204	1	palm	palm	PROPN
ct-9353	204	2	fm	fm	PROPN
ct-9353	204	3	,	,	PUNCT
ct-9353	204	4	schenk	schenk	PROPN
ct-9353	204	5	i	i	PROPN
ct-9353	204	6	,	,	PUNCT
ct-9353	204	7	neuhauser	neuhauser	PROPN
ct-9353	204	8	s	s	PROPN
ct-9353	204	9	,	,	PUNCT
ct-9353	204	10	et	et	PROPN
ct-9353	204	11	al	al	PROPN
ct-9353	204	12	:	:	PUNCT
ct-9353	204	13	concentrations	concentration	NOUN
ct-9353	204	14	of	of	ADP
ct-9353	204	15	altrenogest	altrenogest	NOUN
ct-9353	204	16	in	in	ADP
ct-9353	204	17	plasma	plasma	NOUN
ct-9353	204	18	of	of	ADP
ct-9353	204	19	mares	mare	NOUN
ct-9353	204	20	and	and	CCONJ
ct-9353	204	21	foals	foal	NOUN
ct-9353	204	22	and	and	CCONJ
ct-9353	204	23	in	in	ADP
ct-9353	204	24	allantoic	allantoic	NOUN
ct-9353	204	25	and	and	CCONJ
ct-9353	204	26	amniotic	amniotic	ADJ
ct-9353	204	27	fluid	fluid	NOUN
ct-9353	204	28	at	at	ADP
ct-9353	204	29	parturition	parturition	NOUN
ct-9353	204	30	.	.	PUNCT
ct-9353	205	1	theriogenology	theriogenology	NOUN
ct-9353	205	2	2010;74:229	2010;74:229	PROPN
ct-9353	205	3	-	-	PUNCT
ct-9353	205	4	235	235	NUM
ct-9353	205	5	.	.	PUNCT
ct-9353	205	6	51	51	NUM
ct-9353	205	7	.	.	PUNCT
ct-9353	206	1	squires	squires	PROPN
ct-9353	206	2	el	el	PROPN
ct-9353	206	3	,	,	PUNCT
ct-9353	206	4	shideler	shideler	PROPN
ct-9353	206	5	rk	rk	PROPN
ct-9353	206	6	,	,	PUNCT
ct-9353	206	7	mckinnon	mckinnon	PROPN
ct-9353	206	8	ao	ao	PROPN
ct-9353	206	9	:	:	PUNCT
ct-9353	206	10	reproductive	reproductive	ADJ
ct-9353	206	11	performance	performance	NOUN
ct-9353	206	12	of	of	ADP
ct-9353	206	13	offspring	offspring	NOUN
ct-9353	206	14	from	from	ADP
ct-9353	206	15	mares	mare	NOUN
ct-9353	206	16	administered	administer	VERB
ct-9353	206	17	altrenogest	altrenogest	NOUN
ct-9353	206	18	during	during	ADP
ct-9353	206	19	gestation	gestation	NOUN
ct-9353	206	20	.	.	PUNCT
ct-9353	207	1	j	j	PROPN
ct-9353	207	2	equine	equine	PROPN
ct-9353	207	3	vet	vet	NOUN
ct-9353	207	4	sci	sci	PROPN
ct-9353	207	5	1989;9:73	1989;9:73	PROPN
ct-9353	207	6	-	-	PUNCT
ct-9353	207	7	76	76	NUM
ct-9353	207	8	.	.	PUNCT
ct-9353	207	9	52	52	NUM
ct-9353	207	10	.	.	PUNCT
ct-9353	208	1	naden	naden	PROPN
ct-9353	208	2	j	j	PROPN
ct-9353	208	3	,	,	PUNCT
ct-9353	208	4	squires	squires	PROPN
ct-9353	208	5	el	el	PROPN
ct-9353	208	6	,	,	PUNCT
ct-9353	208	7	nett	nett	PROPN
ct-9353	208	8	tm	tm	PROPN
ct-9353	208	9	,	,	PUNCT
ct-9353	208	10	et	et	PROPN
ct-9353	208	11	al	al	PROPN
ct-9353	208	12	:	:	PUNCT
ct-9353	208	13	effect	effect	NOUN
ct-9353	208	14	of	of	ADP
ct-9353	208	15	maternal	maternal	ADJ
ct-9353	208	16	treatment	treatment	NOUN
ct-9353	208	17	with	with	ADP
ct-9353	208	18	altrenogest	altrenogest	NOUN
ct-9353	208	19	on	on	ADP
ct-9353	208	20	pituitary	pituitary	ADJ
ct-9353	208	21	response	response	NOUN
ct-9353	208	22	to	to	ADP
ct-9353	208	23	exogenous	exogenous	ADJ
ct-9353	208	24	gnrh	gnrh	NOUN
ct-9353	208	25	in	in	ADP
ct-9353	208	26	pubertal	pubertal	ADJ
ct-9353	208	27	stallions	stallion	NOUN
ct-9353	208	28	.	.	PUNCT
ct-9353	209	1	j	j	PROPN
ct-9353	209	2	reprod	reprod	PROPN
ct-9353	209	3	fertil	fertil	VERB
ct-9353	209	4	1990;88:177	1990;88:177	NUM
ct-9353	209	5	-	-	SYM
ct-9353	209	6	83	83	NUM
ct-9353	209	7	.	.	PUNCT
ct-9353	210	1	53	53	NUM
ct-9353	210	2	.	.	PUNCT
ct-9353	210	3	gygax	gygax	PROPN
ct-9353	210	4	ap	ap	PROPN
ct-9353	210	5	,	,	PUNCT
ct-9353	210	6	ganjam	ganjam	VERB
ct-9353	210	7	vk	vk	PROPN
ct-9353	210	8	,	,	PUNCT
ct-9353	210	9	kenney	kenney	PROPN
ct-9353	210	10	rm	rm	PROPN
ct-9353	210	11	:	:	PUNCT
ct-9353	210	12	clinical	clinical	ADJ
ct-9353	210	13	,	,	PUNCT
ct-9353	210	14	microbiological	microbiological	ADJ
ct-9353	210	15	and	and	CCONJ
ct-9353	210	16	histological	histological	ADJ
ct-9353	210	17	changes	change	NOUN
ct-9353	210	18	associated	associate	VERB
ct-9353	210	19	with	with	ADP
ct-9353	210	20	uterine	uterine	ADJ
ct-9353	210	21	involution	involution	NOUN
ct-9353	210	22	in	in	ADP
ct-9353	210	23	the	the	DET
ct-9353	210	24	mare	mare	NOUN
ct-9353	210	25	.	.	PUNCT
ct-9353	211	1	j	j	PROPN
ct-9353	211	2	reprod	reprod	PROPN
ct-9353	211	3	fertil	fertil	PROPN
ct-9353	211	4	suppl	suppl	ADJ
ct-9353	211	5	1979:571	1979:571	NUM
ct-9353	211	6	-	-	PUNCT
ct-9353	211	7	578	578	NUM
ct-9353	211	8	.	.	PUNCT
ct-9353	212	1	54	54	NUM
ct-9353	212	2	.	.	PUNCT
ct-9353	213	1	blanchard	blanchard	PROPN
ct-9353	213	2	tl	tl	PROPN
ct-9353	213	3	,	,	PUNCT
ct-9353	213	4	thompson	thompson	PROPN
ct-9353	213	5	ja	ja	PROPN
ct-9353	213	6	,	,	PUNCT
ct-9353	213	7	brinsko	brinsko	PROPN
ct-9353	213	8	sp	sp	NOUN
ct-9353	213	9	,	,	PUNCT
ct-9353	213	10	et	et	PROPN
ct-9353	213	11	al	al	PROPN
ct-9353	213	12	:	:	PUNCT
ct-9353	213	13	mating	mate	VERB
ct-9353	213	14	mares	mare	NOUN
ct-9353	213	15	on	on	ADP
ct-9353	213	16	foal	foal	NOUN
ct-9353	213	17	heat	heat	NOUN
ct-9353	213	18	:	:	PUNCT
ct-9353	213	19	a	a	DET
ct-9353	213	20	five	five	NUM
ct-9353	213	21	-	-	PUNCT
ct-9353	213	22	year	year	NOUN
ct-9353	213	23	retrospective	retrospective	ADJ
ct-9353	213	24	study	study	NOUN
ct-9353	213	25	.	.	PUNCT
ct-9353	214	1	proc	proc	PROPN
ct-9353	214	2	am	be	AUX
ct-9353	214	3	assoc	assoc	PROPN
ct-9353	214	4	equine	equine	PROPN
ct-9353	214	5	pract	pract	PROPN
ct-9353	214	6	2004	2004	NUM
ct-9353	214	7	.	.	PUNCT
ct-9353	215	1	p.	p.	NOUN
ct-9353	215	2	525	525	NUM
ct-9353	215	3	-	-	SYM
ct-9353	215	4	530	530	NUM
ct-9353	215	5	.	.	PUNCT
ct-9353	216	1	55	55	NUM
ct-9353	216	2	.	.	PUNCT
ct-9353	217	1	loy	loy	PROPN
ct-9353	217	2	rg	rg	PROPN
ct-9353	217	3	:	:	PUNCT
ct-9353	217	4	characteristics	characteristic	NOUN
ct-9353	217	5	of	of	ADP
ct-9353	217	6	postpartum	postpartum	NOUN
ct-9353	217	7	reproduction	reproduction	NOUN
ct-9353	217	8	in	in	ADP
ct-9353	217	9	mares	mare	NOUN
ct-9353	217	10	.	.	PUNCT
ct-9353	218	1	vet	vet	NOUN
ct-9353	218	2	clin	clin	PROPN
ct-9353	218	3	north	north	PROPN
ct-9353	218	4	am	be	AUX
ct-9353	218	5	large	large	ADJ
ct-9353	218	6	anim	anim	NOUN
ct-9353	218	7	pract	pract	NOUN
ct-9353	218	8	1980;2:345	1980;2:345	PROPN
ct-9353	218	9	-	-	SYM
ct-9353	218	10	349	349	NUM
ct-9353	218	11	.	.	PUNCT
ct-9353	219	1	56	56	NUM
ct-9353	219	2	.	.	PUNCT
ct-9353	219	3	mckinnon	mckinnon	PROPN
ct-9353	219	4	ao	ao	PROPN
ct-9353	219	5	,	,	PUNCT
ct-9353	219	6	squires	squires	PROPN
ct-9353	219	7	el	el	PROPN
ct-9353	219	8	,	,	PUNCT
ct-9353	219	9	harrison	harrison	PROPN
ct-9353	219	10	la	la	PROPN
ct-9353	219	11	,	,	PUNCT
ct-9353	219	12	et	et	PROPN
ct-9353	219	13	al	al	PROPN
ct-9353	219	14	:	:	PUNCT
ct-9353	219	15	ultrasonographic	ultrasonographic	ADJ
ct-9353	219	16	studies	study	NOUN
ct-9353	219	17	on	on	ADP
ct-9353	219	18	the	the	DET
ct-9353	219	19	reproductive	reproductive	ADJ
ct-9353	219	20	tract	tract	NOUN
ct-9353	219	21	of	of	ADP
ct-9353	219	22	mares	mare	NOUN
ct-9353	219	23	after	after	ADP
ct-9353	219	24	parturition	parturition	NOUN
ct-9353	219	25	:	:	PUNCT
ct-9353	219	26	effect	effect	NOUN
ct-9353	219	27	of	of	ADP
ct-9353	219	28	involution	involution	NOUN
ct-9353	219	29	and	and	CCONJ
ct-9353	219	30	uterine	uterine	ADJ
ct-9353	219	31	fluid	fluid	NOUN
ct-9353	219	32	on	on	ADP
ct-9353	219	33	pregnancy	pregnancy	NOUN
ct-9353	219	34	rates	rate	NOUN
ct-9353	219	35	in	in	ADP
ct-9353	219	36	mares	mare	NOUN
ct-9353	219	37	with	with	ADP
ct-9353	219	38	normal	normal	ADJ
ct-9353	219	39	and	and	CCONJ
ct-9353	219	40	delayed	delay	VERB
ct-9353	219	41	first	first	ADJ
ct-9353	219	42	postpartum	postpartum	ADJ
ct-9353	219	43	ovulatory	ovulatory	ADJ
ct-9353	219	44	cycles	cycle	NOUN
ct-9353	219	45	.	.	PUNCT
ct-9353	220	1	j	j	PROPN
ct-9353	220	2	am	be	AUX
ct-9353	220	3	vet	vet	NOUN
ct-9353	220	4	med	med	ADJ
ct-9353	220	5	assoc	assoc	PROPN
ct-9353	220	6	1988;192:350	1988;192:350	NUM
ct-9353	220	7	-	-	PUNCT
ct-9353	220	8	353	353	NUM
ct-9353	220	9	.	.	PUNCT
ct-9353	220	10	57	57	NUM
ct-9353	220	11	.	.	PUNCT
ct-9353	221	1	sigler	sigler	PROPN
ct-9353	221	2	dh	dh	PROPN
ct-9353	221	3	,	,	PUNCT
ct-9353	221	4	ericson	ericson	PROPN
ct-9353	221	5	de	de	PROPN
ct-9353	221	6	,	,	PUNCT
ct-9353	221	7	gibbs	gibbs	PROPN
ct-9353	221	8	pg	pg	PROPN
ct-9353	221	9	,	,	PUNCT
ct-9353	221	10	et	et	PROPN
ct-9353	221	11	al	al	PROPN
ct-9353	221	12	:	:	PUNCT
ct-9353	221	13	reproductive	reproductive	ADJ
ct-9353	221	14	traits	trait	NOUN
ct-9353	221	15	,	,	PUNCT
ct-9353	221	16	lactation	lactation	NOUN
ct-9353	221	17	and	and	CCONJ
ct-9353	221	18	foal	foal	NOUN
ct-9353	221	19	growth	growth	NOUN
ct-9353	221	20	in	in	ADP
ct-9353	221	21	mares	mare	NOUN
ct-9353	221	22	fed	fed	PROPN
ct-9353	221	23	altrenogest	altrenogest	PROPN
ct-9353	221	24	.	.	PUNCT
ct-9353	222	1	j	j	PROPN
ct-9353	222	2	anim	anim	NOUN
ct-9353	222	3	sci	sci	PROPN
ct-9353	222	4	1989;67:1154	1989;67:1154	PROPN
ct-9353	222	5	-	-	SYM
ct-9353	222	6	1159	1159	NUM
ct-9353	222	7	.	.	PUNCT
ct-9353	223	1	58	58	NUM
ct-9353	223	2	.	.	PUNCT
ct-9353	224	1	loy	loy	PROPN
ct-9353	224	2	rg	rg	PROPN
ct-9353	224	3	,	,	PUNCT
ct-9353	224	4	hughes	hughes	PROPN
ct-9353	224	5	jp	jp	PROPN
ct-9353	224	6	,	,	PUNCT
ct-9353	224	7	richards	richards	PROPN
ct-9353	224	8	wp	wp	PROPN
ct-9353	224	9	et	et	PROPN
ct-9353	224	10	al	al	PROPN
ct-9353	224	11	:	:	PUNCT
ct-9353	224	12	effects	effect	NOUN
ct-9353	224	13	of	of	ADP
ct-9353	224	14	progesterone	progesterone	NOUN
ct-9353	224	15	on	on	ADP
ct-9353	224	16	reproductive	reproductive	ADJ
ct-9353	224	17	function	function	NOUN
ct-9353	224	18	in	in	ADP
ct-9353	224	19	mares	mare	NOUN
ct-9353	224	20	after	after	ADP
ct-9353	224	21	parturition	parturition	NOUN
ct-9353	224	22	.	.	PUNCT
ct-9353	225	1	j	j	PROPN
ct-9353	225	2	reprod	reprod	PROPN
ct-9353	225	3	fertil	fertil	PROPN
ct-9353	225	4	suppl	suppl	PROPN
ct-9353	225	5	1975:291	1975:291	PROPN
ct-9353	225	6	-	-	PUNCT
ct-9353	225	7	295	295	NUM
ct-9353	225	8	.	.	PUNCT
ct-9353	226	1	59	59	NUM
ct-9353	226	2	.	.	PUNCT
ct-9353	227	1	bruemmer	bruemmer	PROPN
ct-9353	227	2	je	je	PROPN
ct-9353	227	3	,	,	PUNCT
ct-9353	227	4	brady	brady	PROPN
ct-9353	227	5	ha	ha	PROPN
ct-9353	227	6	,	,	PUNCT
ct-9353	227	7	blanchard	blanchard	PROPN
ct-9353	227	8	tl	tl	PROPN
ct-9353	227	9	:	:	PUNCT
ct-9353	227	10	uterine	uterine	ADJ
ct-9353	227	11	involution	involution	NOUN
ct-9353	227	12	,	,	PUNCT
ct-9353	227	13	day	day	NOUN
ct-9353	227	14	and	and	CCONJ
ct-9353	227	15	variance	variance	NOUN
ct-9353	227	16	of	of	ADP
ct-9353	227	17	first	first	ADJ
ct-9353	227	18	postpartum	postpartum	NOUN
ct-9353	227	19	ovulation	ovulation	NOUN
ct-9353	227	20	in	in	ADP
ct-9353	227	21	mares	mare	NOUN
ct-9353	227	22	treated	treat	VERB
ct-9353	227	23	with	with	ADP
ct-9353	227	24	progesterone	progesterone	NOUN
ct-9353	227	25	and	and	CCONJ
ct-9353	227	26	estradiol-17beta	estradiol-17beta	NOUN
ct-9353	227	27	for	for	ADP
ct-9353	227	28	1	1	NUM
ct-9353	227	29	or	or	CCONJ
ct-9353	227	30	2	2	NUM
ct-9353	227	31	days	day	NOUN
ct-9353	227	32	postpartum	postpartum	NOUN
ct-9353	227	33	.	.	PUNCT
ct-9353	228	1	theriogenology	theriogenology	NOUN
ct-9353	228	2	.	.	PUNCT
ct-9353	229	1	2002;57:989	2002;57:989	PROPN
ct-9353	229	2	-	-	PUNCT
ct-9353	229	3	995	995	NUM
ct-9353	229	4	.	.	PUNCT
ct-9353	230	1	60	60	NUM
ct-9353	230	2	.	.	PUNCT
ct-9353	231	1	hall	hall	PROPN
ct-9353	231	2	oj	oj	PROPN
ct-9353	231	3	,	,	PUNCT
ct-9353	231	4	nachbagauer	nachbagauer	NOUN
ct-9353	231	5	r	r	NOUN
ct-9353	231	6	,	,	PUNCT
ct-9353	231	7	vermillion	vermillion	NOUN
ct-9353	231	8	ms	ms	NOUN
ct-9353	231	9	,	,	PUNCT
ct-9353	231	10	et	et	PROPN
ct-9353	231	11	al	al	PROPN
ct-9353	231	12	:	:	PUNCT
ct-9353	231	13	progesterone	progesterone	NOUN
ct-9353	231	14	-	-	PUNCT
ct-9353	231	15	based	base	VERB
ct-9353	231	16	contraceptives	contraceptive	NOUN
ct-9353	231	17	reduce	reduce	VERB
ct-9353	231	18	adaptive	adaptive	ADJ
ct-9353	231	19	immune	immune	ADJ
ct-9353	231	20	responses	response	NOUN
ct-9353	231	21	and	and	CCONJ
ct-9353	231	22	protection	protection	NOUN
ct-9353	231	23	against	against	ADP
ct-9353	231	24	sequential	sequential	ADJ
ct-9353	231	25	influenza	influenza	NOUN
ct-9353	231	26	a	a	DET
ct-9353	231	27	virus	virus	NOUN
ct-9353	231	28	infections	infection	NOUN
ct-9353	231	29	.	.	PUNCT
ct-9353	232	1	j	j	PROPN
ct-9353	232	2	virol	virol	PROPN
ct-9353	232	3	2017;91	2017;91	PROPN
ct-9353	232	4	.	.	PUNCT
ct-9353	233	1	61	61	NUM
ct-9353	233	2	.	.	PUNCT
ct-9353	234	1	hardy	hardy	PROPN
ct-9353	234	2	db	db	PROPN
ct-9353	234	3	,	,	PUNCT
ct-9353	234	4	janowski	janowski	PROPN
ct-9353	234	5	ba	ba	PROPN
ct-9353	234	6	,	,	PUNCT
ct-9353	234	7	corey	corey	PROPN
ct-9353	234	8	dr	dr	PROPN
ct-9353	234	9	,	,	PUNCT
ct-9353	234	10	et	et	PROPN
ct-9353	234	11	al	al	PROPN
ct-9353	234	12	:	:	PUNCT
ct-9353	234	13	progesterone	progesterone	NOUN
ct-9353	234	14	receptor	receptor	NOUN
ct-9353	234	15	plays	play	VERB
ct-9353	234	16	a	a	DET
ct-9353	234	17	major	major	ADJ
ct-9353	234	18	antiinflammatory	antiinflammatory	NOUN
ct-9353	234	19	role	role	NOUN
ct-9353	234	20	in	in	ADP
ct-9353	234	21	human	human	ADJ
ct-9353	234	22	myometrial	myometrial	ADJ
ct-9353	234	23	cells	cell	NOUN
ct-9353	234	24	by	by	ADP
ct-9353	234	25	antagonism	antagonism	NOUN
ct-9353	234	26	of	of	ADP
ct-9353	234	27	nuclear	nuclear	ADJ
ct-9353	234	28	factor	factor	NOUN
ct-9353	234	29	-	-	PUNCT
ct-9353	234	30	kappab	kappab	NOUN
ct-9353	234	31	activation	activation	NOUN
ct-9353	234	32	of	of	ADP
ct-9353	234	33	cyclooxygenase	cyclooxygenase	NOUN
ct-9353	234	34	2	2	NUM
ct-9353	234	35	expression	expression	NOUN
ct-9353	234	36	.	.	PUNCT
ct-9353	235	1	mol	mol	ADP
ct-9353	235	2	endocrinol	endocrinol	VERB
ct-9353	235	3	2006;20:2724	2006;20:2724	NUM
ct-9353	235	4	-	-	SYM
ct-9353	235	5	733	733	NUM
ct-9353	235	6	.	.	PUNCT
ct-9353	236	1	62	62	NUM
ct-9353	236	2	.	.	PUNCT
ct-9353	237	1	jones	jones	PROPN
ct-9353	237	2	la	la	PROPN
ct-9353	237	3	,	,	PUNCT
ct-9353	237	4	kreem	kreem	ADJ
ct-9353	237	5	s	s	PROPN
ct-9353	237	6	,	,	PUNCT
ct-9353	237	7	shweash	shweash	VERB
ct-9353	237	8	m	m	PRON
ct-9353	237	9	,	,	PUNCT
ct-9353	237	10	et	et	PROPN
ct-9353	237	11	al	al	PROPN
ct-9353	237	12	:	:	PUNCT
ct-9353	237	13	differential	differential	ADJ
ct-9353	237	14	modulation	modulation	NOUN
ct-9353	237	15	of	of	ADP
ct-9353	237	16	tlr3and	tlr3and	PROPN
ct-9353	237	17	tlr4	tlr4	NOUN
ct-9353	237	18	-	-	PUNCT
ct-9353	237	19	mediated	mediate	VERB
ct-9353	237	20	dendritic	dendritic	ADJ
ct-9353	237	21	cell	cell	NOUN
ct-9353	237	22	maturation	maturation	NOUN
ct-9353	237	23	and	and	CCONJ
ct-9353	237	24	function	function	NOUN
ct-9353	237	25	by	by	ADP
ct-9353	237	26	progesterone	progesterone	NOUN
ct-9353	237	27	.	.	PUNCT
ct-9353	238	1	j	j	PROPN
ct-9353	238	2	immunol	immunol	NOUN
ct-9353	238	3	2010;185:4525	2010;185:4525	PROPN
ct-9353	238	4	-	-	SYM
ct-9353	238	5	4534	4534	NUM
ct-9353	238	6	.	.	PUNCT
ct-9353	239	1	63	63	NUM
ct-9353	239	2	.	.	PUNCT
ct-9353	240	1	lei	lei	PROPN
ct-9353	240	2	k	k	PROPN
ct-9353	240	3	,	,	PUNCT
ct-9353	240	4	chen	chen	PROPN
ct-9353	240	5	l	l	PROPN
ct-9353	240	6	,	,	PUNCT
ct-9353	240	7	georgiou	georgiou	PROPN
ct-9353	240	8	ex	ex	PROPN
ct-9353	240	9	,	,	PUNCT
ct-9353	240	10	et	et	PROPN
ct-9353	240	11	al	al	PROPN
ct-9353	240	12	:	:	PUNCT
ct-9353	240	13	progesterone	progesterone	NOUN
ct-9353	240	14	acts	act	NOUN
ct-9353	240	15	via	via	ADP
ct-9353	240	16	the	the	DET
ct-9353	240	17	nuclear	nuclear	ADJ
ct-9353	240	18	glucocorticoid	glucocorticoid	ADJ
ct-9353	240	19	receptor	receptor	NOUN
ct-9353	240	20	to	to	PART
ct-9353	240	21	suppress	suppress	VERB
ct-9353	240	22	il-1beta	il-1beta	VERB
ct-9353	240	23	-	-	PUNCT
ct-9353	240	24	induced	induce	VERB
ct-9353	240	25	cox-2	cox-2	ADJ
ct-9353	240	26	expression	expression	NOUN
ct-9353	240	27	in	in	ADP
ct-9353	240	28	human	human	ADJ
ct-9353	240	29	term	term	NOUN
ct-9353	240	30	myometrial	myometrial	ADJ
ct-9353	240	31	cells	cell	NOUN
ct-9353	240	32	.	.	PUNCT
ct-9353	241	1	plos	plos	PROPN
ct-9353	241	2	one	one	NUM
ct-9353	241	3	.	.	PUNCT
ct-9353	242	1	2012;7	2012;7	NOUN
ct-9353	242	2	:	:	PUNCT
ct-9353	242	3	e50167	e50167	X
ct-9353	242	4	.	.	NOUN
ct-9353	242	5	64	64	NUM
ct-9353	242	6	.	.	PUNCT
ct-9353	243	1	butts	butts	NOUN
ct-9353	243	2	cl	cl	NOUN
ct-9353	243	3	,	,	PUNCT
ct-9353	243	4	shukair	shukair	PROPN
ct-9353	243	5	sa	sa	PROPN
ct-9353	243	6	,	,	PUNCT
ct-9353	243	7	duncan	duncan	PROPN
ct-9353	243	8	km	km	PROPN
ct-9353	243	9	,	,	PUNCT
ct-9353	243	10	et	et	PROPN
ct-9353	243	11	al	al	PROPN
ct-9353	243	12	:	:	PUNCT
ct-9353	243	13	progesterone	progesterone	NOUN
ct-9353	243	14	inhibits	inhibit	VERB
ct-9353	243	15	mature	mature	ADJ
ct-9353	243	16	rat	rat	NOUN
ct-9353	243	17	dendritic	dendritic	ADJ
ct-9353	243	18	cells	cell	NOUN
ct-9353	243	19	in	in	ADP
ct-9353	243	20	a	a	DET
ct-9353	243	21	receptor	receptor	NOUN
ct-9353	243	22	-	-	PUNCT
ct-9353	243	23	mediated	mediate	VERB
ct-9353	243	24	fashion	fashion	NOUN
ct-9353	243	25	.	.	PUNCT
ct-9353	244	1	int	int	NOUN
ct-9353	244	2	immunol	immunol	NOUN
ct-9353	244	3	2007;19:287	2007;19:287	ADV
ct-9353	244	4	-	-	SYM
ct-9353	244	5	296	296	NUM
ct-9353	244	6	.	.	PUNCT
ct-9353	245	1	65	65	NUM
ct-9353	245	2	.	.	PUNCT
ct-9353	246	1	deese	deese	PROPN
ct-9353	246	2	j	j	PROPN
ct-9353	246	3	,	,	PUNCT
ct-9353	246	4	masson	masson	PROPN
ct-9353	246	5	l	l	PROPN
ct-9353	246	6	,	,	PUNCT
ct-9353	246	7	miller	miller	PROPN
ct-9353	246	8	w	w	PROPN
ct-9353	246	9	,	,	PUNCT
ct-9353	246	10	et	et	PROPN
ct-9353	246	11	al	al	PROPN
ct-9353	246	12	:	:	PUNCT
ct-9353	246	13	injectable	injectable	ADJ
ct-9353	246	14	progestin	progestin	NOUN
ct-9353	246	15	-	-	PUNCT
ct-9353	246	16	only	only	ADV
ct-9353	246	17	contraception	contraception	NOUN
ct-9353	246	18	is	be	AUX
ct-9353	246	19	associated	associate	VERB
ct-9353	246	20	with	with	ADP
ct-9353	246	21	increased	increase	VERB
ct-9353	246	22	levels	level	NOUN
ct-9353	246	23	of	of	ADP
ct-9353	246	24	pro	pro	ADJ
ct-9353	246	25	-	-	ADJ
ct-9353	246	26	inflammatory	inflammatory	ADJ
ct-9353	246	27	cytokines	cytokine	NOUN
ct-9353	246	28	in	in	ADP
ct-9353	246	29	the	the	DET
ct-9353	246	30	female	female	ADJ
ct-9353	246	31	genital	genital	ADJ
ct-9353	246	32	tract	tract	NOUN
ct-9353	246	33	.	.	PUNCT
ct-9353	247	1	am	be	AUX
ct-9353	247	2	j	j	PROPN
ct-9353	247	3	reprod	reprod	PROPN
ct-9353	247	4	immunol	immunol	NOUN
ct-9353	247	5	2015;74:357	2015;74:357	PROPN
ct-9353	247	6	-	-	SYM
ct-9353	247	7	367	367	NUM
ct-9353	247	8	.	.	PUNCT
ct-9353	248	1	66	66	NUM
ct-9353	248	2	.	.	PUNCT
ct-9353	249	1	coleman	coleman	PROPN
ct-9353	249	2	js	js	PROPN
ct-9353	249	3	,	,	PUNCT
ct-9353	249	4	mwachari	mwachari	PROPN
ct-9353	249	5	c	c	NOUN
ct-9353	249	6	,	,	PUNCT
ct-9353	249	7	balkus	balkus	PROPN
ct-9353	249	8	j	j	PROPN
ct-9353	249	9	,	,	PUNCT
ct-9353	249	10	et	et	PROPN
ct-9353	249	11	al	al	PROPN
ct-9353	249	12	:	:	PUNCT
ct-9353	249	13	effect	effect	NOUN
ct-9353	249	14	of	of	ADP
ct-9353	249	15	the	the	DET
ct-9353	249	16	levonorgestrel	levonorgestrel	NOUN
ct-9353	249	17	intrauterine	intrauterine	ADJ
ct-9353	249	18	device	device	NOUN
ct-9353	249	19	on	on	ADP
ct-9353	249	20	genital	genital	ADJ
ct-9353	249	21	hiv-1	hiv-1	X
ct-9353	249	22	rna	rna	NOUN
ct-9353	249	23	shedding	shedding	NOUN
ct-9353	249	24	among	among	ADP
ct-9353	249	25	hiv-1infected	hiv-1infected	ADJ
ct-9353	249	26	women	woman	NOUN
ct-9353	249	27	not	not	PART
ct-9353	249	28	taking	take	VERB
ct-9353	249	29	antiretroviral	antiretroviral	ADJ
ct-9353	249	30	therapy	therapy	NOUN
ct-9353	249	31	in	in	ADP
ct-9353	249	32	nairobi	nairobi	PROPN
ct-9353	249	33	,	,	PUNCT
ct-9353	249	34	kenya	kenya	PROPN
ct-9353	249	35	.	.	PUNCT
ct-9353	250	1	j	j	PROPN
ct-9353	250	2	acquir	acquir	PROPN
ct-9353	250	3	immune	immune	VERB
ct-9353	250	4	defic	defic	ADJ
ct-9353	250	5	syndr	syndr	NOUN
ct-9353	250	6	2013;63:245	2013;63:245	NOUN
ct-9353	250	7	-	-	SYM
ct-9353	250	8	248	248	NUM
ct-9353	250	9	.	.	PUNCT
ct-9353	251	1	67	67	NUM
ct-9353	251	2	.	.	PUNCT
ct-9353	251	3	eastman	eastman	PROPN
ct-9353	251	4	aj	aj	PROPN
ct-9353	251	5	,	,	PUNCT
ct-9353	251	6	bergin	bergin	PROPN
ct-9353	251	7	il	il	PROPN
ct-9353	251	8	,	,	PUNCT
ct-9353	251	9	chai	chai	NOUN
ct-9353	251	10	d	d	PROPN
ct-9353	251	11	,	,	PUNCT
ct-9353	251	12	et	et	PROPN
ct-9353	251	13	al	al	PROPN
ct-9353	251	14	:	:	PUNCT
ct-9353	251	15	impact	impact	NOUN
ct-9353	251	16	of	of	ADP
ct-9353	251	17	the	the	DET
ct-9353	251	18	levonorgestrelreleasing	levonorgestrelrelease	VERB
ct-9353	251	19	intrauterine	intrauterine	ADJ
ct-9353	251	20	system	system	NOUN
ct-9353	251	21	on	on	ADP
ct-9353	251	22	the	the	DET
ct-9353	251	23	progression	progression	NOUN
ct-9353	251	24	of	of	ADP
ct-9353	251	25	chlamydia	chlamydia	NOUN
ct-9353	251	26	trachomatis	trachomatis	ADJ
ct-9353	251	27	infection	infection	NOUN
ct-9353	251	28	to	to	PART
ct-9353	251	29	pelvic	pelvic	ADJ
ct-9353	251	30	inflammatory	inflammatory	ADJ
ct-9353	251	31	disease	disease	NOUN
ct-9353	251	32	in	in	ADP
ct-9353	251	33	a	a	DET
ct-9353	251	34	baboon	baboon	NOUN
ct-9353	251	35	model	model	NOUN
ct-9353	251	36	.	.	PUNCT
ct-9353	252	1	j	j	PROPN
ct-9353	252	2	infect	infect	VERB
ct-9353	252	3	dis	dis	PROPN
ct-9353	252	4	2018;217:656	2018;217:656	NUM
ct-9353	252	5	-	-	SYM
ct-9353	252	6	666	666	NUM
ct-9353	252	7	.	.	PUNCT
ct-9353	253	1	68	68	NUM
ct-9353	253	2	.	.	PUNCT
ct-9353	254	1	attardi	attardi	NOUN
ct-9353	254	2	bj	bj	NOUN
ct-9353	254	3	,	,	PUNCT
ct-9353	254	4	zeleznik	zeleznik	X
ct-9353	254	5	a	a	NOUN
ct-9353	254	6	,	,	PUNCT
ct-9353	254	7	simhan	simhan	ADJ
ct-9353	254	8	h	h	NOUN
ct-9353	254	9	,	,	PUNCT
ct-9353	254	10	et	et	PROPN
ct-9353	254	11	al	al	PROPN
ct-9353	254	12	:	:	PUNCT
ct-9353	254	13	comparison	comparison	NOUN
ct-9353	254	14	of	of	ADP
ct-9353	254	15	progesterone	progesterone	NOUN
ct-9353	254	16	and	and	CCONJ
ct-9353	254	17	glucocorticoid	glucocorticoid	ADJ
ct-9353	254	18	receptor	receptor	NOUN
ct-9353	254	19	binding	bind	VERB
ct-9353	254	20	and	and	CCONJ
ct-9353	254	21	stimulation	stimulation	NOUN
ct-9353	254	22	of	of	ADP
ct-9353	254	23	gene	gene	NOUN
ct-9353	254	24	expression	expression	NOUN
ct-9353	254	25	by	by	ADP
ct-9353	254	26	progesterone	progesterone	NOUN
ct-9353	254	27	,	,	PUNCT
ct-9353	254	28	17	17	NUM
ct-9353	254	29	-	-	PUNCT
ct-9353	254	30	alpha	alpha	NOUN
ct-9353	254	31	hydroxyprogesterone	hydroxyprogesterone	NOUN
ct-9353	254	32	caproate	caproate	NOUN
ct-9353	254	33	,	,	PUNCT
ct-9353	254	34	and	and	CCONJ
ct-9353	254	35	related	related	ADJ
ct-9353	254	36	progestins	progestin	NOUN
ct-9353	254	37	.	.	PUNCT
ct-9353	255	1	am	be	AUX
ct-9353	255	2	j	j	PROPN
ct-9353	255	3	obstet	obstet	PROPN
ct-9353	255	4	gynecol	gynecol	PROPN
ct-9353	255	5	2007;197:599	2007;197:599	NUM
ct-9353	255	6	e1	e1	NOUN
ct-9353	255	7	-	-	PUNCT
ct-9353	255	8	7	7	NUM
ct-9353	255	9	.	.	NUM
ct-9353	255	10	69	69	NUM
ct-9353	255	11	.	.	PUNCT
ct-9353	256	1	kontula	kontula	PROPN
ct-9353	256	2	k	k	PROPN
ct-9353	256	3	,	,	PUNCT
ct-9353	256	4	paavonen	paavonen	PROPN
ct-9353	256	5	t	t	PROPN
ct-9353	256	6	,	,	PUNCT
ct-9353	256	7	luukkainen	luukkainen	PROPN
ct-9353	256	8	t	t	PROPN
ct-9353	256	9	,	,	PUNCT
ct-9353	256	10	et	et	PROPN
ct-9353	256	11	al	al	PROPN
ct-9353	256	12	:	:	PUNCT
ct-9353	256	13	binding	bind	VERB
ct-9353	256	14	of	of	ADP
ct-9353	256	15	progestins	progestin	NOUN
ct-9353	256	16	to	to	ADP
ct-9353	256	17	the	the	DET
ct-9353	256	18	glucocorticoid	glucocorticoid	ADJ
ct-9353	256	19	receptor	receptor	NOUN
ct-9353	256	20	.	.	PUNCT
ct-9353	257	1	correlation	correlation	NOUN
ct-9353	257	2	to	to	ADP
ct-9353	257	3	their	their	PRON
ct-9353	257	4	glucocorticoid	glucocorticoid	ADJ
ct-9353	257	5	-	-	PUNCT
ct-9353	257	6	like	like	ADJ
ct-9353	257	7	effects	effect	NOUN
ct-9353	257	8	on	on	ADP
ct-9353	257	9	in	in	ADP
ct-9353	257	10	vitro	vitro	X
ct-9353	257	11	functions	function	NOUN
ct-9353	257	12	of	of	ADP
ct-9353	257	13	human	human	ADJ
ct-9353	257	14	mononuclear	mononuclear	ADJ
ct-9353	257	15	leukocytes	leukocyte	NOUN
ct-9353	257	16	.	.	PUNCT
ct-9353	258	1	biochem	biochem	PROPN
ct-9353	258	2	pharmacol	pharmacol	VERB
ct-9353	258	3	1983;32:1511	1983;32:1511	NUM
ct-9353	258	4	-	-	SYM
ct-9353	258	5	1518	1518	NUM
ct-9353	258	6	.	.	PUNCT
ct-9353	259	1	70	70	NUM
ct-9353	259	2	.	.	PUNCT
ct-9353	260	1	huijbregts	huijbregts	PROPN
ct-9353	260	2	rp	rp	PROPN
ct-9353	260	3	,	,	PUNCT
ct-9353	260	4	helton	helton	PROPN
ct-9353	260	5	es	es	PROPN
ct-9353	260	6	,	,	PUNCT
ct-9353	260	7	michel	michel	PROPN
ct-9353	260	8	kg	kg	PROPN
ct-9353	260	9	,	,	PUNCT
ct-9353	260	10	et	et	PROPN
ct-9353	260	11	al	al	PROPN
ct-9353	260	12	:	:	PUNCT
ct-9353	260	13	hormonal	hormonal	ADJ
ct-9353	260	14	contraception	contraception	NOUN
ct-9353	260	15	and	and	CCONJ
ct-9353	260	16	hiv-1	hiv-1	PUNCT
ct-9353	260	17	infection	infection	NOUN
ct-9353	260	18	:	:	PUNCT
ct-9353	260	19	medroxyprogesterone	medroxyprogesterone	NOUN
ct-9353	260	20	acetate	acetate	NOUN
ct-9353	260	21	suppresses	suppress	VERB
ct-9353	260	22	innate	innate	ADJ
ct-9353	260	23	and	and	CCONJ
ct-9353	260	24	adaptive	adaptive	ADJ
ct-9353	260	25	immune	immune	ADJ
ct-9353	260	26	mechanisms	mechanism	NOUN
ct-9353	260	27	.	.	PUNCT
ct-9353	261	1	endocrinology	endocrinology	NOUN
ct-9353	261	2	.	.	PUNCT
ct-9353	262	1	2013;154:1282	2013;154:1282	NUM
ct-9353	262	2	-	-	SYM
ct-9353	262	3	1295	1295	NUM
ct-9353	262	4	.	.	PUNCT
ct-9353	263	1	71	71	NUM
ct-9353	263	2	.	.	PUNCT
ct-9353	263	3	lavreys	lavreys	PROPN
ct-9353	263	4	l	l	PROPN
ct-9353	263	5	,	,	PUNCT
ct-9353	263	6	chohan	chohan	PROPN
ct-9353	263	7	v	v	PROPN
ct-9353	263	8	,	,	PUNCT
ct-9353	263	9	overbaugh	overbaugh	PROPN
ct-9353	263	10	j	j	PROPN
ct-9353	263	11	,	,	PUNCT
ct-9353	263	12	et	et	PROPN
ct-9353	263	13	al	al	PROPN
ct-9353	263	14	:	:	PUNCT
ct-9353	263	15	hormonal	hormonal	ADJ
ct-9353	263	16	contraception	contraception	NOUN
ct-9353	263	17	and	and	CCONJ
ct-9353	263	18	risk	risk	NOUN
ct-9353	263	19	of	of	ADP
ct-9353	263	20	cervical	cervical	ADJ
ct-9353	263	21	infections	infection	NOUN
ct-9353	263	22	among	among	ADP
ct-9353	263	23	hiv-1	hiv-1	ADJ
ct-9353	263	24	-	-	PUNCT
ct-9353	263	25	seropositive	seropositive	ADJ
ct-9353	263	26	kenyan	kenyan	ADJ
ct-9353	263	27	women	woman	NOUN
ct-9353	263	28	.	.	PUNCT
ct-9353	264	1	aids	aids	PROPN
ct-9353	264	2	2004;18:2179	2004;18:2179	PROPN
ct-9353	264	3	-	-	SYM
ct-9353	264	4	2184	2184	NUM
ct-9353	264	5	.	.	PUNCT
ct-9353	265	1	72	72	NUM
ct-9353	265	2	.	.	PUNCT
ct-9353	266	1	lavreys	lavreys	PROPN
ct-9353	266	2	l	l	PROPN
ct-9353	266	3	,	,	PUNCT
ct-9353	266	4	baeten	baeten	VERB
ct-9353	266	5	jm	jm	PROPN
ct-9353	266	6	,	,	PUNCT
ct-9353	266	7	martin	martin	PROPN
ct-9353	266	8	hl	hl	PROPN
ct-9353	266	9	,	,	PUNCT
ct-9353	266	10	jr	jr	PROPN
ct-9353	266	11	.	.	PROPN
ct-9353	266	12	,	,	PUNCT
ct-9353	266	13	et	et	PROPN
ct-9353	266	14	al	al	PROPN
ct-9353	266	15	:	:	PUNCT
ct-9353	266	16	hormonal	hormonal	ADJ
ct-9353	266	17	contraception	contraception	NOUN
ct-9353	266	18	and	and	CCONJ
ct-9353	266	19	risk	risk	NOUN
ct-9353	266	20	of	of	ADP
ct-9353	266	21	hiv-1	hiv-1	X
ct-9353	266	22	acquisition	acquisition	NOUN
ct-9353	266	23	:	:	PUNCT
ct-9353	266	24	results	result	NOUN
ct-9353	266	25	of	of	ADP
ct-9353	266	26	a	a	DET
ct-9353	266	27	10	10	NUM
ct-9353	266	28	-	-	PUNCT
ct-9353	266	29	year	year	NOUN
ct-9353	266	30	prospective	prospective	ADJ
ct-9353	266	31	study	study	NOUN
ct-9353	266	32	.	.	PUNCT
ct-9353	267	1	aids	aids	PROPN
ct-9353	267	2	2004;18:695	2004;18:695	PROPN
ct-9353	267	3	-	-	SYM
ct-9353	267	4	697	697	NUM
ct-9353	267	5	.	.	PUNCT
ct-9353	267	6	73	73	NUM
ct-9353	267	7	.	.	PUNCT
ct-9353	268	1	lavreys	lavreys	PROPN
ct-9353	268	2	l	l	PROPN
ct-9353	268	3	,	,	PUNCT
ct-9353	268	4	baeten	baeten	PROPN
ct-9353	268	5	jm	jm	PROPN
ct-9353	268	6	,	,	PUNCT
ct-9353	268	7	kreiss	kreiss	PROPN
ct-9353	268	8	jk	jk	PROPN
ct-9353	268	9	,	,	PUNCT
ct-9353	268	10	et	et	PROPN
ct-9353	268	11	al	al	PROPN
ct-9353	268	12	:	:	PUNCT
ct-9353	268	13	injectable	injectable	ADJ
ct-9353	268	14	contraceptive	contraceptive	ADJ
ct-9353	268	15	use	use	NOUN
ct-9353	268	16	and	and	CCONJ
ct-9353	268	17	genital	genital	ADJ
ct-9353	268	18	ulcer	ulcer	NOUN
ct-9353	268	19	disease	disease	NOUN
ct-9353	268	20	during	during	ADP
ct-9353	268	21	the	the	DET
ct-9353	268	22	early	early	ADJ
ct-9353	268	23	phase	phase	NOUN
ct-9353	268	24	of	of	ADP
ct-9353	268	25	hiv-1	hiv-1	PUNCT
ct-9353	268	26	infection	infection	NOUN
ct-9353	268	27	increase	increase	NOUN
ct-9353	268	28	plasma	plasma	NOUN
ct-9353	268	29	virus	virus	NOUN
ct-9353	268	30	load	load	NOUN
ct-9353	268	31	in	in	ADP
ct-9353	268	32	women	woman	NOUN
ct-9353	268	33	.	.	PUNCT
ct-9353	269	1	j	j	PROPN
ct-9353	269	2	infect	infect	VERB
ct-9353	269	3	dis	dis	PROPN
ct-9353	269	4	2004;189:303	2004;189:303	NUM
ct-9353	269	5	-	-	SYM
ct-9353	269	6	311	311	NUM
ct-9353	269	7	.	.	PUNCT
ct-9353	270	1	74	74	NUM
ct-9353	270	2	.	.	PUNCT
ct-9353	271	1	mcclelland	mcclelland	ADJ
ct-9353	271	2	rs	rs	NOUN
ct-9353	271	3	,	,	PUNCT
ct-9353	271	4	lavreys	lavrey	VERB
ct-9353	271	5	l	l	NOUN
ct-9353	271	6	,	,	PUNCT
ct-9353	271	7	katingima	katingima	NOUN
ct-9353	271	8	c	c	NOUN
ct-9353	271	9	,	,	PUNCT
ct-9353	271	10	et	et	PROPN
ct-9353	271	11	al	al	PROPN
ct-9353	271	12	:	:	PUNCT
ct-9353	271	13	contribution	contribution	NOUN
ct-9353	271	14	of	of	ADP
ct-9353	271	15	hiv-1	hiv-1	ADJ
ct-9353	271	16	infection	infection	NOUN
ct-9353	271	17	to	to	ADP
ct-9353	271	18	acquisition	acquisition	NOUN
ct-9353	271	19	of	of	ADP
ct-9353	271	20	sexually	sexually	ADV
ct-9353	271	21	transmitted	transmit	VERB
ct-9353	271	22	disease	disease	NOUN
ct-9353	271	23	:	:	PUNCT
ct-9353	271	24	a	a	DET
ct-9353	271	25	10	10	NUM
ct-9353	271	26	-	-	PUNCT
ct-9353	271	27	year	year	NOUN
ct-9353	271	28	prospective	prospective	ADJ
ct-9353	271	29	study	study	NOUN
ct-9353	271	30	.	.	PUNCT
ct-9353	272	1	j	j	PROPN
ct-9353	272	2	infect	infect	VERB
ct-9353	272	3	dis	dis	PROPN
ct-9353	272	4	2005;191:333	2005;191:333	NUM
ct-9353	272	5	-	-	SYM
ct-9353	272	6	338	338	NUM
ct-9353	272	7	.	.	PUNCT
ct-9353	273	1	clinical	clinical	ADJ
ct-9353	273	2	theriogenology	theriogenology	NOUN
ct-9353	273	3	2021	2021	NUM
ct-9353	273	4	;	;	PUNCT
ct-9353	273	5	13	13	NUM
ct-9353	273	6	:	:	SYM
ct-9353	273	7	253	253	NUM
ct-9353	273	8	75	75	NUM
ct-9353	273	9	.	.	PUNCT
ct-9353	274	1	ralph	ralph	PROPN
ct-9353	274	2	lj	lj	PROPN
ct-9353	274	3	,	,	PUNCT
ct-9353	274	4	mccoy	mccoy	PROPN
ct-9353	274	5	si	si	PROPN
ct-9353	274	6	,	,	PUNCT
ct-9353	274	7	shiu	shiu	PROPN
ct-9353	274	8	k	k	PROPN
ct-9353	274	9	,	,	PUNCT
ct-9353	274	10	et	et	PROPN
ct-9353	274	11	al	al	PROPN
ct-9353	274	12	:	:	PUNCT
ct-9353	274	13	hormonal	hormonal	ADJ
ct-9353	274	14	contraceptive	contraceptive	NOUN
ct-9353	274	15	use	use	NOUN
ct-9353	274	16	and	and	CCONJ
ct-9353	274	17	women	woman	NOUN
ct-9353	274	18	’s	’s	PART
ct-9353	274	19	risk	risk	NOUN
ct-9353	274	20	of	of	ADP
ct-9353	274	21	hiv	hiv	PROPN
ct-9353	274	22	acquisition	acquisition	PROPN
ct-9353	274	23	:	:	PUNCT
ct-9353	274	24	a	a	DET
ct-9353	274	25	meta	meta	ADJ
ct-9353	274	26	-	-	PUNCT
ct-9353	274	27	analysis	analysis	NOUN
ct-9353	274	28	of	of	ADP
ct-9353	274	29	observational	observational	ADJ
ct-9353	274	30	studies	study	NOUN
ct-9353	274	31	.	.	PUNCT
ct-9353	275	1	lancet	lancet	PROPN
ct-9353	275	2	infect	infect	PROPN
ct-9353	275	3	dis	dis	PROPN
ct-9353	275	4	2015;15:181	2015;15:181	PROPN
ct-9353	275	5	-	-	SYM
ct-9353	275	6	189	189	NUM
ct-9353	275	7	.	.	PUNCT
ct-9353	276	1	76	76	NUM
ct-9353	276	2	.	.	PUNCT
ct-9353	277	1	quispe	quispe	PROPN
ct-9353	277	2	calla	calla	PROPN
ct-9353	277	3	ne	ne	PROPN
ct-9353	277	4	,	,	PUNCT
ct-9353	277	5	vicetti	vicetti	PROPN
ct-9353	277	6	miguel	miguel	PROPN
ct-9353	277	7	rd	rd	PROPN
ct-9353	277	8	,	,	PUNCT
ct-9353	277	9	boyaka	boyaka	PROPN
ct-9353	277	10	pn	pn	PROPN
ct-9353	277	11	,	,	PUNCT
ct-9353	277	12	et	et	PROPN
ct-9353	277	13	al	al	PROPN
ct-9353	277	14	:	:	PUNCT
ct-9353	277	15	medroxyprogesterone	medroxyprogesterone	NOUN
ct-9353	277	16	acetate	acetate	NOUN
ct-9353	277	17	and	and	CCONJ
ct-9353	277	18	levonorgestrel	levonorgestrel	NOUN
ct-9353	277	19	increase	increase	VERB
ct-9353	277	20	genital	genital	ADJ
ct-9353	277	21	mucosal	mucosal	NOUN
ct-9353	277	22	permeability	permeability	NOUN
ct-9353	277	23	and	and	CCONJ
ct-9353	277	24	enhance	enhance	VERB
ct-9353	277	25	susceptibility	susceptibility	NOUN
ct-9353	277	26	to	to	ADP
ct-9353	277	27	genital	genital	ADJ
ct-9353	277	28	herpes	herpe	NOUN
ct-9353	277	29	simplex	simplex	NOUN
ct-9353	277	30	virus	virus	NOUN
ct-9353	277	31	type	type	NOUN
ct-9353	277	32	2	2	NUM
ct-9353	277	33	infection	infection	NOUN
ct-9353	277	34	.	.	PUNCT
ct-9353	278	1	mucosal	mucosal	ADJ
ct-9353	278	2	immunol	immunol	NOUN
ct-9353	278	3	2016;9:1571	2016;9:1571	NUM
ct-9353	278	4	-	-	SYM
ct-9353	278	5	1583	1583	NUM
ct-9353	278	6	.	.	PUNCT
ct-9353	279	1	77	77	NUM
ct-9353	279	2	.	.	PUNCT
ct-9353	280	1	kaushic	kaushic	PROPN
ct-9353	280	2	c	c	X
ct-9353	280	3	,	,	PUNCT
ct-9353	280	4	ashkar	ashkar	PROPN
ct-9353	280	5	aa	aa	PROPN
ct-9353	280	6	,	,	PUNCT
ct-9353	280	7	reid	reid	PROPN
ct-9353	280	8	la	la	PROPN
ct-9353	280	9	,	,	PUNCT
ct-9353	280	10	et	et	PROPN
ct-9353	280	11	al	al	PROPN
ct-9353	280	12	:	:	PUNCT
ct-9353	280	13	progesterone	progesterone	NOUN
ct-9353	280	14	increases	increase	VERB
ct-9353	280	15	susceptibility	susceptibility	NOUN
ct-9353	280	16	and	and	CCONJ
ct-9353	280	17	decreases	decrease	VERB
ct-9353	280	18	immune	immune	ADJ
ct-9353	280	19	responses	response	NOUN
ct-9353	280	20	to	to	ADP
ct-9353	280	21	genital	genital	ADJ
ct-9353	280	22	herpes	herpe	NOUN
ct-9353	280	23	infection	infection	NOUN
ct-9353	280	24	.	.	PUNCT
ct-9353	281	1	j	j	PROPN
ct-9353	281	2	virol	virol	PROPN
ct-9353	281	3	.	.	PUNCT
ct-9353	282	1	2003;77:4558	2003;77:4558	NUM
ct-9353	282	2	-	-	SYM
ct-9353	282	3	4565	4565	NUM
ct-9353	282	4	.	.	PUNCT
ct-9353	283	1	78	78	NUM
ct-9353	283	2	.	.	PUNCT
ct-9353	283	3	gillgrass	gillgrass	PROPN
ct-9353	283	4	ae	ae	PROPN
ct-9353	283	5	,	,	PUNCT
ct-9353	283	6	fernandez	fernandez	PROPN
ct-9353	283	7	sa	sa	PROPN
ct-9353	283	8	,	,	PUNCT
ct-9353	283	9	rosenthal	rosenthal	PROPN
ct-9353	283	10	kl	kl	PROPN
ct-9353	283	11	,	,	PUNCT
ct-9353	283	12	et	et	PROPN
ct-9353	283	13	al	al	PROPN
ct-9353	283	14	:	:	PUNCT
ct-9353	283	15	estradiol	estradiol	PROPN
ct-9353	283	16	regulates	regulate	VERB
ct-9353	283	17	susceptibility	susceptibility	NOUN
ct-9353	283	18	following	follow	VERB
ct-9353	283	19	primary	primary	ADJ
ct-9353	283	20	exposure	exposure	NOUN
ct-9353	283	21	to	to	ADP
ct-9353	283	22	genital	genital	ADJ
ct-9353	283	23	herpes	herpe	NOUN
ct-9353	283	24	simplex	simplex	NOUN
ct-9353	283	25	virus	virus	NOUN
ct-9353	283	26	type	type	NOUN
ct-9353	283	27	2	2	NUM
ct-9353	283	28	,	,	PUNCT
ct-9353	283	29	while	while	SCONJ
ct-9353	283	30	progesterone	progesterone	NOUN
ct-9353	283	31	induces	induce	VERB
ct-9353	283	32	inflammation	inflammation	NOUN
ct-9353	283	33	.	.	PUNCT
ct-9353	284	1	j	j	PROPN
ct-9353	284	2	virol	virol	PROPN
ct-9353	284	3	2005;79:3107	2005;79:3107	PROPN
ct-9353	284	4	-	-	SYM
ct-9353	284	5	3116	3116	NUM
ct-9353	284	6	.	.	PUNCT
ct-9353	285	1	79	79	NUM
ct-9353	285	2	.	.	PUNCT
ct-9353	286	1	kaushic	kaushic	PROPN
ct-9353	286	2	c	c	X
ct-9353	286	3	,	,	PUNCT
ct-9353	286	4	zhou	zhou	PROPN
ct-9353	286	5	f	f	X
ct-9353	286	6	,	,	PUNCT
ct-9353	286	7	murdin	murdin	VERB
ct-9353	286	8	ad	ad	NOUN
ct-9353	286	9	,	,	PUNCT
ct-9353	286	10	et	et	PROPN
ct-9353	286	11	al	al	PROPN
ct-9353	286	12	:	:	PUNCT
ct-9353	286	13	effects	effect	NOUN
ct-9353	286	14	of	of	ADP
ct-9353	286	15	estradiol	estradiol	PROPN
ct-9353	286	16	and	and	CCONJ
ct-9353	286	17	progesterone	progesterone	VERB
ct-9353	286	18	on	on	ADP
ct-9353	286	19	susceptibility	susceptibility	NOUN
ct-9353	286	20	and	and	CCONJ
ct-9353	286	21	early	early	ADJ
ct-9353	286	22	immune	immune	ADJ
ct-9353	286	23	responses	response	NOUN
ct-9353	286	24	to	to	ADP
ct-9353	286	25	chlamydia	chlamydia	NOUN
ct-9353	286	26	trachomatis	trachomatis	ADJ
ct-9353	286	27	infection	infection	NOUN
ct-9353	286	28	in	in	ADP
ct-9353	286	29	the	the	DET
ct-9353	286	30	female	female	ADJ
ct-9353	286	31	reproductive	reproductive	ADJ
ct-9353	286	32	tract	tract	NOUN
ct-9353	286	33	.	.	PUNCT
ct-9353	287	1	infect	infect	VERB
ct-9353	287	2	immun	immun	PROPN
ct-9353	287	3	2000;68:4207	2000;68:4207	PROPN
ct-9353	287	4	-	-	SYM
ct-9353	287	5	4216	4216	NUM
ct-9353	287	6	.	.	PUNCT
ct-9353	288	1	80	80	NUM
ct-9353	288	2	.	.	PUNCT
ct-9353	289	1	kaushic	kaushic	PROPN
ct-9353	289	2	c	c	X
ct-9353	289	3	,	,	PUNCT
ct-9353	289	4	murdin	murdin	VERB
ct-9353	289	5	ad	ad	NOUN
ct-9353	289	6	,	,	PUNCT
ct-9353	289	7	underdown	underdown	ADJ
ct-9353	289	8	bj	bj	NOUN
ct-9353	289	9	,	,	PUNCT
ct-9353	289	10	et	et	PROPN
ct-9353	289	11	al	al	PROPN
ct-9353	289	12	:	:	PUNCT
ct-9353	289	13	chlamydia	chlamydia	NOUN
ct-9353	289	14	trachomatis	trachomatis	ADJ
ct-9353	289	15	infection	infection	NOUN
ct-9353	289	16	in	in	ADP
ct-9353	289	17	the	the	DET
ct-9353	289	18	female	female	ADJ
ct-9353	289	19	reproductive	reproductive	ADJ
ct-9353	289	20	tract	tract	NOUN
ct-9353	289	21	of	of	ADP
ct-9353	289	22	the	the	DET
ct-9353	289	23	rat	rat	NOUN
ct-9353	289	24	:	:	PUNCT
ct-9353	289	25	influence	influence	NOUN
ct-9353	289	26	of	of	ADP
ct-9353	289	27	progesterone	progesterone	NOUN
ct-9353	289	28	on	on	ADP
ct-9353	289	29	infectivity	infectivity	NOUN
ct-9353	289	30	and	and	CCONJ
ct-9353	289	31	immune	immune	ADJ
ct-9353	289	32	response	response	NOUN
ct-9353	289	33	.	.	PUNCT
ct-9353	290	1	infect	infect	VERB
ct-9353	290	2	immun	immun	PROPN
ct-9353	290	3	1998;66:893	1998;66:893	PROPN
ct-9353	290	4	-	-	PUNCT
ct-9353	290	5	898	898	NUM
ct-9353	290	6	.	.	PUNCT
ct-9353	291	1	81	81	NUM
ct-9353	291	2	.	.	PUNCT
ct-9353	292	1	xu	xu	PROPN
ct-9353	293	1	l	l	PROPN
ct-9353	293	2	,	,	PUNCT
ct-9353	293	3	dong	dong	PROPN
ct-9353	293	4	b	b	PROPN
ct-9353	293	5	,	,	PUNCT
ct-9353	293	6	wang	wang	PROPN
ct-9353	293	7	h	h	PROPN
ct-9353	293	8	,	,	PUNCT
ct-9353	293	9	et	et	PROPN
ct-9353	293	10	al	al	PROPN
ct-9353	293	11	:	:	PUNCT
ct-9353	293	12	progesterone	progesterone	NOUN
ct-9353	293	13	suppresses	suppress	VERB
ct-9353	293	14	th17	th17	PROPN
ct-9353	293	15	cell	cell	NOUN
ct-9353	293	16	responses	response	NOUN
ct-9353	293	17	,	,	PUNCT
ct-9353	293	18	and	and	CCONJ
ct-9353	293	19	enhances	enhance	VERB
ct-9353	293	20	the	the	DET
ct-9353	293	21	development	development	NOUN
ct-9353	293	22	of	of	ADP
ct-9353	293	23	regulatory	regulatory	ADJ
ct-9353	293	24	t	t	NOUN
ct-9353	293	25	cells	cell	NOUN
ct-9353	293	26	,	,	PUNCT
ct-9353	293	27	through	through	ADP
ct-9353	293	28	thymic	thymic	ADJ
ct-9353	293	29	stromal	stromal	ADJ
ct-9353	293	30	lymphopoietin	lymphopoietin	NOUN
ct-9353	293	31	-	-	PUNCT
ct-9353	293	32	dependent	dependent	ADJ
ct-9353	293	33	mechanisms	mechanism	NOUN
ct-9353	293	34	in	in	ADP
ct-9353	293	35	experimental	experimental	ADJ
ct-9353	293	36	gonococcal	gonococcal	ADJ
ct-9353	293	37	genital	genital	ADJ
ct-9353	293	38	tract	tract	NOUN
ct-9353	293	39	infection	infection	NOUN
ct-9353	293	40	.	.	PUNCT
ct-9353	294	1	microbes	microbe	NOUN
ct-9353	294	2	infect	infect	VERB
ct-9353	294	3	2013;15:796	2013;15:796	NUM
ct-9353	294	4	-	-	SYM
ct-9353	294	5	805	805	NUM
ct-9353	294	6	.	.	PUNCT
ct-9353	295	1	82	82	NUM
ct-9353	295	2	.	.	PUNCT
ct-9353	296	1	hall	hall	PROPN
ct-9353	296	2	oj	oj	PROPN
ct-9353	296	3	,	,	PUNCT
ct-9353	296	4	limjunyawong	limjunyawong	PROPN
ct-9353	296	5	n	n	X
ct-9353	296	6	,	,	PUNCT
ct-9353	296	7	vermillion	vermillion	PROPN
ct-9353	296	8	ms	ms	PROPN
ct-9353	296	9	,	,	PUNCT
ct-9353	296	10	et	et	PROPN
ct-9353	296	11	al	al	PROPN
ct-9353	296	12	:	:	PUNCT
ct-9353	296	13	progesterone	progesterone	NOUN
ct-9353	296	14	-	-	PUNCT
ct-9353	296	15	based	base	VERB
ct-9353	296	16	therapy	therapy	NOUN
ct-9353	296	17	protects	protect	VERB
ct-9353	296	18	against	against	ADP
ct-9353	296	19	influenza	influenza	NOUN
ct-9353	296	20	by	by	ADP
ct-9353	296	21	promoting	promote	VERB
ct-9353	296	22	lung	lung	NOUN
ct-9353	296	23	repair	repair	NOUN
ct-9353	296	24	and	and	CCONJ
ct-9353	296	25	recovery	recovery	NOUN
ct-9353	296	26	in	in	ADP
ct-9353	296	27	females	female	NOUN
ct-9353	296	28	.	.	PUNCT
ct-9353	297	1	plos	plos	PROPN
ct-9353	297	2	pathog	pathog	VERB
ct-9353	297	3	2016;12	2016;12	NUM
ct-9353	297	4	:	:	PUNCT
ct-9353	297	5	e1005840	e1005840	NUM
ct-9353	297	6	.	.	PUNCT
ct-9353	297	7	83	83	NUM
ct-9353	297	8	.	.	PUNCT
ct-9353	298	1	fedorka	fedorka	PROPN
ct-9353	298	2	ce	ce	PROPN
ct-9353	298	3	,	,	PUNCT
ct-9353	298	4	ball	ball	PROPN
ct-9353	298	5	ba	ba	PROPN
ct-9353	298	6	,	,	PUNCT
ct-9353	298	7	walker	walker	PROPN
ct-9353	298	8	of	of	ADP
ct-9353	298	9	,	,	PUNCT
ct-9353	298	10	et	et	PROPN
ct-9353	298	11	al	al	PROPN
ct-9353	298	12	:	:	PUNCT
ct-9353	298	13	alteration	alteration	NOUN
ct-9353	298	14	of	of	ADP
ct-9353	298	15	the	the	DET
ct-9353	298	16	mare	mare	NOUN
ct-9353	298	17	’s	’s	PART
ct-9353	298	18	immune	immune	ADJ
ct-9353	298	19	system	system	NOUN
ct-9353	298	20	by	by	ADP
ct-9353	298	21	the	the	DET
ct-9353	298	22	synthetic	synthetic	ADJ
ct-9353	298	23	progestin	progestin	NOUN
ct-9353	298	24	,	,	PUNCT
ct-9353	298	25	altrenogest	altrenogest	PROPN
ct-9353	298	26	.	.	PUNCT
ct-9353	298	27	am	be	AUX
ct-9353	298	28	j	j	PROPN
ct-9353	298	29	reprod	reprod	PROPN
ct-9353	298	30	immunol	immunol	PROPN
ct-9353	298	31	2019	2019	NUM
ct-9353	298	32	:	:	PUNCT
ct-9353	298	33	e13145	e13145	VERB
ct-9353	298	34	.	.	PUNCT
ct-9353	299	1	84	84	NUM
ct-9353	299	2	.	.	PUNCT
ct-9353	300	1	montes	montes	PROPN
ct-9353	300	2	aj	aj	PROPN
ct-9353	300	3	,	,	PUNCT
ct-9353	300	4	montes	montes	PROPN
ct-9353	300	5	lf	lf	PROPN
ct-9353	300	6	,	,	PUNCT
ct-9353	300	7	vaughan	vaughan	PROPN
ct-9353	300	8	jt	jt	PROPN
ct-9353	300	9	,	,	PUNCT
ct-9353	300	10	et	et	PROPN
ct-9353	300	11	al	al	PROPN
ct-9353	300	12	:	:	PUNCT
ct-9353	300	13	vulvo	vulvo	ADP
ct-9353	300	14	vaginal	vaginal	ADJ
ct-9353	300	15	candidiasis	candidiasis	NOUN
ct-9353	300	16	in	in	ADP
ct-9353	300	17	thoroughbred	thoroughbred	ADJ
ct-9353	300	18	mares	mare	NOUN
ct-9353	300	19	following	follow	VERB
ct-9353	300	20	progestogen	progestogen	PROPN
ct-9353	300	21	administration	administration	NOUN
ct-9353	300	22	intravaginal	intravaginal	ADJ
ct-9353	300	23	treatment	treatment	NOUN
ct-9353	300	24	with	with	ADP
ct-9353	300	25	clotrimazole	clotrimazole	NOUN
ct-9353	300	26	.	.	PUNCT
ct-9353	301	1	j	j	PROPN
ct-9353	301	2	equine	equine	PROPN
ct-9353	301	3	vet	vet	PROPN
ct-9353	301	4	sci	sci	PROPN
ct-9353	301	5	.	.	PUNCT
ct-9353	302	1	2001;21:68	2001;21:68	NUM
ct-9353	302	2	-	-	SYM
ct-9353	302	3	70	70	NUM
ct-9353	302	4	.	.	PUNCT
ct-9353	302	5	85	85	NUM
ct-9353	302	6	.	.	PUNCT
ct-9353	303	1	palm	palm	NOUN
ct-9353	303	2	f	f	PROPN
ct-9353	303	3	,	,	PUNCT
ct-9353	303	4	walter	walter	PROPN
ct-9353	303	5	i	i	PROPN
ct-9353	303	6	,	,	PUNCT
ct-9353	303	7	nowotny	nowotny	PROPN
ct-9353	303	8	n	n	CCONJ
ct-9353	303	9	,	,	PUNCT
ct-9353	303	10	et	et	PROPN
ct-9353	303	11	al	al	PROPN
ct-9353	303	12	:	:	PUNCT
ct-9353	303	13	progestin	progestin	NOUN
ct-9353	303	14	treatment	treatment	NOUN
ct-9353	303	15	does	do	AUX
ct-9353	303	16	not	not	PART
ct-9353	303	17	affect	affect	VERB
ct-9353	303	18	expression	expression	NOUN
ct-9353	303	19	of	of	ADP
ct-9353	303	20	cytokines	cytokine	NOUN
ct-9353	303	21	,	,	PUNCT
ct-9353	303	22	steroid	steroid	NOUN
ct-9353	303	23	receptors	receptor	NOUN
ct-9353	303	24	,	,	PUNCT
ct-9353	303	25	oxytocin	oxytocin	NOUN
ct-9353	303	26	receptor	receptor	NOUN
ct-9353	303	27	,	,	PUNCT
ct-9353	303	28	and	and	CCONJ
ct-9353	303	29	cyclooxygenase	cyclooxygenase	NOUN
ct-9353	303	30	2	2	NUM
ct-9353	303	31	in	in	ADP
ct-9353	303	32	fetal	fetal	ADJ
ct-9353	303	33	membranes	membrane	NOUN
ct-9353	303	34	and	and	CCONJ
ct-9353	303	35	endometrium	endometrium	NOUN
ct-9353	303	36	from	from	ADP
ct-9353	303	37	pony	pony	ADJ
ct-9353	303	38	mares	mare	NOUN
ct-9353	303	39	at	at	ADP
ct-9353	303	40	parturition	parturition	NOUN
ct-9353	303	41	.	.	PUNCT
ct-9353	304	1	theriogenology	theriogenology	NOUN
ct-9353	304	2	2013;79:59	2013;79:59	NUM
ct-9353	304	3	-	-	SYM
ct-9353	304	4	68	68	NUM
ct-9353	304	5	.	.	PUNCT
ct-9353	305	1	86	86	NUM
ct-9353	305	2	.	.	PUNCT
ct-9353	306	1	willmann	willmann	PROPN
ct-9353	306	2	c	c	PROPN
ct-9353	306	3	,	,	PUNCT
ct-9353	306	4	budik	budik	PROPN
ct-9353	306	5	s	s	PROPN
ct-9353	306	6	,	,	PUNCT
ct-9353	306	7	walter	walter	PROPN
ct-9353	306	8	i	i	PROPN
ct-9353	306	9	,	,	PUNCT
ct-9353	306	10	et	et	PROPN
ct-9353	306	11	al	al	PROPN
ct-9353	306	12	:	:	PUNCT
ct-9353	306	13	influences	influence	NOUN
ct-9353	306	14	of	of	ADP
ct-9353	306	15	treatment	treatment	NOUN
ct-9353	306	16	of	of	ADP
ct-9353	306	17	early	early	ADJ
ct-9353	306	18	pregnant	pregnant	ADJ
ct-9353	306	19	mares	mare	NOUN
ct-9353	306	20	with	with	ADP
ct-9353	306	21	the	the	DET
ct-9353	306	22	progestin	progestin	NOUN
ct-9353	306	23	altrenogest	altrenogest	ADV
ct-9353	306	24	on	on	ADP
ct-9353	306	25	embryonic	embryonic	ADJ
ct-9353	306	26	development	development	NOUN
ct-9353	306	27	and	and	CCONJ
ct-9353	306	28	gene	gene	NOUN
ct-9353	306	29	expression	expression	NOUN
ct-9353	306	30	in	in	ADP
ct-9353	306	31	the	the	DET
ct-9353	306	32	endometrium	endometrium	NOUN
ct-9353	306	33	and	and	CCONJ
ct-9353	306	34	conceptus	conceptus	NOUN
ct-9353	306	35	.	.	PUNCT
ct-9353	307	1	theriogenology	theriogenology	NOUN
ct-9353	307	2	2011;76:61	2011;76:61	NUM
ct-9353	307	3	-	-	SYM
ct-9353	307	4	73	73	NUM
ct-9353	307	5	.	.	PUNCT
ct-9353	307	6	87	87	NUM
ct-9353	307	7	.	.	PUNCT
ct-9353	308	1	lei	lei	PROPN
ct-9353	308	2	k	k	PROPN
ct-9353	308	3	,	,	PUNCT
ct-9353	308	4	georgiou	georgiou	PROPN
ct-9353	308	5	ex	ex	PROPN
ct-9353	308	6	,	,	PUNCT
ct-9353	308	7	chen	chen	PROPN
ct-9353	308	8	l	l	PROPN
ct-9353	308	9	,	,	PUNCT
ct-9353	308	10	et	et	PROPN
ct-9353	308	11	al	al	PROPN
ct-9353	308	12	:	:	PUNCT
ct-9353	308	13	progesterone	progesterone	NOUN
ct-9353	308	14	and	and	CCONJ
ct-9353	308	15	the	the	DET
ct-9353	308	16	repression	repression	NOUN
ct-9353	308	17	of	of	ADP
ct-9353	308	18	myometrial	myometrial	ADJ
ct-9353	308	19	inflammation	inflammation	NOUN
ct-9353	308	20	:	:	PUNCT
ct-9353	308	21	the	the	DET
ct-9353	308	22	roles	role	NOUN
ct-9353	308	23	of	of	ADP
ct-9353	308	24	mkp-1	mkp-1	PUNCT
ct-9353	308	25	and	and	CCONJ
ct-9353	308	26	the	the	DET
ct-9353	308	27	ap-1	ap-1	ADJ
ct-9353	308	28	system	system	NOUN
ct-9353	308	29	.	.	PUNCT
ct-9353	309	1	mol	mol	ADP
ct-9353	309	2	endocrinol	endocrinol	VERB
ct-9353	309	3	2015;29:1454	2015;29:1454	NUM
ct-9353	309	4	-	-	SYM
ct-9353	309	5	1467	1467	NUM
ct-9353	309	6	.	.	PUNCT
ct-9353	310	1	88	88	NUM
ct-9353	310	2	.	.	PUNCT
ct-9353	311	1	neuhauser	neuhauser	PROPN
ct-9353	311	2	s	s	PROPN
ct-9353	311	3	,	,	PUNCT
ct-9353	311	4	palm	palm	NOUN
ct-9353	311	5	f	f	PROPN
ct-9353	311	6	,	,	PUNCT
ct-9353	311	7	ambuehl	ambuehl	PROPN
ct-9353	311	8	f	f	X
ct-9353	311	9	,	,	PUNCT
ct-9353	311	10	et	et	PROPN
ct-9353	311	11	al	al	PROPN
ct-9353	311	12	:	:	PUNCT
ct-9353	311	13	effect	effect	NOUN
ct-9353	311	14	of	of	ADP
ct-9353	311	15	altrenogest	altrenogest	NOUN
ct-9353	311	16	-	-	PUNCT
ct-9353	311	17	treatment	treatment	NOUN
ct-9353	311	18	of	of	ADP
ct-9353	311	19	mares	mare	NOUN
ct-9353	311	20	in	in	ADP
ct-9353	311	21	late	late	ADJ
ct-9353	311	22	gestation	gestation	NOUN
ct-9353	311	23	on	on	ADP
ct-9353	311	24	adrenocortical	adrenocortical	ADJ
ct-9353	311	25	function	function	NOUN
ct-9353	311	26	,	,	PUNCT
ct-9353	311	27	blood	blood	NOUN
ct-9353	311	28	count	count	NOUN
ct-9353	311	29	and	and	CCONJ
ct-9353	311	30	plasma	plasma	NOUN
ct-9353	311	31	electrolytes	electrolyte	NOUN
ct-9353	311	32	in	in	ADP
ct-9353	311	33	their	their	PRON
ct-9353	311	34	foals	foal	NOUN
ct-9353	311	35	.	.	PUNCT
ct-9353	312	1	equine	equine	NOUN
ct-9353	312	2	vet	vet	NOUN
ct-9353	312	3	j	j	PROPN
ct-9353	312	4	2009;41:572	2009;41:572	NOUN
ct-9353	312	5	-	-	PUNCT
ct-9353	312	6	577	577	NUM
ct-9353	312	7	.	.	PUNCT
ct-9353	313	1	clinical	clinical	ADJ
ct-9353	313	2	theriogenology	theriogenology	NOUN
ct-9353	313	3	2021	2021	NUM
ct-9353	313	4	;	;	PUNCT
ct-9353	313	5	13	13	NUM
ct-9353	313	6	:	:	SYM
ct-9353	313	7	254	254	NUM
ct-9353	313	8	progestin	progestin	NOUN
ct-9353	313	9	use	use	NOUN
ct-9353	313	10	in	in	ADP
ct-9353	313	11	mares	mare	NOUN